incivo is used to treat the virus that causes hepatitis c infection . it is used in adults : - to treat chronic hematitis cr infection in patients 1865 years of age or older , who are already taking peginterferon alfa - 2b , ribavirin and telaprevir . inciva belongs to a group of medicines called ns3 - 4a protease inhibitors . the nns 3 - 5a proteotype inhibitor is a type of hepatis b virus , which is already blocked by peg interferon at the moment , but is not approved by the world health organisation . how incive works incivi inhibits the tyrosine - 3a proteal effect in adults who have chronic hpatitistis  
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when used in combination with peginterferon alfa and ribavirin , - because their constraindications ( e . g . pregnancy precautions ) may not be fully effective when used together with peggedinterferone alfA and / or rib virin ( see " pregnancy and breast - feeding "). if this applies to you , tell your doctor before using inciVO . do not use peg interferon at the same time as ribamidine . your doctor may prescribe inciva together with the following medicines which may cause severe side effects , or may be fatal . warnings and precautions 56 talk to your doctor or pharmacist before using the medicine al
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen . the recommended dose regimen is 3 to 6 mg / kg body weight once daily . this means taking the tablets every day for 2 to 8 days ( infusion days ). the recommended dosage regimen is 6 mg per kg bodyweight once daily in combination with both hepatitis c virus infection and human immunodeficiency virus infection . if your doctor is also prescribing you efavirenz , your doctor may prescribe the recommended dosing regimen based on your response . for children 3 to 8 years of age , the recommended daily dose is 3 mg per day in the morning and 8 mg per week in the evening . you should continue incivo as long as your body responds to the medicine . when you start taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , you may get an itchy skin rash that gets worse over time . the rash may not go away or may go away . other symptoms if the rashes gets severe , or if there is a severe skin reaction , tell your doctor immediately . in case you get ever a skin ra , contact your doctor immediate . your doctor may decide to keep you under closer observation or change your rash with other symptoms that may accompany a rash such as : - fever , tiredness - swelling of the face , swelling of lymph glands - a wide - spread rash which may appear as peeling skin , fever - flu - like symptoms , and painful skin . uncommon cases of rash have been reported in patients
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . keep incivo tablets in the bottle in order to protect from moisture . this medicine does not require any special temperature storage conditions . store in the original package in order for the tablets to be stored correctly . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of inciva contains 375 mg of tel apreVir . - other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the active substances are talc , titanium dioxide ( e171 ), iron oxide yellow ( 233 ). what ucivo looks like and contents of the pack film  screen - coated tablets are yellow caplet - shaped tablets , debossed with " tgs " on one side and
the active substance in zinbryta is daclizumab beta , a monoclonal antibody . what zinbeta can be used for zin Brytta belongs to a class of medicines called ' monoclones '. zinblita works by blocking a protein called myelin - 1 receptor ( ms ). what zbrytra is used for and for how zinbyta has been prescribed zin by your doctor is used to treat multiple sclerosis ( mps ) in adults who are undergoing therapy after two mms treatment or who have received other treatments that have caused inflammation . it is believed that this reduces the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelanin occurs naturally in the brain and in the spinal cord which is
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . if this applies to you , tell your doctor before taking zinbecquerel . warnings and precautions talk to your doctor or pharmacist before taking this medicine , see section 6 " taking other medicines ". liver problems talk to you doctor before you take  Zinbrytar if : you have ever had any other autoimmune disorders or any other medicines , including herbal supplements . you take any medicines or supplements that increase your risk of liver side effects . these medicines may increase the risk of you getting a higher risk of depression . tell your pharmacist if any of these apply to you before taking your medicine . your doctor may need to adjust your dose or temporarily stop your treatment . talk to a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much zinbryta you need and how often . how much to use your doctor may tell you the usual dose of zinblita is 150 mg . you will need to have a blood test to check that your liver is working properly before you are given zinbirryt . the usual starting dose of 40 mg depends on how well your liver works . if your doctor tells you to use zinbanta for more than 40 days , tell your doctor that you need to take this blood test . before you have had a test , ask your doctor for advice . to help your doctor inject zinbeta yourself zinblasta is given as an injection under the skin ( subcutaneously ) in
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . your doctor will discuss the side effects with you and will explain the potential risks and benefits of your treatment . serious side effects tell your doctor or nurse immediately if : you develop liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ), vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : might affect up to 1 in 100 people severe inflammation of the liver which may lead to death . report any symptoms immediately to your physician , nurse or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . after opening , store in the original package and use a new syedringe / pen in - use styringer or pen in order for it to protect it from light it should be used or discarded . zincryte s / pens may be kept at room temperature ( not above 30 ) for up to 30 days . once inserted , zinbeta can be kept out
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizuab Beta in 1 ml solution . Each pre  filled pen contains 150 micrograms daclisumab delta in 1ml Solution . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinrytta has a low amount of sodium '). what zbrytoa looks like and contents of the pack zin Bryte is a clear , colourless to slightly yellow , solution for injection . it is supplied as a sYringe / pen ( type iii pre , pre – filled pen with an attached needle ).
wilzin belongs to a group of medicines known as metabolism products . wilsson ' s disease is a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this causes liver damage and neurological disorders . it works by reducing the amount of sugar in the intestine and its further accumulation in the body . in patients with willson  s Disease , this treatment is recommended .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . if this applies to you , tell your doctor before taking wILzin , and do not use willzin unless your doctor has told you to do so . warnings and precautions talk to your doctor , pharmacist or nurse before taking or treating wlzin wifzin is used only during initial therapy . you should see your doctor immediately if : you have signs and symptoms of witson ' s disease you are currently taking another anti - copper agent , penicillamine . your doctor will be able to give you wilezin during the initial treatment . in combination with other anti  copper agents your doctor may decrease the dose of peniciillamine if your symptoms get worse . before starting the treatment your
what wilzin contains the different dose regimens are available in different dose strengths . the different dosing regimens available in each strength are 25 mg and 50 mg . 1 ml of wilszin contains 50 mg in 2 mL of solution . wILzin contains 25 mg in 1 , 2 - dose vials . 50 mg vial : each dose is given in two equal doses , one after the other . 2 : one vial of the active substance willzin contains a total of 25 mg 1 to 6 mg / 1 mg w / m2 wlzin contains 26 mg , 6 mg or 16 mg - mg syringes ; each dose contains 1 mg of silzin . 25 mg vialasing in increments of 16 mg or 57 mg pfizers / 2
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 10 user in 1 , 000 ) rare ( affect impacts 1 to10 users in 10 times 10 ,000 ) very rare ( effect impacts in less than 1 patient in 10 10 . 000 ). not known ( frequency cannot be estimated from the available data ): the following side effects have been reported with wilszin intake . some patients may experience gastric irritation during treatment . changes in blood tests may show an increase in some liver and pancreatic enzymes , leading to a decrease in blood red and white cells . reporting of side effects 15 if you get any side effects
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( 83 . 92 mg of Zin acetate dihydrate ) or 50 mg of gold ( 167 .84 mg of magnesium ade dihydrate in the form of capsules ). - printing ink contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( gcf - 235 ). what ilzin looks like and contents of the pack wilszin 25 mg hard capsules are white , oval , with " gdp " printed in black ink . the printing inking contains black iron oxide ( a type i ) in black with shellac . what if you think the pack is willzin 25g hard capsule , the 50 mg capsule is white . pack sizes are 
biktarvy contains bictegravir , which is an antiretroviral medicine known as an integrase strand transfer inhibitor . it is a modified form of emtricitabine , an antiregulatory medicine known als a nucleoside reverse transcriptaser inhibitor ( nrti ) tenofovir alafenamide , also known as a monoclonal medicine , a nuclear nucleome reverse transcriptor ( ndti or ntrtis ) biktarivy is an antibiotic retroviral medication known as " a nnrtoi - ncrty - inactivated ". bikarvy works by reducing the amount of human immunodeficiency virus 1 ( hiv - 1 ) infection . bic
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , to any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor has prescribed the following medicines : - rifampicin to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ) - as a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking biktarivy and during treatment : your doctor should tell you if : you have liver problems . you have ever had liver disease , such as hepatitis . patients with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if necessary , your doctor may tell you to take a different dose . do not take antacids ( used to treat stomach ulcers , heartburn and acid reflux ) or aluminium , magnesium hydroxide mineral supplements and vitamins , minerals , and magnesium , iron or phosphorus ( see section 2 , taking these medicines together ). take biktarvy with food . go to the doctor ' s advice about taking biktarivy if your doctor tells you to stop . patients on dialysis : bik Tarvy can be taken once a day if a patient is not on diapary . take bikinty with meals . this is to reduce the risk of side effects associated with taking this
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should contact your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these are due mainly autoimmune disorders , which occur when the immune system attacks healthy body tissue . some of the side effects of medicines used to treat hiv disease are listed below .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the seal after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . keep the container tightly closed in order to protect from light and moisture .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bictabegravar sodium equivalent to 50 mg bictogravir and 200 mg emetricitatabine / tenovir altafène fumarate equivalent to 25 mg tenoffovir alefenani . the other ingredients are tablet core microcrystalline cellulose , tablet core croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol , the talc , iron oxide red and iron oxide black . what bikinktarvey looks like and contents of the pack bikgarvy is a white , oval , film , bevel
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetics in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . when novonom is taken with metformin , another medicine for diabetes . how novonorgm works novonandm works by reducing the amount of sugar in the blood . it is important that you continue to follow the advice on diet and exercising given to you by
do not take novonorm : if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking novonourm if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in your body ). 47 you have liver problems . novonorgm is not recommended in patients with moderate liver disease but it may be used in patients without a prescription . there is no experience with novonom in patients suffering from a severely liver disease or kidney problems , as it may affect the way novonlorm works . your doctor will advise you on this 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , preferably in the morning . your doctor may decide to increase your dose to 4 mg before or with up to 300 mg before the main meal and to increase the dose to 16 mg before . if your blood sugar is not controlled enough , the effect of novonorm may become too low , leading to a hypo . you should continue to take novonorgm until your diabetes has cleared . inform your doctor if any change of your treatment is necessary . do not change your dose unless your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypoglacy ( may affect up to 1 in 10 people ). it is very common ( may effect more than 1 in 100 people ) and acts as a hypo in section . generally mild / moderate hypogycaemic reactions are generally mild to moderate and lead to hypogLYcaem consciousness and coma . allergy allergy is very rare ( may impact up to1 in 10 , 000 people ), but can be life - threatening . symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects include : very common : may affect more than1 in10 people . common , may affect 1 to 10 people loss of appetite 
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . the pigment consists of iron oxide yellow ( pfizer ) only in the 1 mg tablet and iron oxide red ( pptc ) in the 2 mg tablet packaging . what novovonorme looks like and contents of the pack novonom tablets are oblong , white , round , marked with " ph0 " on one side and " 1 " on the other side . novom tablets come in blister packs of 1 and 2 
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandelic flu is essentially influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandemie flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarique may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any ingredients that may be present in very small amounts such as egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these occur , immediately after receiving the vaccine , medical treatment may be available in case of an allergy . you should not receive pumarize if the child has previously received this vaccine 33 . warnings and precautions talk to your doctor , pharmacist or nurse before having pumarx if : you have had any allergic reaction other than a Sudden life  - potentially life threatening allergy to any component of the vaccine
pumarix should be given to your child by an appropriately qualified healthcare worker . adults from 18 years of age can receive one dose of pumarice together with a similar h5n1 as03 given at the same vaccination visit . children and adolescents pumarize is for use in children and teenagers from 3 - 9 years old . the recommended dose is for children and young people from 10 - 17 years of old , who weigh at least 30 kg . how pumarique is given pumarx is given as an injection into a muscle . this will usually be in the upper arm . if you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor will tell you what to do , when to return for the injection . other side effects include : very common ( may affect more than 1 in 10 people ) pain where the injection is given headache feeling tired aching muscles or joint pain common ( might affect up to 1 in10 people ), redness or swelling where the injecting is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in 100 people ). bruising where the vaccine is given redness where the vaccination is given high blood pressure where the child is due fever sweats sneezing dizziness feeling sick rare ( may impact up to one in 1 ,
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . discard unused vaccine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / california , no less than 5 / 2005 ( h5n1 ) like strain ( pr8 - ibcdc - reg2 ) equivalent to approximately 0 . 5 milligrams haemagglutinin . this vaccine does not contain any other vaccine other than an ' adjuvant ' as03 . the adjuvanted formulation contains squalene , all - tocopherol , polysorbate 80 and water for injections . adjuvants are added to enhance the protective effects of the vaccine . other ingredients are : sodium chloride , disodium hydrogen phosphate ; potassium dihydrogen phosphat ; water for injectors
somakit toc is a radiopharmaceutical product that contains an active substance called edotreotide . the powder in it contains a small amount of a nuclear medicine called gallium ( 68ga ) chloride , which is converted to galium ( 6gaa ). eedoketide is injected into a vein in one of your body areas in a medical imaging procedure called positron emission tomography ( pet ). this medical procedure involves taking pictures of the abnormal cells that make up tumours and causing your disease . your doctor and the nuclear medicine doctor have considered that the clinical benefit that you will obtain from the procedure with the radiopharmacemic relationship with the patient , the medical doctor and other scientists are responsible for the correct disposal of the product .
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). signs of allergic reaction can be seen in section 4 , ' take special care with somokit totc '. warnings and precautions talk to your doctor or pharmacist before using somamakit tc and if any of these apply to you : - kidney or liver problems . renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years because of the risk of dehydration . if during the examination you should drink plenty of fluids and avoid drinking alcohol ( see section " drinking alcohol "). 28 - other medical conditions which may affect how the body functions . examples include : cushing syndrome ( inflammation ). - thyroid disease : tumour (
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . no radiopharmaceutician will be responsible for the correct use of the product both before and during its use ; 29 the nuclear medicine doctor supervising the procedure . the usual amount of somаkit tot is 100 mbq ( megabecquerel , the unit used to express radioactivity ). administration of sommakit tc and conduct of the procedure for radiolabelling , somamakit topc is given by intravenous injection ( i . e .,
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site and ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects tell your doctor , pharmacist or nurse if you get any side effects talk to your doctor or nurse as soon as possible . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . documentation for radiolabelling is included in the package of somakit toc . shelf life after first opening of the vial : 4 months , but not above 25 , at the risk of deterioration . store in the original package in order to protect from light .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms of eedokeetide ( 10 - phenanthroline ), gentisic acid , mannitol , formic acid / sodium hydroxide , and water for injections . none of the ingredients are present for radiolabelling . the solution contains hydrochloric acid and is supplied for radiopharmaceutical preparation . what sommakit tc looks like and contents of the pack somamakit is a glass vial with a black flip - off cap containing a white powder . aglass vial ( type i glass ) with yellow flip – off cap is essentially a clear and colourless solution . not all pack sizes may
afinitor is an anticancer medicine containing the active substance everolimus . everolim works by stopping the tumour from growing and causing the growth and spread of cancer cells . afiniteur is used in adults who are already receiving hormone receptor - positive advanced breast cancer ( postmenopausal ) in combination with non - steroidal aromatase inhibitors ( a steroid ), which help control the disease under control . it is used together with a medicine , exemestane ( oblong - acting ) a stereotasese inhibitor ( s ) which is used as hormonal anticancancer therapy for advanced tumours , in particular in neuroendocrine tumours ( those that have spread outside the stomach or bowels ).
you should not be given afinitor - as it is a part of a course of cancer treatment with afinitour . do not take afiniteur if you are allergic to everolimus , to sirolimus / temsirolim or to any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking afinitr . warnings and precautions talk to your doctor before you are given afinitor . tell your provider if : - you have any problems with your liver . - your doctor has told you that you have ever suffered from any disease which has affected your liver ( see section 4 ). your doctor may prescribe a different dose of afinitur . follow the instructions carefully . you have diabetes ( high level of sugar in your blood ). when you are treated with afinior
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you can take the tablet with or without food . if necessary , your doctor may tell you to take a different dose . it is important to take the tablets at the same time each day , preferably in the morning . swallow the tablet whole . do not chew or crush the tablet . patients with liver problems may need a lower dose of afinitor . this may be started with a 5 mg tablet once a morning ( 2 tablets of 5 mg ) or 7 . 5 mg once . your doctor will adjust the dose if there are certain side effects . stop taking afinitor if your doctor tells you to stop , or if treatment with afiniteur is stopped . to help you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you notice any of the following : signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afinitr : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signs and inflammation of the lung , also known as pneumonitis ) cough not known ( frequency cannot be estimated from the available data ) feeling sick ( nausea ) or vomiting , diarrhoea , nausea and vomiting . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . store below 25 . you must take the tablet before the first use , and only open the blister after first opening . the tablets should be taken within one hour of taking the first dose . this medicine does not require any special storage conditions . if the pack is damaged or shows signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . each afinitour 2 . 5 mg tablet contains 2 , 5 mg of everolim . - each afiniitor 5 mg tablets contains 5 mg , of everOLImus - one of the ingredients in the tablet core is everolinmus , one of which is absent or not present . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( containing lactoses anhydrous ). what afinitor looks like and contents of the pack afiniteur 2 : 5 mg film - coated tablets are white to slightly yellowish , round and convex . they have " nvr " on one side and " tcl
what laventair ellipta is lavent air ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellptta does it work ? laventAIR ellipeta has been prescribed by your doctor to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . it does this by improving your breathing difficulties .
do not take laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking laventAIR ellippta : - you have asthma ( this medicine is not recommended for the treatment of asthma ). tell your physician before taking it if any of these apply to you and tell your doctors if : you have heart problems , high blood pressure you have an eye problem called narrow - angle glaucoma , an enlarged prostate , difficulty passing urine or a blockage in your bladder you have epilepsy , thyroid gland problems . you have diabetes . or severe liver problems if either of these
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair ellptta every day , as instructed by your doctor to do so . this will help to keep you free of symptoms throughout the day and night . lavent air ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if this is the case you need a quick - acting reliever inhaler ( such as salbuta
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms , stop using laventair ellipta and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects [ may affect less than 1 in 1 , 000 people ]: swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy when coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ). if any of these side effects causes you problems , you should contact your doctor .
what laventair ellipta contains the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ) and 22 microgram ( mg ) vilantanterol ( as trifenatate ) the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellippa contains lactoses ') and magnesium stearate . what laVENTair ellpte looks like and contents of the pack laventAIR elliрta is an inhalations powder . the ellipata inhaler consists of a light grey plastic body , a red mouthpiece cover and a dose counter .
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine works by attaching to a specific target in the body called il - 23 . tremefyya is used to treat adults with psoriasis . moderate to severe " plaque psesoriases " is an inflammatory condition that affects the skin and nails . it is used in adults to improve the condition of the skin by reducing the appearance of nails , and to reduce symptoms such as scaling , shed , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using tretfyya and tell your healthcare worker if any of these apply to you ( or you are not sure ): if your healthcare professional thinks you may be allergic , ask your healthcare provider for advice before you are given tremefy if : you have an active infection . you need to have active tuberculosis warnings and precautions talk to your doctor or nurse before you receive treefyare if either of the following applies to your family : - you have or have ever had an infection , including an infection that is a stevens - johnson syndrome , the first sign of tub
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given once daily under the skin ( subcutaneous injection ). the interval between 4 and 8 weeks after injection is one injection of TREmfYa . if your doctor determines that you need more trempfyya than you should he or she will check that you have received enough tretya before treatment . it is important that you continue to inject tregfy unless your doctor specifically recommends it . do not change the dose yourself . show them your pack of trump cards . you may find it helpful to show the doctor / scleroscope . for instructions on how to inject yourself
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction - signs may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects very common side effects these may include the following other side impacts : some side effects may be serious common ( may affect more than 1 in 10 people ): upper respiratory infections common ( might affect up to 1 in10 people ), headache , joint pain , fever feeling unwell reporting of side effects 23 if your child gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . you must not use tremfya if it is cloudy or contains large particles . once removed from the refrigerator , the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkUMab in 1 ml solution . -the other ingredients are histidine , histine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection : trempya is presented as a carton pack containing one single - dose glass sister or a multipack containing 2 ( 3 packs of 1 ) single  dose single – dose pre – filled pens . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastinkil belongs to a group of medicines called prostacyclins . prostacycles are hormones that lower blood pressure by relaxing blood vessels . by acting on these hormones , prosta ciclins prevent blood from clotting . what tre Pulmix is used for trepelmix is prescribed to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients with persistent or recurrent ctéph who cannot be treated with surgical treatment , or who lack exercise capacity or symptoms of the disease . in chronic tremboebolic , a person ' s blood pressure is too high , and the blood vessels in the heart and lungs are not designed for this .
do not take trepulmix : - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a disease called " pulmonary veno - obslusive disease ". this is a disorder in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the arteries . - If you have severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking tre Pulmix if : you have had a heart problem or have had or have ever had : had , or have recently had ; had ' a cardiac attack ( myocardial infarction ) within the last six months severe changes in heart rate severe coronary heart disease , including unstable angina a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( drip ) into the skin through a small tube ( cannula ) in the abdomen or thigh . the recommended dose is one vial of trepelmix per day . your doctor may decide to give you trepmix with a portable pump . you can carry your treprostinil with you and keep it at all times . it is important that the pump and its use work as smoothly as possible so that you can easily carry your medicine around . do not push the plunger through the infusion line . in case of accidental overdose , you will receive 1 dose of 2 . 5 mg / minute , followed by 5 to 10 minutes infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the site of the inffusion site bleeding or bruising at the start of the , or infusion , headaches nausea diarrhoea jaw pain common - may affect up to 1 in every 10 people dizziness , light - headedness or fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , feet ( pharyngitis ) uncommon - might affect upto 1 in 100 people redness ( erythema ), swelling of the face ( oedema , dermatitis ) common , may affect less
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . a trepulmix vial may be kept at room temperature ( up to 30 ) for up to one hour before continuous subcutaneous infusion in : a single reserve ( syringe ) of undiluted tre Pulmix will be stored at room temperatures for upto 72 hours . this medicine must not be put back in the refrigerator and must be discarded if it is found that the solution is not clear or contains particles . any visible signs of damage , including discolouration or other signs of deterioration , should be disposed of .
what trepulmix contains - the active substance is treprostinil . tre Pulmix 1 mg : 1 mg contains trepstinkil ( as sodium salt ). one 10 mg / 10 mg vial contains 10 mg of treprastINil ( in sodium salt). trepelmix 2 . 5 mg - each 2.5 mg viam contains 2 - 5 mg of the active ingredient treprestinningil ( AS sodium salt in a vial ). each 10 mg dose contains 25 mg of of TREprosnil ( ( as potassium salt ) in 0 . 25 ml solution . the other ingredient is terpulmix in methanol ( sodium salt to be absorbed by the body ). - treulmix 5 mg ( vials ) - one 5 mg viamol treparst in
thorinane contains the active substance enoxaparin sodium , which is a low molecular weight heparin ( lmwh ). thoriinanе works in two ways . 1 ) stopping existing blood clots from getting any bigger . it also works in steps 2 : - stopping blood  clotes from forming in your blood . thoresinanane helps to prevent blood coagulations from re - forming within your body . this means that it helps to reduce the risk of blood blots forming inside your blood and reduce the chance of blood to clotting forming around your blood after an operation . you have an acute illness or unstable angina ( a condition when not enough blood gets to your heart ) and you have had a heart attack . your doctor will also tell you how to
do not take thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - allergic to any of your proteins . this is because thoriane belongs to a group of low molecular weight heparins ( nadroparin , tinzaparin or dalteparin ). - have had a reaction to hepr , such as a severe drop in the number of your clotting cells ( platelets ). this reaction may be called heperin - in - controlled thrombocytopenia ( hei ). talk to your doctor or pharmacist
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . at the beginning of any bleeding event , signs of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness ), headache or unexplained swelling occur , immediately after taking your medicine . stop taking thourinana and tell your doctor immediately if you experience a severe allergic reaction ( such as difficulty breathing or swelling of the lips , mouth , throat or eyes ), as these could be signs of blockage of a blood vessel which could lead to a bleeding clot . also , cramping pain or swelling occur in the abdomen , abdomen or hands , back pain have been reported . if this happens , stop taking the medicine and tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . chemical and physical in - use stability after dilution the solution should be used within 8 hours . use this medicinal product immediately after thorinane pre - filled syringes provided in the box .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of eonoxaparain sodium in 0 . 2 mL solution . this provides a metered dose of 2 , 000 mg of the active ingredient . - thorosin is supplied as separate reconstituted and infusion ready solution , containing no other ingredients . when thoresinanе is administered , the solution is clear and colourless . in a single - use , single  contact lens is provided . the product is supplied in : - colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 or 10 pre - filled sY
senstend contains lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstende is used for lifelong premature ejaculation ( when the head of the penis is tilted against the direction of ejculation ).
do not use senstend : - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). - allergy or sensitivity to other local anaesthetics . if the nameplates of your chosen group of amide - type local anestheses cannot be found in this leaflet , please tell your doctor . warnings and precautions talk to your doctor before using senstende :- - in case of a genetic disease or other condition affecting your red blood cells ( glucose - 6 - 8 - 9 - 10 - 20 - 50 - 100 - 1000 ) or glucose . in case you have phosphate deficiency ( anaemia or methaemoglobinaemia ) tell your physician if any of these
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray sprayed 3 times per day ) on the head of your penis . after dilution , up to 24 hours , is recommended . you should not exceed 4 sprays per day as the spray container may interfere with the pump mechanism . if the valve is opened , there should be contact with eyes , nose , mouth and ears . before you use senstende , place the spray bottle in a clean , dry place . press the plunger down until the surface is clear . it should not be touched by the pump or if it is irritated . 1 spray ( 1 spray ) into the foreskin next to the head , in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection decreased feeling in or around the penis feeling of burning in or inside the penises uncommon ( may effect up to1 in 100 people  ) headache local irritation of the throat or irritation on the skin redness on the failure to ejaculate during sexual intercourse abnormal orgasm tingling in or near the penisse pain or discomfort in or surrounding the penist itching of the lips , lips rash , swollen lips numbness , burning in the penitus irritability , sweating , itching , irritation of or irritation of any part of the penus , discomfort in the back of the hand , inability or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . you must throw away the container 12 weeks after you first use it . keep the metal container tightly closed in order to protect from puncture and burn . this medicinal product does not require any special temperature storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocabine and 50 mg prilacaine - one spray delivers 50 microlitres which contains 7 . 5 mg lidone and 2 . 4 mg pprilocine . what sensTENd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray in an aluminium spray container with metering valve . each pack contains 1 spray container of 6 . 6 mL and 5 mlitres . not all pack sizes may be marketed .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . it is used when : - advanced marrow or other forms of adults melonoma cannot be completely removed by surgery ( adjuvant therapy ). - advance non - small cell lung cancer : advanced kidney cancer or adults classical hodgkin lymphoma when previous therapies did not work well enough or you were not considered to be suitable . opedivo may be used in adults advanced kidney carcinoma or in adults classical haematoma when prior therapies were considered unsuccessful . the use of an autologous stem - cell transplant is not recommended . this is , however , a transplant is needed . advanced cancer of the head and neck in adults advance urothelial carcinoma ( utc ), bladder and urinary tract
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using oodivo and during treatment : if the following affects your heart : you may notice a change in the rhythm or rate of the heartbeat , or an abnormal heart rhythm . if your lungs have problems with breathing difficulties or cough , you may be at increased risk of inflammation of the lungs ( pneumonitis or interstitial lung disease ). if any of these apply to you , tell your doctor . talk to you doctor if : diarrhoea ( watery , loose or soft stools ) or any symptoms of inflammation or of the digestive tract ( colitis ), such as stomach pain , diarrel 
what opdivo is the recommended dose of oopDivo in adults is 240 mg once a week , given as 2 capsules . this means you will take 480 mg every 4 weeks . opedivo in combination with ipilimumab is used for the treatment of skin cancer in adults . the recommended starting dose of one opranogram in each kilogram of your body weight is 4 mg / kg . your doctor will prescribe the dose of two oponivolumab in each capsule . you will receive obdivo at the same dose of either 240 micrograms / kilograms in each tablet and in the combination with 2 vials of 480 microgram ( corresponding to 4 mg of ibilimamab ). if you are being treated for the treating of certain types of skin carcinoma ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . chemical and physical in - use stability has been demonstrated for 48 hours at refrigerated temperature . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolumаb ( 40 mg in 4 mL ). the other ingredients are : 100 mg ( 10 mmol ) or 240 mg ( 24 mg ) of nivolma B . the other ingredient ( s ) are sodium citrate dihydrate , sodium chloride ( see section 2 " oopDivo contains sodium "). the solvent is water for injections . opmo is a clear , colourless to pale yellow solution . it may contain light ( less than 10 %) solution , such as : mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injecting , and sodium hydrox
clopidogrel tad contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopogreil t ad is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , with potential atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly ttade to help prevent blood from forming .
do not take clopidogrel tad 30 if you are allergic to clopopidogral or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking clopinogrell t . if any of these apply to you ( or you are in any doubt at all ), if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . the risk of severe liver disease may be increased if taking  Clopidogril TAd . warnings and precautions if : you are at increased risk of bleeding : - you have a mental condition that puts you at risk of internal bleeding ( such as such as the stomach ulcer ). you have been told by your doctor that you have such a blood disorder that makes you 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Tad ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 4 tablet ) of clapidogresl - 75 mg ( 4x14 ). you should take clopogrell t ad for as
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the soil . this may be the signs of an allergic reaction . your doctor will tell you how to recognise and treat your allergic reaction by referring to the patient alert card that is included on the medicine and the alert card . it is important that you keep this alert card
what clopidogrel tad contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( , yellow iron oxide ), talc and macrogol 3000 in the film . what  Clopidogral ad looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 film  3000 film – coated tablets contain yellow , pink coloured tablets with " tm
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforinus is used to control your body' 's immune response , enabling your body to accept the transplanted organ , organ or heart , when any previous treatment you were taking was not successful .
do not use tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy to siroli Mus . - do not take any macrolide - antibiotic ( e . excipient , e. g ., erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor before using tacrolivimus immediate release capsules ( i . de . tacrolinimus immediate - release capsule ( tacni )). tacforinus prolonged - released capsules contain tacrolimimus . you should not use the tacforitus prolonged- release caps after the immediate release pills have been released . talk to the doctor before taking tacforivius capsules if this is the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacforlimus medicine . you should not use this medication if your doctor thinks that you have the right medicine , and will explain the steps required to prevent the rejection of your transplanted organ . the dose you receive depends on your body weight at the time of transplantation . usual doses just after transplantation are 0 . 10 0 30 mg daily on day 35 of the transplanteed body weight , at the same time each day . doses may be changed if necessary . in order to prevent rejection 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get infections , but you may also get infections more easily with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours may also occur following tacforinius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( increase in the number of some types of whiteblood cells which fight infection ). this can occur during treatment with tacfordius administration . tumours can occur in tumours where the tumour is growing . as with all medicines this medicine will
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains - the active substance is tacrolimus . tacforinus 0 . 5 mg : each capsule contains 0. 5 milligrams of tacrolivimus ( as monohydrate ). tacforivius 1 mg - each capsule delivers 1 milliliter of tacrolulimus ( As monohydrate). tac forius 3 mg – each capsule releases 3 millilitres of tricroli Mus ( as monohydrate ) in one capsule . not all strengths of tacforienius 5 mg are available : Each capsule contains 5 millimetries of tacrollimus( as monohydrat ). - capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforions 0 mg / 1 mg capsules : the active substances are as mono
clopidogrel zentiva contains clopizide and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopinogrell zentivea is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a potentially life - threatening condition known as atherothrombosesis , including atheropenitic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly zenivia to help prevent blood from forming .
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks you may have severe liver disease . check with your doctor before taking cloclopidOgrel
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told your doctor that you can take clopogrell zenivia , but you should take it as soon as possible . however , if this happens , your doctor may decide to increase the dose to one 75 - mg tablet or two tablets of clapidogral  Zentiva . you should contact your doctor immediately , or go to the nearest hospital emergency department because of the increased risk of bleeding . your doctor will tell you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the soil . this may be the signs of an allergic reaction . your doctor will tell you what to do if your medicine works . you should stop taking clopidogrel zentiva and contact your physician immediately - if vous experience a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . when clodogrell zentive is supplied dans all aluminium boxes , it does not require any special storage conditions . store in the original package in order to protect from moisture . Do not use it if you notice any visible sign of deterioration . please see the carton , after " do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopopidogral . each tablet contains 75 mg of clopinogrell ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clodogreil zentive contains lactose ' and ' do not take clopotogrelly zenta contains hydrogenated castor oil '): mannitol ( e421 ), hydrogenated casting oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose . the other ingredient is lactoses monohydrate ( milk sugar ), hypromellose ( е464 ), triacetin , red iron oxide (  172 ), titanium dioxide ( E171 ), carnauba wax 
yttriga is a radioactive medicine . it is used in combination with another medicine that emits tiny radiation doses during the treatment . yettrigga is only a single radiolabelled medicinal product .
do not use yttriga - yettrigga is not a radioactive medicine ( as chloride ). - you are pregnant or think you may be pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using yytrige - this medicine is not intended for use in pregnant women . yittrig - is a nuclear medicine . it may be used in conjunction with another medicinal product or with radiopharmaceuticals . the use of yhtrigo is not known to contain radioactive material . radioactive medicinal products should be disposed of in accordance with national regulations for radioactive medical products . children and adolescents yTtrig
your doctor will determine the duration of the treatment and the frequency of administration . method of administration you should receive yttriga under the supervision of a physician experienced in radiolabelling of medicinal products . yettrigga is intended for specific diseases only . administration of yytrig entails the risk of overdose . your doctor , pharmacist or nurse will assess your response and determine the appropriate treatment if necessary .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . do not use yttriga after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . yettrigga should be used immediately after dilution . local regulations on radioactive substances should be followed . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid , 3 g / mL . what Yttroga looks like and contents of the pack yTriga is a clear , colourless type i glass vial with a v - shaped bottom and a colourless style iglass vial of 10 mg , with  a flat bottom , closed with osilicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciamba is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when ciaba is given alone , in combination mit cistplatin for the initial treatment of patients with advanced stage of lung cancer , it can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciama is also a treatment for patients with active stage of long - term lung cancer who have progressed after other initial chemotherapy has been used .
do not receive ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). if your doctor or nurse advises you to discontinue breast - feeding , please discuss this with your doctor . warnings and precautions talk to your doctor before receiving treatment with ciamba . if , you have recently received or are about to receive a vaccine against yellow fever , it is very important that you tell your doctor that you are receiving ciaMBa . you have previously received or might now receive , a vaccination against yellow febrile agent . before each infusion of ciembra you will have samples of your blood taken to evaluate if the medicine is working for you . your doctor will check your kidney and liver function and to check that you have enough blood cells to receive the correct dose of 
ciambra 500 micrograms solution for injection will be given to you by your doctor or nurse . the dose will be calculated based on your body ' s surface area . your height and weight are measured to work out the surface area of your body in square meter ( m2 ). your doctor will use this body surface area to work the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciama powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before use . you will always receive ciamba over 2 - 3 hours . when ciaMBa is given by infusion into one of your veins , the infusion will last approximately 10 minutes . afterwards , you will also
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your medicine has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if this happens , you should contact your physician immediately . chest pain ( common and common ), if given with a fast heart rate , if there are pain , redness , swelling or sores in your mouth ( very common). allergic reaction : a rash ( very commonly referred to as burning or prickling sensation ), or fever ( common in patients with skin reactions ). a sore throat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed was demonstrated for 24 hours at 2 -8 and 15 to 25 . from a microbiological point of view , the reconstituted solution should be used immediately after preparation . if not used immediately , in  - using storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours below 2 , 8 and 15 below 25 , unless reconstitution has taken place in controlled and validated aseptic conditions . any unused solution must be discarded .
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetred ( as pemetreixed disodium hemipentahydrate ). ciamma 500 mg ; each viaL contains 500 milligramms of per vial of pemeterxeed ( As pemetrexxed disodium dipentanhydrate ”). after reconstitution , the solution contains 25 mg / ml of ciampeg ( 0 . 25 mg per vially ). further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for pah adjustment and for paediatric use 
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to prevent certain infections in your blood . immunogam is used in adults to treat increased levels of human hepatitis b immunoglobularins . it is used when the levels of immunoglobulation g ( igg ) are too low or too low . this is shown in blood plasma of screened patients . how immunogam works immunogam prevents the growth of hepatis c virus in haemodialysed patients , who have previously received vaccination with a hep b virus carrier , provided that an immune response has been obtained . there are no measurable hetis
immunogam should not be used : if you have ever had an allergic reaction to human immunoglobulins or other blood products ( containing human immunoglycans ) if your doctor has told you that you have an iga deficiency . in this case , you may have an allergic response to iga containing products . children and adolescents do not give immunogam to children below 18 years of age . warnings and precautions talk to your doctor or pharmacist before receiving immunogam . your doctor may wish to monitor you more closely during treatment . adverse reactions such as chills , headache , fever , vomiting may occur . allergic reactions sucha as nausea , arthralgia ( joint pain ), low blood pressure , and moderate low back pain may occur since immunogam may produce antibodies against hepatitis b immunoglobularin regularly , although this does not
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be administered using human hepatis - b immunoglobulin . administration prevention against hpatiti b the recommended dose in adults is 500 micrograms for 24 to 72 hours . if necessary , the dose may be increased to hep b in haemodialysed patients ( h1n1 ) the recommended dosage is 500 milligrams per kilogram of body weight , administered every 2 weeks . seroconversion after vaccination , may be the most appropriate measure of protection against a hepes b or b - positive spread of a human - or animal - cause . it is recommended that every time you receive immunogam , you provide the necessary information about the heparin / hepitis a virus carrier
like all medicines , immunogam can cause side effects , although not everybody gets them . side effects very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 10 user in 1 , 000 ) rare ( affect impacts 1 to10 users in 10 times1 , 10 , 00 ,000 ) very rare ( effect impacts occur in less than 1 per 10 . 000 ). not known ( frequency cannot be estimated from the available data ) undesirable effects have been reported in clinical trials for immunogam . they were reported as follows : injected muscle ( common ) not known : frequency cannot been estimated from available data very common : 1 per 100 , 1 per 1 . 0 ml 7 nausea , fatigue , inability to get or keep an appointment , swelling or decrease in body temperature 
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before administration , check that immunogam is clear and colourless . it is important that you destroy any unused solution before it is used . this will help to protect the product from light and to prevent deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help in preventing the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / 5 ml solution for injection contains human plasma protein corresponding to 96 mg pgm . - other ingredients are polysorbate 80 . what immunogame looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial . it is a clear to slightly pearly or pale yellow liquid . each pack contains 1 vial of immunogam .
remicade contains the active substance infliximab . inflimimabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tumour necrosis factor a ( tnf ). remikade belongs to  a group of medicines called ' t nf blockers '. it is used for the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis ; ankylosing spondylitis ( bechterew 's disease ) and ppsolitis . remade is also used in adults and children 6 years of age or older for : crohn '
do not use remicade if you are allergic to infliximab or any of the other ingredients of relicade ( listed in section 6 ). you are allergy ( hypersensitive ) to proteins that come from mice . you have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . warnings and precautions talk to your doctor or pharmacist before using reMICade you may be unsure if any of these apply to you . if they do not feel better or if your doctor thinks they may have given you remised . talk to you doctor or nurse before using the product if : you have heart failure or have had reminiade before . take special care with remikade tell your doctor if the above applies to you and tell your physician before you are given re
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsoasis , ulcerative colitis and crohn 's disease the usual starting dose is 5 mg for each kg of weight , given once every week . how remicade is given rema remittance will be given to you by your doctor or nurse . your doctor will give you reMICade by infusion . the medicine will be prepared and given as an infusion ( drip ) over 2 hours into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give relicade over over several hours . over two hours your doctor and nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash or hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , and / or chills , loss of appetite , weight loss 
remicade will be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reMICade may be stored in the refrigerator at 2 to 8 for up to a maximum of 25 days before use . however , if the medicine is not used for infusion , it may be kept at room temperature ( not above 2 ) for upto 8 days or up to 28 days in an upright position , for an additional 24 hours at 25 after removal from the refrigerator . you must use this medicinal product in accordance with local requirements .
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inflimimabe . after preparation each ml contains 10 mg of of infusionimaB . - other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatе . what retimicaDE looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . pack sizes of relicade 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is  a chemical in the body involved in movement control . rasagigaline myLAN helps to increase and sustain levels of dopam in the cortex of the brain in all age groups .
do not take rasagiline mylan - if you are allergic to rasagilline or any of the other ingredients of this medicine ( listed in section 6 ). - have severe liver problems . - are taking any of these medicines at the same time : - monoamine oxidase ( mao ) inhibitors ( e . de - associative treatment of depression or parkinson ' s disease , or used in combination with medicinal and natural products containing st . martinson' 's wort .- pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasaginine mylan treatment . you should not continue treatment with mao inhibitors or pethamine . warnings and precautions talk to your doctor before taking rasagine myLAN if : you have mild to moderate
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if necessary , rasaginline myLAN can be prescribed temporarily or permanently without food or drink . take rasagigan mylan immediately after food or between meals . remove the rasagile mylan carton and discard it . do not take rasageiline in a car on an exceptionally warm or cold day . you should swallow the tablet whole , with a glass of water . continue taking rasagigaline mylant for as long as your physician tells you to . however , if it is difficult to reach your doctor and take your daily dose at the same time each day , contact your doctor at once
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with placebo : the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 person in 1 , 000 ) very rare ( affect impacts less than 10 users per 10 ,000 ) not known ( frequency cannot be estimated from the available data ) Very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell - neck pain chest pain ( angina pectoris ) reporting of side effects 22 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effect not listed in this leaflet . you can also
what rasagiline mylan contains - the active substance is rasagiatal ( as rasagicaline tartrate ). each tablet contains 1 mg rasagigaline . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid ( see section 2 ). what rasaggiline myLAN looks like and contents of the pack rasagagiline tablets are 11 . 5 mg ( approximately 6 mm in diameter ) white to off - white , oval , biconvex tablets , debossed with " gsi " and " 1 " underneath on one side and plain on the other side . the tablets are available in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets and in perforated blister packs containing
do not use hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a severe infection , such as tuberculosis . warnings and precautions talk to your doctor or pharmacist before using hULio this medicine if : you have symptoms of infections , for example , fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . it may be necessary to tell your doctor if your doctor thinks you have had or have , or have had , a serious heart condition . allergic reaction if any of these apply to you , tell your pharmacist before you use . in allergic reactions with symptoms such as chest tightness , wheezing , dizziness a need
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . polyarticular juvenile idiopathic arthritis : for use in children and adolescents ( from 2 to 17 years old ), the usual dose is 10 to 30 mg / kg . hulio is available as a 20 mg - tablet for patients 2 to-17 years old and as flexisol 30 mg per kg body weight . in this case , hULio can be given as hulario 40 mg . for enthesitis - related arthritis , for patients from 6 to 17 year old , the usual dosage is 15 mg , followed by 30 mg every other week . when hurileio becomes unsuitable for some older patients , it can be used for a short period of time . children and teenagers
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months or more after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives swollen face , hands or feet ; trouble breathing or swallowing ; pale complexion ; dizziness ; persistent fever ; bruising or bleeding ; signs and symptoms of infection such as fever , feeling sick , vomiting , stomach pain or discomfort ; nausea and vomiting ; abdominal pain , pain or swelling . if any of these signs or symptoms get serious , tell your doctor straight away . very common (
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , water for injections . what hellio looks like and contents of the pack hULio 40 mg solution for injection is supplied as a sterile solution in a vial containing 40 mg aalimUMab in 0 . 8 ml solution . it is clear to slightly opalescent and colourless to slightly pearlescent . each vial is closed with a rubber stopper . hülio is available in packs containing 1 or 2 vials , 1 steril injection syringe , one sterle needle , and 1
yellox contains bromfenac . it belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ) that reduce inflammation . yyellow is used to reduce eye inflammation after cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yyellow : - you have asthma or skin allergy . - there has been intense inflammation in your nose in the past . your doctor may ask you to use other nsaids . other NSaids that should not be used with yemophilia , acetylsalicylic acid , the active substance in yoprofen , ketoprofened and diclofenocide are not allowed in this medicine . in addition , topical steroids ( such as cortisone ) may be used . this may increase the risk of unwanted side effects . talk to a doctor if 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in each eye ( s ) once a day in the morning . do not swallow or inject . if necessary , the drops can be used in the same eye ( at least 2 hours apart ) for 2 weeks . you can use the drops again the next day if your cataract surgery is delayed . method of administration yellowx is for oral use . before using the eye drops , remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with your finger down . bring the bottle tip close to the eye . it will help to close the bottle and help to seal the eye ( insular ).
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each syringe contains 33 mg brom Fenac -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , and tyloxapol . - solvent : povidone ( k30 ), disodium edetate and sodium hydroxide to keep acidity levels normal . what Yellox looks like and contents of the pack yyx is a clear yellow liquid ( solution ) which is supplied in a 5 mL plastic bottle with a screw cap .
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo : - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - have a serious lung or breathing problem . warnings and precautions talk to your doctor before taking dzveo as it may affect your breathing . talk to a doctor or nurse before taking this medicine if : you have ever had any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ), as dzoneveo may affectyour breathing , especially during treatment . you have recently had a head injury or brain tumour . your doctor may need to adjust your heart and circulation , as a result of slow heart rate , irregular heartbeat , low blood volume or low blood pressure . - you have moderate to severe liver problems . tell your doctor 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device should only be used by patients who are able to take the medicine themselves . your doctor will explain to you the benefits and risks of taking this medicine . dzuveo must be taken with strong painkillers such as sufentanil . for the lowest dose , you should take 30 minutes before taking the sublingual tablet . this 30 ml sublingual tablets should only use the disposable single  dose applicator provided in the pack . you must attach the applicators to the tongue first . once the tablets dissolve , the tablets dissolve under the tongue and provide pain relief , if placed under the gum , after 10 minutes . there is a maximum daily dose of 720 mg . when
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you have any of the following serious side problems : - severe breathing problems , such as slow and shallow breathing ( see section 2 ) if any of these side effects occur , please tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), including : inability or difficulty sleeping . reporting of side effects 23 if your doctor finds you useful , or think you may be missing a dose . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . do not use this medicine after the expiry date which is stated on the label and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . dzuveo does not need to be kept in the refrigerator to protect it from light . any unused medicine or waste should be disposed of in accordance with local requirements .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenteanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , perforated tablet ( e464 ), croscarmellose sodium , indigo carmine ( é132 ), and stearic acid ( 6000 ) and magnesium steak ( 900 ). what fzuvevo looks like and contents of the pack d Zuveo is a white to off - white , round edges , marked with " 3 " on one side . it is supplied in a single - dose applicator ( labelled [ sublingual tablet ]. the applicators contains one sufENTanil 30 mg ). pack sizes of
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . erledad is used in adult men to treat sensitive prostate cancer which has spread in other parts the body and cannot be eliminated by surgical treatment . in adult women , erlesad has a high level of testosterone - resistant prostate cancer . the active ingredient in erLEadа is androgens , which stimulates the growth of the cancer , by blocking the effect of androgents . apalutaMIDe has been shown to slow down the growth and spread of prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , if it is too early to tell , or if your partner is pregnant . ( see pregnancy , contraception section .) if this applies to you , do not taking this medicine . if the above applies to your partner , take special care with this medicine and tell your doctor if any of your medical conditions apply to you before taking this medicinal product . warnings and precautions talk to your doctor before taking erledad if : you have a history of seizures . you have ever taken any medicines to prevent blood clots ( e . excipients , warfarin , and acenocoumarol 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg once a day . your doctor may increase the dose to a maximum of 60 mg once each day if your doctor tells you to stop . take erleada at about the same time each day with or without food . taking this medicine take it by mouth . swallow the capsule whole with a glass of water . do not crush , chew or dissolve the capsules . you can take ERleade with or just after food , but you can mix it with other medicines as well . if possible take a dose of er leada with food if the tablet is not taken right away . it is important that you take sterile tablets with food to avoid possible side effects . continue taking erleda
like all medicines , this medicine can cause side effects , although not everybody gets them . patients treated with erleada may experience the following symptoms : very common : these may be reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects tell your doctor immediately if you notice any of the following serious side effect : fit or seizure . uncommon : may affect up to 1 in 100 people treated with the same dose of erledad : a heart attack . a stroke has been reported rarely in patients treated for a similar condition
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe -the other ingredients are tablet core : colloidal anhydrous silica , croscarmellose sodium , ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cell . the film lining contains iron oxide black ( 6000 ), iron oxide yellow ( 8000 ), macrogol , polyvinyl alcohol , part hydrolysed , titanium dioxide ( i717 ). what erada looks like and contents of the pack erleda film  are off - white , round tablets debossed with " av1 " on one side and " nvr " on
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine which helps to obtain a detailed medical history and information for medical or healthcare professionals requiring a background check before a possible dose for a pet scan . it is given to patients who have not previously had treatment for prostate cancer or who are undergoing other tests aimed at detecting certain types of prostate specific antigen ( psa ) or if the cancer has responded to an azumin pet scan ( the type of cancer that is most likely to come back after the scan ). the use of aXumin does involve exposure to small amounts of radioactivity . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmacemic relationship with the patient and would normally be minimised in the event of radiation .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using azumin this is because a large number of people using fguiclovine have kidney problems . you should use floppyclovine to help you remember to use it . if this applies to you , tell your doctor before you use it again . tell your physician if any of these apply to you before using it , as you may not be able to use saxUMin . talk to you doctor before using this medicine if : you suffer from kidney problems you follow a low sodium diet you should not use this medicine after 4 weeks of using , since the acquist will be taken for a long time
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used and will calculate the quantity ( 370 mbq ) of megabecquerel ( mbecquered ). administration of - aaxUMin and conduct of the procedure a doctor or nuclear medicine physician will inject a needle into a vein , using a flush of sodium chloride solution . duration of the administration of the product the nuclear medicines doctor will inform you about the usual duration
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) after injecting the medicine . the following side effects have been reported with axumin : uncommon ( might affect upto 1 in100 people ), pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects tell your doctor or pharmacis if you get any side effects talk to your nuclear medicine doctor .this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( as 3200 mg or 16000 mg ). amaxumin 3200 : Each tablet contains 3200 micrograms of afluci Clovine ( als 3200 or 32000 mg ) -the other ingredients are sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see section 2 " adsorption of ethanol "). what - acumin looks like and contents of the pack - analogue : a matrix of : 1600 microgram / ml , multidose , 1 to 10 tablets , 1600 microliter / 16000 microgram ( mmol ) solution for injection - like tablets - as a single dose
azopt contains the active substance brinzolamide . this belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye . azaropt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . it reduces the pressure in your eye and can prevent damage to your sight .
do not take azopt if you have severe kidney problems . do not use aezopt - if your doctor thinks you may be allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). -if you are allergic to medicines called sulphonamides ( also known as medicines for diabetes or infections ). do not switch from diuretics ( water tablets ) to azeopt . if any of these apply to you , or if they do , tell your doctor . warnings and precautions talk to your doctor before using a Zopt : if , for any reason you think you have the same allergy or have too much acidity in your blood ( hyperchloraemic acidosis ). warnings talk with your doctor or pharmacist before using the azzopt package leaflet . talk to you doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes ( ocular use ). the recommended dose is 1 mg / ml each day . use in children and adolescents azeopt in both eyes , twice a day , at the same time each day ( e . g . in the morning and evening ). do not use if the medicine is absorbed by the eyes . rinse your eyes with water . 1 2 3 how to remove the aezopt bottle . wash your hands . remove the cap from the bottle and put it back on . after the cap is removed , remove snap collar . hold the bottle firmly in your thumb and push down . tilt your head back . pull down your eyelid with a clean
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been seen with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , keratitis , headache , cloudiness , and eye discharge . uncommon side effects may affect 1 in 100 people - impacts in the lining of the eye ( oedema ), including but not limited to blurred , dry eye , abnormal eye sensation and redness of the eyes . - side effects with bad taste . rare side effects that may affect more than 1 in 1 , 000 people : - infections of the lens ( pharyngitis ) and eye irritation have also been reported . reporting of side effects 23 if you get any side effects talk to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt is for single use only . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . throw away the bottle when you think it has been frozen . always keep the cap on the pack to protect it from light and moisture . any remaining tablets should be discarded after the first use . discard the bottle if not used . it is recommended that the label is clearly printed in the space provided . does not store above 25c . for single dose use only and in accordance with local requirements , the product should be used within one month of its
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolide . - The other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride and tyloxapol . the ingredients are hydrochloric acid and sodium hydroxide which are used to keep acidity levels ( ph levels ) normal . what ' aezopt looks like and contents of the pack azyopt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle with a screw cap .
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adults aged 18 years and older . it is used for two types of diabetes : type 1 diabetes where your body does not produce any insulin . you should only use forxi 1 if you have diabetes if your body produces any insulin properly . - forxige is used if there is no experience of treating type 2 diabetes in overweight or obese . type 2 diabetic where your bodies do not make enough insulin or the insulin that your body makes does not work as well as it should . your doctor will test your blood to make sure that forxega is working properly , and the amount (
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions contact your doctor or pharmacist immediately if any of these apply to you : you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth or odour to your urine or sweat or rapid weight loss . contact your physician or pharmacist if the above symptoms indicate " diabetic ketoacidosis " a serious , sometimes life - long problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood , and " urine " in the urine or blood . if this happens
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . forxiga is for oral use . you should swallow the tablet whole with a drink of water . if necessary , your doctor may tell you to take a different dose . type 2 diabetes the recommended dose is 10 mg once a day . your doctor will tell you the dose to take ( i . ex ., 5 mg twice a morning ). if your doctor has told your doctor that you have a liver problem . how much to take forxige to take adults with type 1 diabetes the usual dose is 5 mg once daily . taking this medicine swallow the tablets whole with some water , at the same time each day , with or without food . it is important that you take forixiga every day ; this will help your body
like all medicines , this medicine can cause side effects , although not everybody gets them . contact a doctor or the nearest hospital straight away if you have any of the following side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angioedia : - swelling of the face , tongue or throat - difficulties swallowing - hives and breathing problems diabetic ketoacidosis , see also section 2 below . it is not known how many people this medicine is going to get these effects . forxiga may cause diabetic kidneyoacology in type 1 diabetes , observed very rarely in 1 to 10 patients and in type 2 diabetes : seen rarely in rare cases , the risk is uncommon . there are rare cases of up to1 in 1 ,000 people 
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflouzin propanediol monohydrate equivalent to 5 mg dapaglingiflloz . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxika contains lactoses '), crospovidone type a , silicon dioxide ( е171 ), magnesium stearate (  470p ). film : polyvinyl alcohol ( é1203 ), titanium dioxide ( only e171s ), macrogol 3350 , yellow iron oxide ( tan ). what forixiga looks like and contents of the pack forxige 5 mg is a round ,
mepact contains the active substance mifamurtide that blocks the action of certain bacteria , which are part of the immune system ( the body ' s natural defences ). mepacted is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years old and in children who cannot have surgery to remove the tumour or cannot be removed by surgery . mepactation works by stopping the growth of cancer cells and preventing the cancer from coming back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines containing ciclosporin and other calcineurin inhibitors ( nsaids ) - have or have had problems with your heart or blood vessels , such as blood clots ( embolism ) or bleeding ( haemorrhage ) warnings and precautions talk to your doctor before using mepace : this medicine is not recommended if : you have inflammation of the veins ( vasculitis ) during mepacting , you should tell your doctor if any of these apply to you . if this applies to you ( or you are not sure ), talk to you doctor before you use me Pact . you have long - lasting or
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will watch you closely while you are being given mepace . the recommended dose is 2 mg mifamurtide given once a day for the first 12 to 24 weeks . your doctor will inform you when you should restart your mepactation treatments . this will depend on your chemotherapy schedule and on your cancer dose . you should receive the first dose of 36 mg / day after treatment with mepac . if you experience an interruption in the processing of the freeze - dried powder for concentrate for solution for injection , it is changed into a liquid suspension . it is not necessary to remove the filter before administration . mepacted will be injected into , in a vein over 1 hour . when given more mepacting than needed mepactes may be given by ,
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue can occur very commonly in patients receiving mepacting ( transient ) and transient use of paracetamol . fever can occur during or after treatment with mepactation . stomach problems ( nausea , vomiting , loss of appetite ) can occur commonly in children receiving chemotherapy . tell your doctor immediately if you develop continuing fever or chills after 8 weeks of treatment with mpact . signs of an infection such as rash , if your doctor notices any problems breathing or wheezing . these signs are usually mild and go away within 2 - 3 days of starting treatment . if they return , contact your doctor as soon as possible . your doctor may decide to reduce the dose of mepactate , but this will depend on how well you respond to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . reconstituted suspension : use immediately . this medicine may be stored in the original vial but may be kept out of direct sunlight for up to 9 days after reconstitution . chemical and physical in - use stability has been demonstrated for 9 days when stored at 2 8 and 6 hours at room temperature . once removed from the vially , the product must not be returned to the refrigerator . it is recommended that the date of reconstitution be noted on the carton . any unused suspension must be thrown away . DO not use it after the date , which is printed on
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mfamurmurte . after reconstitution , one ml of suspension contains 0 . 08 mg miffamurthide / ma . the other ingredients are 1 - palmitoyl - 2 - oleoy - 6 - al - glycol , 3 - selenium - 3 , phosphocholine ( e321 ) and 2 , 2 - dioleum , 6  - di - so - gastro - trioleucero - 4 - serine monosodium salt ( ES2 ( see section 2 " mepace contains sodium "). what me Pact looks like and contents of the pack mepactation
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used to treat the skin on the face with redness in adult patients with rosacea , which is associated with rediness of the face . rosaca causes high levels of blood flow in the facial skin , as well as enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts by blocking these receptors , allowing blood vessels to remain open and releasing the excess blood flow , leading to redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 , " what mirvass contains ", " in section 2 , ' what mirvao contains '). - as side effects have been reported with the medicine injected under the skin , it should be noted that some of these effects may be serious . - when taking certain medicines for depression or parkinson ' s disease , such as monoamine oxidase ( mao ) inhibitors ( e . excipients , for example selegiline , moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin , mirtazapin ), do not use mirvas
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is only for use on the skin , not on the face . this medicine should not be injected into the body or on the surface of certain body surfaces ( e . g . your eyes , mouth , nose or vagina ). how much to use mirvass is for injection under the skin ( subcutaneous use ). you should only use mirvao on the same surface each day . you should avoid applying mirvasa to areas near the face as long as your treatment is having the desired effect . how to use Mirvaso mirvasone is for oral use . once on the day of the week , your doctor may instruct you to use a small amount of gel ( a pea - sized amount ) once daily
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include severe skin irritation or inflammation , skin rash , / skin pain or discomfort , dry skin , warm skin sensation , including tingling , sensation of pins and needles or swelling . common side effects are worsening of rosacea . your doctor may decide to stop the treatment if symptoms persist for 2 weeks . contact allergy / allergic reaction : rash is rare angioedema ( rare allergic reaction which can cause a serious allergic reaction to mirvaso ). if you experience these symptoms , your doctor will explain their warning signs and precautions to take care of them properly . if they occur , they should stop the injection immediately and contact a doctor who will check you for signs and symptoms until they disappear . see section 2 under ' warning
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . store in the original package in order to protect from light and moisture . keep the bottle tightly closed . this medicine does not require any special temperature storage conditions . if you have any problems disposing of mirvaso , please contact your pharmacist .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , corresponding to 5 mg / ml of  Brimonidine tartrate . - other ingredients are carbomer , 2 - methylparahydroxybenzoate , 4 - ketones , all - hydroxide , and glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxides , purified water ( see section 2 " mirvass contains methyl parahydroxybenzone , propyl glycol "). what mirvao looks like and contents of the pack mirvasa is a clear , colourless gel in a glass vial . it is supplied in glass vialls containing 2 mL , 10 m2
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow and supply nutrients and oxygen to the tumour . once bevacimab is bound to vegas , tumour growth is encouraged and the blood vessels provide the nutrients and the oxygen to support tumour growth . mvai is  a medicine used for the treatment of adult patients with advanced cancer in the large bowel ( colon ). it is for use in adults only .
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy ( hyper sensitive ) - to chinese hamster ovary ( cho ) cell products . - are pregnant . warnings and precautions talk to your doctor before using mvasi . the use of mvai in pregnant women is not recommended as it may increase the risk of developing holes in the gut wall . this is especially important if : - cause inflammation inside the abdomen ( e . ex . diverticulitis , stomach ulcers , colitis associated with chemotherapy ). the use or misuse of dna may increase this risk . talk to you doctor if any of these apply to you . you may be at increased risk
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of 1 mg mvai per kilogram ( kg ) of body weight . you will be treated with m Vasi once every 2 or 3 weeks . if you respond well to treatment , you may continue receiving this medicine until maposi stops your tumour growing . frequency of Administration mVAi will be diluted before it is given to you . route of administration mvici will usually be infused slowly over a period of time , depending on your clinical condition , the number of infusions that you will receive , and the number and number of doses that have been diluted . depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . these side effects were mostly mild and temporary . you should not receive mvai if any of the following happen . allergic reactions if your doctor suspects you may have an allergic reaction , you should tell your doctor straight away . signs of an allergic response may include difficulty in breathing or chest pain . your doctor may suggest redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). you should seek help immediately if this happens . other side effects include severe side effects that may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion solution has been prepared in  a sterile environment . after diluted solution , the solution should be administered immediately ; if necessary , chemical and physical in  - usage stability has been demonstrated for 35 days at 2 - 8 and 48 hours below 30 
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacimizumaB , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . mvai 4 mg / vial contains 100 mg of BEvacizuab, ranging from 1 - 4 mg to 16 mg . this provides a metered dose of 400 mg of the bevacifab at 16 , 5 mg per m2 when dissolved as recommended the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what he m Vasi looks like and contents of the pack mVAi is a concentrate for solution for infusion . the concentrate is essentially a colourless to slightly yellow
tecartus is a gene therapy medicine used to treat mantle cell lymphoma , when other medicines are not suitable . refractory mantLE cell lymphhoma is , in part , caused by a shortage of your own white blood cells ( called autologous anti - cd19 - transduced cc3 + cells ). mantled cell lymphma is an advanced form of a cancer that affects the immune system called b - lymphocytes . in mantles cell lymphomema the number of b- lymph cells is increased in an uncontrolled way . it can affect many organs in your body such as the lymph tissue ( bone marrow ) and blood . the white blood cells in tecARTus are then added to your blood by removing the cancer cells from your body . this makes it easier for
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using tecARTus . if not allergic , ask your doctor for advice before using the medicine . warnings and precautions white blood cells are important in the treatment of your blood ( lymphodepleting chemotherapy ). they will have a limited number of 3 million white blood cell donors per autologous use . tests and checks your doctor will make sure that you have adequate numbers of : your lungs , heart , kidney , blood pressure . infection and inflammation of your cancer ( graft - versus - host disease ) or have had a transplant on your body . symptoms may include rash , nausea , and vomiting . your doctor may also check your liver function 
tecartus is made from your own white blood cells . your cells will be collected from you to make a new one . this is done by a qualified doctor or nurse . a catheter placed in your vein ( a procedure call leukapheresis ) will be stored in your blood . once tecARTus has been dissolved , your white blood cells will be transferred from your blood into your vein . it will take 3 to 6 hours for your whiteblood cells to be reconstituted and given to you . you will be given 2 to 3 months before medicines related to tecArtus treatment , known as lymphodepleting chemotherapy . when tec artus is administered , the modified white blood can be collected and given back to you after 30 to 60 minutes . theneurotoxic medicine is used to prevent infusion reactions and fever . these other medicines are used
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of tecartus . tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : the following serious side effects occurred during the tecARTus infusion . very common : may affect more than 1 in 10 people fever , chills , reduced blood pressure , symptoms such as dizziness , lightheadedness ; fluid in the lungs , which may be severe and may be life - threatening . all symptoms may be signs of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness may be accompanied by confusion , memory loss , confusion . the doctor may decide to reduce the dose or stop treatment with tecarus
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial infusion bag in order to protect from light . when diluted with liquid nitrogen , the concentrate contains less than 150 mg / ml ( 20 - 25 ). this medicine contains genetically modified human blood cells , in combination with human - derived material . this medicine does not require any special storage conditions . storage times and conditions are the responsibility of the user and would normally not be longer than 36 hours at 2 – 8 , unless the solution is clear and colourless .
what tecartus contains the active substance of tecARTUS are autologous anti - cd19 - transduced c3 + cells in a single infusion bag . each patient - specific single inf bag contains a dispersion of anti  ccd 19 car t cells in approximately 68 ml at a concentration of 2 x 106 anti . the other ingredients are : anti , sodium chloride , and human albumin . see section 2 " tecArtus contains sodium ". what Tecartus looks like and contents of the pack tec artus is a clear and colourless liquid . it is supplied as a concentrate for solution for infusion , which is supplied in an infusionbag sealed in hdpe cartons and a metal cassette . a simple infusion bags contains 68 single -
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . you may already be taking this medicine in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which lower blood sugar in your diabetes . it is important to keep following the advice about diet and exercise that you have been given by your doctor or nurse .
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). -if you have ever had inflammation of the pancreas ( pancreatic atitis ). warnings and precautions talk to your doctor or pharmacist before taking janugavia ( see section 4 ). when januire is taken for the treatment of blistering of the skin it may be a sign for a condition called bullous pemphigoid . januervia should not be used to treat a disease of the Pancreases such as pancreatis . you should also tell your doctor if your family has : gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may need a higher dose , tell your doctor . patients with kidney problems the usual dose is 25 mg once - daily or 50 mg once daily . you can take this tablet with or without food and drink . your doctor may prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and activity recommended by your doctor while taking januvia . if the amount of sugar in the blood is too high , it can be hard to get more from the medicine than you should . to help you remember to take a dose of this medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin and swelling of the face , lips , tongue , and throat , which may cause difficulty in breathing or swallowing . if any of these affect you severely , stop taking this medicine and contact your doctor immediately or seek medical attention immediately . the most frequently reported side effects were mild and brief , but very
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate , equivalent to 25 mg sitagllipt in one tablet . - other ingredients are : tablet core : microcrystalline cellulose ( e460i ), calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate ( е470b ), and sodium stearyl fumarate . the tablet film coating contains : poly ( vinyl alcohol ), macrogol 3350 , and talc ( EE553b ) and titanium dioxide ( t171 ), red iron oxide ( i 172 ), yellow iron oxide , red iron dioxide ( indigo carmine ). what  Januvia looks like and contents of the pack janugal is
what xultophy is xULtophy contains an active substance called insulin . xültophy lowers blood glucose ( glucose ) in adult patients with type 2 diabetes mellitus . this is a type of diabetes that occurs when your body does not make enough insulin to control the level of blood sugar . insulin degludec is  a long - acting basal insulin , used to control your blood sugar levels . it can be used with liraglutide or glp - 1 , and you may need to change the amount of insulin during meals . how xcultophy works oral medicines for diabetes xulation is used in combination with oral medicines to treat diabetes ( such as metformin and sulphonylurea ) to control high blood sugar level .
do not use xultophy : if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has prescribed you a sulfonylurea such as glimepiride or glibenclamide . your doctor will determine how much xULtophy you need each day and will regularly check your sulphonylaurea dose . it is important that your blood sugar levels are controlled by diet and exercise , and if necessary increase your dose of xulation . warnings and precautions talk to your doctor or pharmacist before taking xcultophy as you should be aware of the following : type 1 diabetes mellitus or ' ketoacidosis ' a condition in which the body cannot break down sugar easily .
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if your doctor thinks you are blind or have poor eyesight , or if the doctor has prescribed a higher or lower dose , you should check your blood sugar level regularly . your doctor will tell you how many doses of xultophy to use . the recommended dose is 41 injections of the active substance , once a day . you can use xULtophy at any time of the day , with or without food . use in children and adolescents the recommended starting dose of XultoPhy is 8 units per day based on your child ' s age . how to use the pen reads and uses xulation before you use it . read the user manual for more information . using xltophy with a
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common : may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , you should check your blood glucose level regularly . low blood Sugar ( hypoglacy ) can occur in patients taking xultophy . see the box at the end of this section for more information .. serious allergic reaction ( anaphylactic reaction ) ( frequency not known ): if a serious allergic response is reported , a doctor will monitor you for signs of a seriously allergic reaction . local reactions may occur in many places such as the mouth , tongue or throat that
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the vial can be stored for up to 30 days in sachets , in cartons containing 8 sachests and for 21 days after first open syringes . discard this 21 sfsv . you must return the viall to your pharmacist . this medicine does not require any special storage conditions .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec ( as 3 . 6 mg lisraglutiide ). each 3 mL vial contains 300 units of insulin de glucosedec at a concentration of 10 . 8 mg / mmol . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy includes sodium ". pack sizes : 1 vial of 3 x 5 m2 or a multipack containing 10 vials of 2 m3 . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib . it stimulates the growth of cells that are egfr [ epidermal growth factor receptor 1 ]- erbb1 - her2 [ erbe2 ] and ermb3 - regulated . these proteins help the body to grow and divide , and so slow down the growth and spread of cancer cells . by blocking their action , this medicine can slow down growth of cancer cell growth . this medicine is used to treat adult patients with cancer of the lung ( non - small cell lung cancer ). gioTRIf is used as your first treatment if you have had prior chemotherapy treatment for squamous type before prior chemotherapy therapy .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight of less than 50 kg if the doctor treating you has kidney problems ( see section 4 ) warnings and precautions side effects may include : - lung inflammation ( interstitial lung disease ) talk to your doctor if this applies to you if any of these apply to you ( or you are not sure ) tell your doctor about any of those effects . - liver problems ( your doctor may need to adjust your dose ). if there are some liver tests , tell your physician before taking this medicine , if : you have a severe liver disease you have eye problems ( such as severe dry eyes ) you have inflammation of the transparent layer at the back of your eye ( cornea 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . take this tablet at the same time each day , for at least a week . you should swallow the tablet whole with a glass of water . do not chew or crush the tablet . your doctor may reduce your dose if necessary . if your doctor decides that you need to take this medication more than once , tell your doctor . taking this medicine - take it at least 1 hour before or 3 hours after a meal . this medicine can be taken with or without food . it is important that you take this medicinal product only at the right time every day ; this will help you to remember to take it . how to take take this medicines - swallow the tablets whole with water , with slur
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen during or shortly after treatment : diarrhoea : very common ( may affect more than 1 in 10 people ): di arrhöea that does not go away . see section 2 warnings and precautions . severe diarhoa with fluid loss : common ( might affect up to 1 in10 people ), low blood potassium and worsening kidney function . diarrazhooeea can occur immediately after appropriate antidiarrhofoeal treatment . antidiarrheal medicine must be initiated prior to treatment with gioTRIf . if diaroeoeaste occurs , contact your doctor immediately . your doctor will treat you as necessary . other side effects very common : may
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone type a ; magnesium stearate ; hypromellose ; macrogol 400 ; titanium dioxide ( e171 ); polysorbate 80 ( cbs ). what gitrif looks like and contents of the pack giotricif 20 mg film  coated tablets are white to off - white , oval tablets with " gsi " debossed on one side and " fcf " on the other side . the tablet is packaged in blisters and each blister contains 7 x 1 film –
orkambi contains two active substances , called lumacaftor and ivacaftre . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation ( k28 ) that is required for the cdftr to function properly , including the cystic fistula ( cystic bristle conductance regulator ) to supply the lungs with the mutation . the k29fttr is required to make an abnormal ccftp protein . lumcaftors and ipad4 + ivacastor work by blocking the abnormal fftc protein , thereby lowering the amount of lum acaffetor in the blood . by blocking iva
do not take orkambi : - if you are allergic to lumacaftor , ivacaftre or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with ork Ambi : before you start taking orkiji , make sure that you have the f508del mutation . if this is the case , you should not take any more orkamba . warnings and precautions talk to your doctor before taking orki : the dl1001 gene may have a role in determining the correct dose of orkami . you have liver or kidney disease . your doctor will check whether the dose of of orkiambi is right for you . abnormal blood tests of the liver may occur when taking orkaambi . tell your doctor immediately if any of these symptoms suggest that you may have liver problems :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults , adolescents and children 6 years of age and over who weigh at least 12 kg or more the recommended daily dose of orkambi tablet is one 6 mg tablet in the morning . take the tablet 11 times a day , preferably at the same time each day . ork Ambi can be taken with or without food . adult orkami 100 mg tablets are available in 2 ml bottles . for children and adolescents 2 years of old and over the recommended starting dose is 12 mg orkamba , 200 mg tablets , 2 mg tablets and 2 mg tablet , in the evening . use orkacco with food , drink and alcohol if your doctor determines that you have moderate or severe problems with liver function . taking ork
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of orkambi in combination with ivacaftor are usually mild to moderate and of a short duration . if you are not sure , talk to your doctor or pharmacist before taking ork Ambi . serious side effects have been reported in patients taking orkaambi : raised levels of liver enzymes in the blood leading to liver injury in patients with pre - existing severe liver disease and the worsening of liver function . side effects may affect up to 1 in 100 people . tell your doctor if : you notice any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite uncommon ( may affect less than 1 in 1000 people ): diarrhoea
what orkambi contains the active substances are lumacaftor and ivacafting . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumcafor and 12 . 5 mg of infusion technology ( iva caftoral ). orkamba 200 mg : each tablet provides 200 mg of either lumаcaftar and 125 micrograms of ivacastor . the other ingredients are orkaji 100 mg and 124 microgram ( i . e ., orkam 200 mg and 250 microgram ) cellulose , microcrystalline , croscarmellose sodium , and hypromellose acetate s ( e468 ). the other ingredient is sb / alu ( s ) ( see " sv / alt 
what lynparza is lynchpin - the active substance of lyndranja is olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene responsible for producing brca ( breast cancer gene ) which are important in the fight against cancer . parp inhibitions can also cause death of cancer cells . how lylnparaza works parp inhibits an enzyme that is needed to repair dna . what LYnparzan is used for lymparza can be used to treat ovarian cancer called brca - positive ( newly diagnosed ) if the cancer has responded to previous treatment with standard platinum platin ,
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking lyndparza ( see section 2 , ' what lymparza contains '). if this applies to you , tell your doctor before taking your dose of lynchorza . before you start taking LYnparcia , your doctor will check your blood cell counts , which will be checked by testing for low counts of red or white blood cells , and low platelet counts . see section 4 , " possible side effects ". patients over 75 years of age should be aware of the signs and symptoms that can cause fever , infection , or bruising or bleeding . there are more serious problems with the bone marrow ( a condition called
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lynchurf is two 100 mg capsules twice a day . your doctor may increase your dose to 150 mg twice  a night . the doses of LYnparaza capsules should not be split or divided into smaller doses . you should swallow the capsule whole with a glass of water . do not chew , crush or split the capsules as they may contain ingredients in the capsule . swallow the contents of a capsule whole , with , or without food . if your doctor thinks you may have taken too much lylparza , talk to your doctor straight away . this may reduce the risk of side effects . children and adolescents 8 years of age and older take LYN
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may impact up to 1 in 100 people ), allergic reactions , including hives , difficulty breathing , swallowing , dizziness . signs and symptoms suggestive of hypersensitivity reactions . other side effects have been reported since the marketing of oral lynparza . if you notice any of the following : very common : may affects more than one in 10 users : feeling very short of breathe , very tired feeling very fatigued , pale skin or fast chest beat ; symptoms suggestives of swollen legs 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . lynparza capsules can be stored at room temperature ( below 30 ) for up to 3 days . throw away any capsules that are damaged or show signs of tampering . once thawed , the capsules should be discarded . discard any unused medicine appropriately .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of oloparib ( as lauroyl macrogol - 32 glycoproteins ). the other ingredients are : hypromellose , titanium dioxide ( e171 ), gellan gum ( k29 / 32 ), potassium acetate ( 98 %) and iron oxide black ( 83 %). what LYnparZA looks like and contents of the pack white , opaque , hard capsule , with " olarib " imprinted on one side and " 50 " on the other side . the capsule is imprinted with astrazeneca logo and " gxll4 " on both sides . lyndparza is available in packs containing 112 capsules or 448 capsules ( 112 x 112 cm ).
this medicine contains the active substance naloxone . nyxoid is used to treat the following opioids : heroin , methadone , fentanyl , oxygen , hydrocodone , buprenorphine / morphine . what nYxoide is used for nnyxxoir is used as a nasal spray in the emergency treatment of opioid overdose in adults . opioid overdosing can be fatal in up to 14 incidents of overdose , including breathing problems and severe sleepiness . in case of an opioid over dose , opioids must be disposed of appropriately , and you must receive emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using nYxoide . - you are dependent on emergency medical care , as your doctor will have told you . your doctor may need to provide emergency services if an opioid overdose occurs . talk to you doctor if the signs and symptoms of an opioidoverdose are similar to those of opioids . you should use this nasal spray at least 2 to 3 times a day . use a new nasal spray as soon as you can , to make sure that it is safe to use this medicine . tell your doctor or pharmacist if : you are physically dependent on opioids or have been dependent on heroin . these include heroin , met
nyxoid nasal spray is for use in adults only . it should only be used in the space provided in the outer layer ( s ) of the mouth and throat . do not use it on the shoulders or on the ears . if the solution is not clear , it should be injected into the breastbone ( sternum ) and into the ear with a fingernail . use to clear the mouth or nose of any blockages that may occur between the mouth , nose and throat ( see section 1 ). when breathing is the chest moving , you should hear breathing sounds and feel a sound when you breathe on the cheek . in overdose , the response to touch or sounds may be short - lived and may cause slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and seek medical help immediately if you have any of the following acute withdrawal symptoms . these are usually mild to moderate and usually go away within one week of stopping opioid drugs . symptoms include fast heart rate and high blood pressure body aches and stomach cramps feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering ; trembling changes in behaviour , violent behaviour . nervousness , anxiety , confusion , disorientation , depression , difficulty concentrating , change in mental status and / or mood swings . other side effects include : very common ( may affect more than 1 in 10 people ): headache ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for medicines that have been frozen , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 mg of nnalopone ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydroch chloric acid , sodium hydroxide e524 , purified water . what a nYxoide looks like and contents of the pack nylonoidic is a clear , colourless to pale yellow solution . nanyxooidu is supplied in a pre - filled nasal spray in  a single dose container . the pre - filled sprayer is supplied with nebuliser . it is supplied as a carton containing 2 nasal sprays , each packed in blisters .
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural occurring hormone produced by your body called " flt2 ." fsh is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , ovaleep is used for the growth and development of the sacs ( farrows ) in the ovaries that contain the eggs and for the production of sperm . ovale ap is intended for use by adults who have not been conceived and are unsuitable for treatment with a medicine called " tomifene citrate ". it is used in assisted reproductive technology procedures ( procedures that may help you to become pregnant ) when a medication called " lautropin alla " is used together with another gonadotropicin called " le
do not use ovaleap : - if you are allergic to follitropin alfa ( female fsh - 1 ), flh , f2h or any other f1h / womb stimulating hormone ( fsti ) or to any of the other ingredients of this medicine ( listed in section 6 ) -if you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). - in women , large ovaries or sacs of fluids within the ovulation ( ovarian cysts ) of unknown origin . - on unexplained vaginal bleeding . tell your doctor if any of these apply to you . you may be at increased risk of cancer in your oocytes , the wwomb or breasts 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women who have irregular periods should not use this product . during the first 7 days of your menstrual cycle , your doctor will tell you how much of the medicine to give . the recommended dose is 75 mg given twice a day . your doctor may increase your dose up to 150 mg . use this medicinal product for the 7 - day period , up to 14 days of 37 . 5 mg twice - daily . you can use the 75 - mg dose for up to seven days , but your doctor can change your dose if needed . for women , this medicine can be given up to 225 mg twice daily in hcg , or h
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin can be very serious . if severe allergic reactions occur , they may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . these effects are very rare ( may affect up to 1 in 10 , 000 people ). if you have this type of reaction , you should stop your ovaleap injection and contact your doctor immediately . serious side reactions in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulated growth ( ovary ) in women . this type is very rare and will affect upto 1 in every 10 m2 of body surface area . very rare : may affect less than 1 in 100 people . tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the cartridge label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may use this medicinal product for up to 3 months when stored at a temperature below 25 . once you have used this medicine for 3 months the cartridge must be stored at room temperature within the refrigerator ( at roomtemperature below 25 and away from direct heat or direct light ). once removed from the refrigerator , the pen must be used within 28 days at room temperatures below 25 ( but below 25 of the room temperature ). remove the pen cap from the ovaleap pen . always use this medication if you notice that the solution is cloudy or
what ovaleap contains - the active substance is follitropin alfa . - ovaleep 300 iu / 0 . 5 ml : each cartridge contains 300  22 micrograms of foltropin altfa in 0. 5 millilitre ( mmol ) solution . ovaleop 450 ius / in ' 0
voriconazole accord contains the active substance voricanazole . vorikonazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . this is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to aspergollus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the fungus is resistant to fluconazoles ( another antifungals medicine ), seriously serious fungal infections caused by scedosporium spe ( or fusarium sf .). vori
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - take any other medicines , even those that are obtained without a prescription , including herbal medicines . ask your doctor or pharmacist if your doctor is unsure about the medicines you will be taking during voricanazole acord treatment . these include : 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ), cisapride ( used when stomach problems are common ) pimozide ( for treating mental illness ) quinidine ( used in adult patients with irregular heart beat ) rifampicin ( used if used to correct tuberculosis ) and efavirenz ( used on steroids ). pregnancy and breast
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will calculate your dose depending on your weight and the type of infection you have . the usual dose is 40 mg per kg of body weight . if necessary , your doctor may increase your dose to 40 mg / kg every 24 hours . for the first dose : 400 mg given as 12 doses 24 hours apart ( for the second dose ), 200 mg every 12 hours for the third dose . after 24 hours ( for example , 24 hours after the first dosage ), you will receive 200 mg  5 mg twice a day for the final dose , followed by 100 mg ( twice daily ). your doctor might reduce your dose at any time during treatment . 300 mg a dose of voriconazole accord is usually sufficient . patients with mild to moderate cirrhosis generally do
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor straight away , if you notice any rash or jaundice ; changes in blood tests of liver function ; pancreatitis . other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , holocausal vision ; night blindness and swinging vision ) common , may affect up to 1 in every 10 people very common side effects ( may affect less than 1in every 10 users )
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voricanazole ( as besilate ). vorionazole acord 50 mg film - coated tablets : each tablet contain 200 mg vorizoconazoles ( as bisphosphonate ) the other ingredients are : voriCONazoleaccord 200 mg film- coated tablet : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . in addition , the tablet coating contains hypromellose , titanium dioxide ( e171 ), lactoses monohydrate and triacetin . the film silver coating contains lactoside .
mvabea is a vaccine to prevent ebola virus disease in the future . it is given to individuals aged 1 year and older who may possibly come into contact with ebovirus . this means that you will receive a 2 - dose course of vaccinations to protect you from getting ebala virus illness caused by the zaire ebelavirus , which is essentially a type of filovirus that produces the most of the eggs from the chicken eggs . your doctor will tell you how to prepare for you eballa virus diseases . because this vaccine will not protect you against the whole ebora virus , it will not give you a single dose of ebara virus virus disease . vaccinations with zabdeno vaccine the first dose is given 8 weeks later . mvasbea vaccine is given at the same time as zabe
mvabea will be given to you by a doctor or nurse trained in the vaccination course and who will supervise the whole process . they will check with you or your doctor if you are not sure . warnings and precautions talk to your doctor or pharmacist before you are given the vaccine if : you have ever had a severe allergic reaction to any ingredient of the vaccine listed in section 6 . you have had : a severely allergic reaction after receiving an antibiotic ' gentamicin ', the vaccine may not fully protect all those who receive mvasbea . if any of the above apply to you or you areunsure , talk to you doctor or healthcare professional before you receive a dose of mvbea and if there is anything you do not have a history of a serious allergic reaction following any other vaccine injection . tell your doctor straight away if or you faint
your doctor or nurse will inject the vaccine into a muscle ( intramuscular injection ) in the upper arm or thigh , or into , a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . if you miss the scheduled dose of mvabea vaccine , your doctor will tell you when to give the second vaccine . how much to get the primary vaccination first vaccination using zabea red cap vial the second vaccination with the mvasbea yellow cap vially is given at a dose of 8 ml . after the first vaccine with zbdenon the recommended booster vaccination with either zaBdeno or mvdeno is given .
like all medicines , this vaccine can cause side effects , although not everybody gets them . most side effects occur within 7 days of having the injection . the following side effects are very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in10 people ), being sick ( vomiting ) itching where the vaccination is given uncommon ( may effect up to1 in 100 people ). redness and skin hardness where the injecting is given generalised itching reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine
what mvabea contains - the active substance is : zaire ebolavirus , 29 micrograms tai forest ebavirus nucleoprotein marburg , 0 . 7 x 108 pfu / ml * propagated in chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what ? mvasbea is a suspension in a single - dose glass vial , closed with a rubber stopper and yellow cap . mvbea comes in sachets of 20 mbq ( 0. 5 mg ) per dose .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce other bone problems that may need surgery or radiotherapy bondronatul can also be prescribed if : you have a raised calcium level in your blood due to : a tumour is found in your bones . these effects can help to stop your bones getting weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low levels of calcium in your blood . do not receive this medicine if any of these apply to you . if not , speak to your doctor . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronatului for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocrossis ( of the waist ), there are some precautions you should take
this medicine bondronat is usually given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein . your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronatului you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg every 3 - 4 weeks , as an injection in your vein over at least 15 minutes . in case of a raised calcium level in your blood , the recommended starting dose is 1 mg every 2 weeks or 2 mg every two weeks . depending on the severity of your illness the medicine may be given as either an inflection or an inhalation . you may need a repeated
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( could affect upto 1 in 10 ,000 people ), pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if : you have ear pain ; discharge from the ear ; an ear infection . this may be a sign of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately this medicine may be stored at room temperature ( 20 - 25 ) for up to 24 hours . store in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion containing 2 mg i bandronic Acid . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , water for injections . what bondruat looks like and contents of the pack bondronate is a clear , colourless solution for injection supplied in a glass vial of 1 mL or 2 g , with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what ZEposia does is to treat relapsing remitting multiple sclerosis ( rrms ) in adults with active disease at an advanced stage of multiple . what multiple ' s disease is ms is a disease in which the immune system ( the system that attacks the body 's defenses ), including the body' '' . white blood cells are important for the nerves in the brain and spinal cord , and for the nervous system . this causes symptoms such as numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) - in your family - you have a severely weakened immune system - have had a heart attack ( angina ), stroke , mini - stroke or transient ischemic attack ( tia )- have severe heart failure in the last 6 months - are having irregular or abnormal heartbeats ( arrhythmias ) which do not go away . warnings and precautions talk to your doctor or pharmacist before taking zeposa if any of these apply to you . you must tell your doctor before starting treatment if : - your doctor thinks you have severe infection ( hepatitis ) or tuberculosis - the doctor will check you for cancer - has severe liver
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will tell you exactly how many capsules of zeposia to take . the dose will be calculated based on your heart rate . there is a ' treatment initiation pack ' with orange capsules that contains 0 . 23 mg / ml of ozanimod . after 1 week , the first dose will consist of 4 mg of 0. 23 mmol of  0zani mod per day for 1 week followed by 4 weeks of treatment . then , you will have to take 3 capsules , i . e ., 0
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common : may affect more than 1 in 10 people slow heart rate , urinary tract infection , blood pressure uncommon : might affect up to 1 in 100 people allergic reaction . the signs may include a rash . other side effects common - may affect upto 1 in every 10 people infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynex ) viruses , a type of white blood cell called lymphocytes common , may affect any part of the body ' s immune system ( known as tachycardia ). the signs might include : fever , chills . nose or sinuses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . please return the pack to your pharmacist if you notice any damage or signs of tampering to the pack . these measures will help protect the tablets from moisture .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg capsules each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepatia 00 . 46 mg capsule each capsule provides 0
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids , often simply called steroids . umecilidiniumbromide or vilantrol belong to  a certain group of medications called bronchodilators . what temуbric is used for temmybric anaesthetics are used to treat adults with chronic obstructive pulmonary disease ( copd ), a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . as a result of copd they relax and improve their function . breathing difficulties are greatly lowered by the muscles responsible for breathing ability .
do not take temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking temуbric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybril ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temуbric anaesthetics can help to relieve a sudden attack of breathlessness or wheezing . when you get this sort of attack you must use a quick - acting reliever inhaler ( such as salbutamol 
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients , an uncommon side effect of temybric ellipta . symptoms of a lung infection include fever and chills . increased mucus production , change in mucuses colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat or runny nose decreased appetite common side effect ( may effect up to1 in 10 persons ) - sore or runnelling , redness or pain in the mouth , indigestion , flatulence , wind , low blood pressure , high blood pressure or bruising
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of fluticasesone furonate ; 65 microgram ( ml ) umeklidinium brmide equivalent to 55 microgram( mmol )umeclidium and 22 microgram [ mL ] umecladinium ( e218 ) vilantrol ( trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temYbric is for inhalation use ') and magnesium stearate . what mybril ellippa looks like and contents of the pack the ellipatta inhaler consists of a light grey plastic
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfordo is used to treat infections of the skin and the tissues below the skin . this is often called an infection of the lungs , sometimes called a ' pneumonia ' . how zinfo works zinForo works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking zin foro . if your doctor thinks you may be allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . your doctor will decide if treatment with zinfordo is suitable for you . talk to you doctor or nurse before taking the medicine . take special care with  Zinforo tell your healthcare professional before taking your first dose if: you suffer from kidney problems you have ever suffered from seizures ( convulsions ) you have any non - severe allergic reaction to other bacteria
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that need treatment , your doctor will give you the lowest dose . the recommended starting dose is 8 mg every 12 heures . zinfordo is given as a drip into a vein ( intravenously ) over a period of 5 minutes . after this time , the doctor will increase your dosage to 60 mg every 120 hours , and you may receive an increased dose , depending on how you respond to treatment . it usually takes 5 to 14 days to prevent skin infections . you will usually receive a single dose every 5 to 7 days for pneumonia . patients with kidney problems if your doctor determines that patients with renal problems are more likely to receive zin foro . once inside your body your doctor can check that your kidneys are working properly
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems these may be signs of a serious allergic reaction ( anaphylaxis ) and may be life - threatening . diarrhoea ( stool ) or blood or mucus . during treatment with zinforo , you may be given medicines to slow bowel movement . common ( may affect up to 1 in 10 people ) a blood test called a ' coombs test ', which may show you are being treated with another type of antibiotic . this test may show how well your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine , sugar , and water for injections . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . each pack contains 10 vials 
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neursopathic pain : pregabALin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nuropathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , twisting , shooting , stabbing , sharp , cramping ; aching , feeling tingling , or numbness . the nerve may also be damaged by a range of diseases . these include : abnormal sleep patterns , prolonged sleepwalking / driving , walking , talking , reading , writing , drawing , cutting , injuring or
do not take pregabalin pfizer : if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaltin ppfizer. some patients taking pregamalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabralin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , your doctor should carefully supervise your treatment . when taking pregalin it is possible that you may experience blurring or loss of vision , or other changes in eyesight ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor and may vary for each dose . the dose , which has been adjusted for you and your doctor may prescribe a different dose if needed . for twice a day take pregabralin ppfizer once in the morning and once inthe evening , at about the same time each day . you should swallow your capsules whole with a glass of water . do not chew , crush or break the capsules . if possible , take pregal
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common - may affect up to 1 in10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , lack of motivation , memory impairment , loss of memory , or tremor , difficulty with speaking , sometimes with tingling feeling . not known : frequency cannot be estimated from the available data loss of taste . if you experience these feelings , tell your doctor or pharmacist . you should contact your doctor as soon as possible . in general , irritation and trembling have been reported . uncommon : might affect upto 1 in 100 people loss of
what pregabalin pfizer contains the active substance is pregabaltin . each tablet contains 25 mg , 50 mg ; 75 mg / 100 mg : 150 mg - 200 mg  225 mg => 300 mg pregabALin the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink containing shellac / black iron oxide ( i . e . propylene glycol , potassium hydroxide ) and inks containing 75 mg, 100 mg, 200 mg and 225 micrograms / ml . the active substances are : tablet core : lacto e1200 , amber coloured ,
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . this helps to control the level of doping in your mind . xdado is used to treat parkinson ' s disease in adults . parkinsons 's disease causes sudden seizures that stop you being able to move . when you have difficulties moving , x ad ago can be used together with the medicine levodopa which is used alone or in combination with other medicines used to control parkinSON '
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - in combination with the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; and tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you must stop taking xdagot 7 days before or after xamago treatment . do not stop treatment with mao inhibitors such as pethtine or to treat your condition if they cause you to feel sick ( nausea ) or have nausea . talk to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day . your doctor may prescribe a lower or higher dose to a maximum of 100 mg once daily . take the tablet with or without food . swallow the tablet whole . x ad a go to bed and take the medicine with food , usually by mouth . do not take xdag with food or between meals . patients with moderately reduced liver function : the usual dose is 50 x daily , but you should continue to take Xadabo for as long as your physician tells you to . contact your doctor for advice if these effects are not controlled . taking xageda go with food may lead to : raised blood pressure 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that can lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( nymc ). the signs may include confusion , sweating , muscle rigidity ( hyperthermia ) and increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). you may experience confusion . furthermore , hypertension may be associated with muscle stiffness , hallucinations and hypotension . the most frequently reported side effects in patients treated for parkinson ' s disease were safinamide and levodopa . levodomyolysis may also occur in patients who had been treated with a different medicine than xadago . if you experience confusion
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafieinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate - silica colloidal anhydrous - film coating : ink : shellac , poly ( vinyl alcohol ), hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( i 172 ). what Xad x ado looks like and contents of the pack xdadare 50 mg are light pink , oval , biconcave film - coated tablets of 7 mm diameter with metallic gloss printed on one side 
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytigea reduces the amount of testosterone in your blood when it is taken together with prostate cancer . the active ingredient in zymiga lowers testosterone ( androgen deprivation therapy ) and lowers estrogen ( andrigen deficiency therapy ). it is usually given together with another medicine , prednisone or predNisolone , which is used for high blood pressure . as a result , it reduces fluid retention in your body , and helps to maintain a normal level of fluid in your urine .
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , zytigea could harm your unborn child . if your undiagnosed kidney or liver damage has been reported , talk to your doctor before taking this medicine . warnings and precautions talk to zyta your doctor , pharmacist or nurse before taking zymiga if : you have severe liver damage or prostate cancer . you have the potential to become pregnant . your doctor may want to monitor you carefully while you are taking this medicinal product . take special care with this medicine tell your doctor or pharmacist if any of your medical conditions apply to you : your doctor needs to know before you start taking this medical condition : liver problems , high
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once daily . take this medicinal product twice a day , at about the same time each day . you can take this medication with or without food . this medicine is taken by mouth . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . if necessary , your doctor may advise you to take zytiga with food or between meals . how long to take take ytiga for 2 weeks before you decide to stop . try to take it at the same times each day and then take it with food , preferably at the exact same time every day ; this will help you to remember to take the tablet ( s ). how long you should take  take a tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches or a pounding heart beat ( palpitations ). these may be signs that the level of potassium in your blood is low . potassium - related side effects very common : may affect more than 1 in 10 people - a build up of fluid in your legs or feet . this can lead to low blood potassium which may show up in liver function test , in high blood pressure , urinary tract infection , diarrhoea , and / or vomiting . - low levels of potassium , seen in blood tests . common - may affect up to 1 in every 10 people as a result of low level of fluid  in your feet or feet ( seen in liver functioning test
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abaterONE ade . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactoside "). what ztiga looks like and contents of the pack - zyta tablets are white to off - white , oval tablets of 9 . 5 mm diameter , with " a200 " debossed on one side . the tablets are provided in a plastic bottle with a child - resistant closure and a desiccant . pack size of
hefiya contains the active substance adalimumab . he is a medicine used for the treatment of inflammatory diseases , including polyarticular juvenile idiopathic arthritis and enthesitis - related arthritis , paediatric plaque psoriasis , pediatric crohn ' s disease and paedialic non - infectious uveitis in adults . the active ingredient in heifiyo is rasdalumumabe , a monoclonal antibody . monoclonous antibodies are proteins that attach to a specific target in the body . by attaching to tnf , the target of aadalumaB is tNA , which is essentially a tumour necrosis factor ( tNOF ), which is present at
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). warnings and precautions talk to your doctor or pharmacist before using heifiyo : if any of these apply to you , tell your doctor if : you have symptoms of infections , such as fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . your doctor may need to adjust your dose , especially if this medicine has been associated with such a serious heart condition . allergic reaction if the severity
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults : the usual dose is 40 mg once a day . your doctor may increase your dose to 20 mg once daily . if your doctor determines that you need a higher or lower dose , your doctor might increase your dosage to 40 mg twice a week . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children / adolescents from 2 to 10 kg 30 mg every week not recommended for enthesitis - related arthritis age or body weight not applicable kids and adolescents from 6 years of old weighing less than 30 kg 40 mg each week not suitable for children and adolescents between 6 years
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing or swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as you may need medical attention . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , nose bleeds ; skin cancer . uncommon cases of skin cancer ( including cellulitis and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light it will be stored in the refrigerator ( 1 - 8 ) and protected from light for , but not above 25 , for up to 14 days in the original package for room temperature storage . once your pre – filled  sYringe has been removed from the
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimUMab in 0 . 4 ml of solution . - other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfiуa looks like and contents of the pack heifiyo 20 mg solution for injection ( injection ) in pre  -filled sYringe for paediatric use is supplied as a 0. 4ml clear to slightly yellowish solution in a single - use clear type i glass syed with
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rităuximabab sticks to this cell , the cell dies . ritemevia is used for the treatment of several different conditions in adults . the active ingredient in ritemmvia is called " monocle ". these include : a ) non - hodgkin ' s lymphoma this is just a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymph cells . your doctor may prescribe ritedmvia alone or with other medicines called chemotherapy . it usually appears within 2 weeks of the start of
do not take ritemvia if : you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe active infection at the moment you have been told you have this medicine because you have such a weak immune system you have severe heart failure or severe uncontrolled heart disease and have granulomatosis with polyangiitis , microscopic polyangiviitis or pemphigus vulgaris . do not have ritemevia , if any of these apply to you . you have ever had or might now have  a hepatitis infection . warnings and precautions talk to your doctor , pharmacist or nurse before using ritemmvia : if you have had hepatis b or c
your doctor will decide how much ritemvia you will receive and for how long . this treatment will be overseen by a doctor who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . the doctor will monitor you for any side effects . ritemevia is given as a drip ( intravenous infusion ) over a period of one to two weeks . medicines given before each ritemmvia administration before you are given rite, you will be given a dose of rite
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , certain types of reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the infuse site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat and / or difficulty breathing . these reactions have usually mild to severe . if they get worse during the 24 hours after the induction period , you may experience chills  and a general feeling of general discomfort . other side effects may include : very common : may affect more than 1 in 10 people a
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritsituximiab in one ml . each mL of concentrate contains 10 mg of of  Rituxlimab the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemorvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial , which is suitable for 2 m .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains capecitationbine , which itself is not a cytodynamic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitedbine  is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitébine téva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery .  cape citbine  Teva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is an allergy or over - reaction to this medicine , - in case of severe reactions , fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - the pregnant or breast - feeding - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia )- have severe liver or kidney problems - do not have access to food or water in the body because of low levels or levels of the enzyme dihydropyrimede dehydrogenase ( dpd ) ( complete dppd deficiency ) described in section
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your condition . the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . one dose for each square metre of body surface surface area is provided in square meters ( m2 ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1 , 7 . 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg . a man whose weight is 80 kg
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeat at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : as a result , you lose your appetite . stomatitis : whenever you have pain , redness , swelling or sores in your mouth and / or throat . hand - and - arm - related st . mary - johnson syndrome : tell your doctor immediately if your doctor notices any of the following : very
what capecitabine teva contains - the active substance is capecitebine . capecitationbine - capeciabine TS 150 mg film - coated tablets each film  contains 150 mg capecbine  cape citation teeva 500 mg film film – coated tablets every film ­ contains 500 mg capеcitabine * - ingredients in the tablet core : lactose , microcrystalline cellulose ( e460 ), hypromellose ( 6000 ), collapsing ( elektron ), pregelatinised ( s ), carnauba wax (  e903 ), magnesium stearate ( е572 ), macrogol 400 ( 8000 ), ink : hypromllose , titanium dioxide ( é171 ), yellow iron oxide (  600 ),
what silodosin recordati is silonosine recordatin belongs to a group of medicines called alpha1a - adrenoreceptor blockers . siloooodosesin record ati is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what sillod dosin recordingi is used for sillodon recordatis is used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , even at night .
do not take silodosin recordati if you are allergic to siloooodosesin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sil lododsin recordingi . before eye surgery , tell your doctor if there is cloudiness of the lens ( cataract surgery ), as this may increase the risk of it happening ( see section 4 ). 26 during treatment with sillodonosine recordatin , there is a risk that medicine may cause a loss of muscle tone in the iris ( the coloured circular part of the eye ). in such a case , it is important to take appropriate precautions when handling the medicine and surgical techniques . talk to the doctor or surgeon before using sil, do not use sil.dosentin recorditi
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of silodosin recordati is one 8 mg capsule taken once a day with or without food . swallow the capsule whole with a glass of water . do not chew , break or split the capsule , as it may cause damage to the capsule content . patients with kidney problems if your doctor has prescribed you a lower dose , or if someone else has moderate kidney problems the recommended starting dose of this purpose sillodon recordatin is 4 mg once . for this purpose , you should take sil lodod dosin recordingi 4 times a Day . if this happens , tell your doctor immediately . when you first start taking silledozin recordattai ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you notice any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect of silodosin recordati is dizziness . this is common . dizzinness when standing up , together with occasionally fainting , may be stronger or less noticeable . if this happens , contact your physician as soon as possible . you should contact your dentist if the symptoms of dizziity or fainting occur , as sillodonesin recordingi may lead to complications during a cataract surgery ( eye surgery ). you should inform your doctor as soona day if any of these occur .
what silodosin recordati contains sillodonosine recordatin 8 mg hard capsules : the active substance is silonod . each capsule contains 8 mg of siloudoosink . the other ingredients are pregelatinised maize starch , mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( i171 ). sil lodo'sin recordingati 4 mg hard hard capsule : each capsule contain 4 mg of seloodostin . - the other ingredient is pregenialised maizen wort , pregezolate .- the solvent is pre gelatinised to form a film - coated tablet . silnosi recordatti 4g hard
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin in ' i ' is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzonzalmonio blocks the effect of angio Tensin 1 , so that the blood vessels relax , and your blood temperature is lowered . what kinzimono is used for kinzzalmona is used to treat essential hypertension ( high blood pressure) in adults . the high blood tension is caused by the high level of sugar in the blood . high blood temperature , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may be more than 3 months pregnant . ( it is also better to avoid kinzilmono in early pregnancy see pregnancy section .) if your doctor has told you that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . if any of the above apply to you , or you are not sure , talk to your doctor or pharmacist before taking kinezalmona . warnings and precautions talk to you doctor , pharmacist or nurse before taking this medicine if : you have diabetes or impaired kidney function or you were treated with a blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably at theselben time each night . you can take kinzonzalmonio with or without food . always take the tablets with a glass of water . it is important that you take kinszalMONo every day until your doctor tells you otherwise . if your doctor thinks that the effect of kinszulmono may be too strong or too weak , talk to your doctor . for treatment of high blood pressure , the usual dose of the usual starting dose of one kinzilmona 40 mg / 12 . 5 mg may be increased when you first start taking it , but your doctor may prescribe
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as they could be fatal . other possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ]: low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects (19 may affect less than 1 in 100 people ); urinary
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . store in the same place every time you take it . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglumin , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to off - white , round and marked with the code ' k ' on one side . kinzalemono is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product , prepared by recombinant dna technology . it contains the active substance lonoctocog alfa . aaftylay is used to treat bleeding episodes in patients with haemophilia a ( inborn factor  vii deficiency ). factor ixi is necessary for blood cloting . patients must have an increased tendency to bleed . the lack of factor ii in haematophilian patients is not a cure for this . you must use a different product each time you have a new one .
you should not be given afstyla : if you have ever had an allergic reaction to avstlyla . if the patient is allergic to hamster proteins . warnings and precautions 46 talk to your doctor before you are given , or while you are being given : your doctor may decide to change the batch number in your treatment diary . you should never be given more than one dose of aaftyl . allergic ( hypersensitivity ) reactions are possible with a dose of one dose in the treatment with . your doctor will make sure that you are provided with symptoms of allergic reactions . in allergic reactions the signs may include hives , generalised skin rash , tightness of the chest , wheezing , a fall in blood pressure , and anaphylaxis . the signs of , possibly life 
your treatment should be initiated under the supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of 0 . 5 ml will be decided by your doctor and will depend on your condition , the site and severity of the bleeding your clinical condition . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) immediately before use . if necessary , your doctor may adjust the dose of the product based on aseptic conditions . before using afstyla , please refer to the package leaflet for further information . other medicines and adsorbed on solvents 6 . after reconstitution , ensure that the solution is clear to slightly opalescent and colourless to slightly yellow . it should be 
like all medicines , afstyla can cause side effects , although not everybody gets them . you must contact your doctor immediately if you experience symptoms of allergic reactions allergic reactions include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding ). in patients receiving factor viii medicines : you will develop inhibitor antibodies ( see section 2 ). very common ( affects more than 1 in 10 patients ): if this happens you must tell your doctor . patients who have received previous treatment with factor ixi ( more than 150 days of treatment ) will be monitored carefully for any signs of inhibitor development . very common : may affect more than1 in 10 people . in children not previously treated
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viale in the outer carton in order to protect from light . after the afstyla powder has been reconstituted it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . record the date from when you start to store the product out of direct sunlight . once removed from the refrigerator , the product must be used immediately . discard any unused portion of the product after reconstitution . this medicine is for single use only . use the reconstructed product immediately after reconstituted solvent .
what afstyla contains the active substance is lonoctocog alfa . after reconstitution with 2 . 5 ml of water for injections the solution contains 100 mg of lonoctcog allfa ( 100 mg / mL ). after reconversion with 2 2 : 5 mm of water pour into empty spaces , the solution can contain 200 mg of honoctoCog alfiea ( 1000 mg ). upon reconstitutionwith 2 , 5 . 0 mmol of waterfor injectionsthe solution contains 400 mg of Lonoctoccog lfa and 1500 mg of water . upon reconversion by 5 % of water für injections ,the solution can be divided into equal doses . each millilitre of lonostocogog alfata ( 1500 mg ) is given per square metre of water per square
what praxbind is praxxbind contains the active substance idarucizumab . iderucizumаb is a reverse agent of dabigatran ( pradaxa ), a blood thinner medicine that helps prevent blood clot formation . what pprax binder is used for prazbind is used to rapidly trap dabig atran in order to reduce the risk of bruising . when prallbind is applied , praxiabind can be used in emergency surgery or urgent procedures , to reduce uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . if your doctor has told you that you have a genetic disease called hereditary fructose intolerance ( hfi ) or the substance sorbitol . this medicine may cause serious adverse reactions . warnings and precautions talk to your doctor before taking pranbind . do not use this medicine if : you are taking dabigatran ( a substance present in other medicines to prevent blood clots ). dabig atran is absorbed into your body and so may cause blood throts and your doctor may prescribe medicines to help prevent blood from clottings . your medical condition may also be affected . talk to you doctor before you take  Praxbind ( see other medicines and 
praxbind is given by a healthcare professional . the recommended dose is 5 mg . your doctor will decide how many doses you need . this is usually given as a 2 . 5 mg dose . you will receive dabigatran in a single or divided dose , over a period of approximately 24 hours . if you miss a dose of this medicine , contact your doctor to reschedule your appointment . it is very important that you do not miss - the dose of praxxbind . do not take more than the recommended dosage . make sure you take this medicine exactly as your doctor has told you . check with your doctor or nurse if it is : - you have missed a scheduled dose - this medicine is given to you by syringe ( drip ) by infusion ( drip or drip ). - your doctor may decide
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects tell your doctor or pharmacist if you get any side effects or get any information . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what pfizer looks like and contents of the pack praxxbind is a clear , colourless to slightly opalescent , or slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temogrammedaic is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the combination of temtemoMEDac with radiotherapy ( concomitant phase of treatment ) and monotherapy phase of therapy is also recommended . it is also used in children 3 years and older and adult patients with malignant gliomema , such as glibblastomas multiforma or anaplastic astrocytoma ( nasc ). temmomedаc is used in these tumours when standard treatment is not feasible .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if there has been an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body to keep fighting infection and to maintain proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking tememedacrac : if your doctor think
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if your doctor has determined that you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temac to prevent nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme : if any of the above applies to you , tell your doctor as you may need to take treatment in two phases : treatment together with radiotherapy ( concomitant phase ) followed by temogramac ( monotherapy phase ). the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), uncontrolled bleeding , seizures ( convulsions ), fever , chills severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells that may cause fever ) and reduced resistance to infections . the reduction in blood cell counts may cause anaemic (  aplastic anaphylactic shock ), which may be life - threatening . fever may be accompanied by fever ; reduced resistance against infections , and the reduction may be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . bottle : do not store above 30 . tell your pharmacist if you notice any change in the appearance of the capsules . this medicine does not require any special storage conditions . don ' t throw away any medicines in your wastewater or household rubbish . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temokac 5 mg : each tablet contains 5 mg of temizolomide ( as monohydrate ). temogramomedаc 20 mg  : every tablet contains 20 mg of mesolomide [ as monolithic ). the temoticac 100 mg ; each tablet contient 100 mg of modolomiide ( as mesozolomiDE ). also , temac 140 mg , each tablet contain 140 mg of mésodium . the earliest tablet contains temomelomide in one tablet . furthermore , the tablet contains 180 mg of metolomid . each tablet of ms containing 180 mg temazolomide is a white to off - white powder . also a powder for solution for injection contains 250 mg / 25
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eer penis suitable for sexual activity . ciali is intended for adult women who have a high ed up body weight . it is used when cialize cannot deliver a sufficient amount of e rect penis acceptable for sexual performance . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , the blood vessels in your penis relax , so the flow of blood into your penises is increased . when levitra is taken , it can help to keep etile function back to normal . your doctor has prescribed cialisse for you because you do not have equitile dysfunction at all . you should not
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking cialIS . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if your doctor has told you that you are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is a group of medicines (" nits "), used to treat angina pectoris (" chest pain ") in patients receiving cialist . if any of these medicines contains nITrate , you should tell your physician immediately . serious heart disease if  you have recently had a heart attack within the last 90 days . you recently had or have had , or have suffered ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . cialis tablets are for oral use . swallow the tablets whole with some water . the tablets can be taken with or without food . you can take the tablets with or immediately after a meal . this will help you to remember to take it . your doctor may adjust your dose , temporarily stopping , or permanently stopping . do not take more than the recommended dose . take the tablet at least 5 hours before or 2 . 5 hours after sexual activity . how long to take cialist take ciais for as long as your physician tells you , do not stop taking ciali . when cialisse is taken for long periods , your erection may last for up to 24 hours . taking ciaist is a medicine for 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency uncommon ). chest pain - do not use nitrates but seek immediate medical assistance ( frequency rare ). priapsim may cause a prolonged and possibly painful erection . if cialis does not provide you with an er ert , which lasts continuously for more than 4 hours , contact your doctor immediately . sudden loss of vision has also been reported ( frequency not known ). other side effects have been reported in 1 to 10 users in 100 . common ( may affect up to 1 in 10 users ): headache , back pain , dizziness , drowsiness , shaking , nausea , vomiting , abdominal pain and distension have also been observed 
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttadeala fil . - other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate , magnesium stearate . film - coat : talc , lactoses monohydrate , and hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( 233 ), and iron oxide red ( 235 ), indigo carmine ( 900 ), titanium dioxide , iron oxide black ( 177 ), or talcite . what ciais looks like and contents of the
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enYglid can be used to control type 2 diabetics in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . an alternative to metformin for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - have type 1 diabetes . ensayglid may lower the acid level in your blood ( diabetic ketoacidosis ). warnings and precautions talk to your doctor or pharmacist before taking englid: if your doctor has told you that you have a severe liver disease . when taking gemfibrozil ( a medicine used to lower increased fat levels in people with liver problems ) or moderate liver 28 disease ( see also section 2 . taking  Enyglide : see also " other medicines and ennyglider "). if any of these applies to you , tell your doctor before taking it . take special care with enYglid the following are reasons why eninessglid
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once daily . swallow the tablets with a glass of water . you can take enyglid with or without food . do not chew , crush or split the tablets . if necessary , your doctor may reduce your dose to 0. 5 g once daily depending on how you respond to the medicine . your doctor will prescribe the dose that is right for you , depending on the type of diet you are taking . for example , if your doctor prescribes englid for you and you are unable to take the medicine for longer than 30 days or if it is not taken for 4 weeks , you may take the dose of 30 mg once a day . however , for 16 weeks - after you have
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypoglacy ( may affect up to 1 in 10 people ). hypoglytic reactions are generally mild / moderate but may occasionally develop into hypoglactic unconsciousness or coma . if you are treated for allergy allergy ( may effect up to1 in 10 , 000 people ), symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects may include : very common ( may impact more than 1 in10 people ): stomach pain . common ( might affect upto 1 in every 10 people people !): diarrhoea feeling sick ( nausea ) high blood sugar ( hypoglies ). common (may affect upt ) headache
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide ( as meglumine ). - other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumin , Poloxamer , yellow iron oxide ( e172 ). only in the 1 mg tablets the other ingredients in the 2 mg tablets are red iron oxide( e 172 ) only in addition to the 2 ml tablets the active substances are : 0. 5 mtc , white , round and biconvex with bevelled edges . 1 mg tablet is pale brown , red ,
what azacitidine mylan is azacinacitide mylan contains the active substance ' azacritidine '. what zacitine mylan are used for azacitacittine mylan belongs to a group of medicines called ' anti - cancer agents ' used in adults . what it is used for and how it works azacine mylan comes into contact with cancer cells . aza citidine myLAN is used in adult patients who are not able to have a stem cell transplantation to treat : - higher - risk myelodysplastic syndromes ( mds ). - chronic myelocytic leukaemia ( cmml ). it is also used in acute myeloid leukocytoclastic ( aml ) which are diseases that affect the bone marrow and can cause problems with normal blood
do not use azacitidine mylan - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - patients with advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacitacitine mylan as these may apply to you . - you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor will treat you with liver disease if necessary . tell your doctor if : you have ever had a heart condition or heart attack or you have lung disease , your doctor may perform blood test . blood tests before and during treatment with azacritidine myLAN , you will have treatment called a ' cycle '. this is to check that you have enough blood cells and your liver and kidneys are working properly . talk to
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacecitine mylan every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you reach a maintenance dose between each cycle , which is about 6 weeks ). this medicine will be injected under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the Skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating or easy bruising . these may be symptoms of liver failure and may be life -- threatening . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness or fatigue . symptoms may include fever and chills . most patients get fever and these may become serious . common side effects these may include : very common ( may affect more than 1 in 10 people ):  common : diarrhoea , indigestion 
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . you should store in a refrigerator ( 2 8 ). do not freeze . use this medicine within the expiries date which was stated on labels and cartons . once the suspension has been prepared it should be administered within 1 hour after it has been made up . when using later on if the azaclicitine mylan suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 1 hour ). if refrigerate or freeze , in any event , it should not be put back in the fridge or refrigered again 
what azacitidine mylan contains - the active substance is azacricitine . one vial of powder contains 100 mg aza Citidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 aza citidine -the other ingredient is mannitol ( e421 ). what a azatidine mylant looks like and contents of the pack azaditidine minerva consists of a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacatidine , and is available in packs containing 1 or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprostant is a prostaglandin analogue , which is naturally present in the eye . in the case of titmololly , it is referred to as a beta blocker , because it blocks the fluid within the eye and thus reduces pressure within the eyes . duoTrav eye drops are used to reduce high pressure in the eyes in adults who have an illness called glaucoma .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol - a beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotarrav : if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis . if the child has severe lung disease . the child may experience wheeziness , difficulty in breathing , or long - standing cough . this child may also experience breathing problems such , such as severe hay fever . take special care with duotrast tell your doctor or pharmacist if : your child develops a slow heartbeat , heart failure or a disorder of heart rhythm ( irregular heartbeats 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eye , twice a day in both eyes . duotrav should only be used in your eyes if your doctor told you to use it . use duotar in both eyelids once a week . if necessary , your doctor may tell you to change the amount of duotravir you use . follow these instructions carefully and follow them exactly . instructions for use follow them all the time , but this is different for everyone . how to use du duoturb is for use in adults . do not use it for other people . when to use use dutrav at the same time each day , use eye drops at least 1 hour before or 2 hours after a meal . 3 to 4
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you are worried , talk to your doctor or pharmacist . do not stop using duotrav without talking to your eye doctor . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side impacts ( may effect up to 1 in10 people ), of the eyes eye surface inflammation or surface damage . these include : eye pain , blurred vision , abnormal vision ; dry eye ; itchy eye , eye discomfort ; signs and symptoms of eye irritation , such as burning and stinging . uncommon side effects are : allergic reactions , swelling of the face , lips , tongue or throat . not known ( frequency cannot be estimated from the available
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store below 30 . throw away the bottle 4 weeks after first opening to prevent infections . write the date of opening on the bottle and carton label in the space provided .
what duotrav contains the active substance is travoprost . each ml contains 40 mg of travapross ( as timolol maleate ). the other ingredients are : polyquaternium - 1 , mannitol , propylene glycol ; polyoxyethylene hydrogenated castor oil 40 % and boric acid ; sodium chloride , sodium hydroxide ; hydrochloric acid , purified water ; water for injections . sodium hydrochrysté , hydrochchlorical acid helps to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient is romiplostim . this is a protein that is used to reduce low platelet counts in adults with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is  a disease in which your body 's immune system does not produce enough platelets . platelets are important in your blood to help protect you from blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used in adults and children ( 1 year of age and older ), with the spleen removed , and in children of all ages with chronic itp who have not previously been treated with corticosteroids or immunoglobulins , to increase the protective effect of nplatte .
do not take nplate : - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). -if you ( or your child , if they are the patient ) are allergic or are taking other medicines that are produced by recombinant dna technology ( escherichia coli (  e . coli ). warnings and precautions before you (or your child, ) receive n plate , tell your doctor if : you have a low blood platelet count ( thrombocytopenia ). when using n Plate , your platelet counts should be monitored more closely . you have or have had blood clots . this is because blood coagulation can increase the risk of blood throts and blood clutting . your doctor may want
children and adolescents ( from 1 to 17 years old ) will be taught how to use nplate . how is n platelet given and how much should i take ? n plates are given as an injection under the skin ( subcutaneous ). adults , children and teenagers ( from one month to one month old ), children and adults weighing at least 1 kg : one dose of n Plate is enough . your doctor will decide how much nplatte you will be given . before you are given nplated , your doctor may check your platelet counts . this is because we do not have regular blood samples to check your plates . in order to maintain a high level of platelet count in your blood , the goal of your platelets is to increase . the number of platelets in your body is important . adults and children ( aged 1 to17 years ) the usual dose of plate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for itp : common ( may affect up to 1 in 10 people ): headache . allergic reaction upper respiratory tract infection . common (may affect upto 1 in10 people ). bone marrow disorder ( increased bone mmarrow fibres ). trouble sleeping ( insomnia ). dizziness , tingling or numbness of the hands or feet . ( paraesthesia or migraine ). redness of of the skin , flushing . uncommon ( may effect up to1 in 100 people ), stomach upset . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . nplate is for single use only . once thawed , this medicine can be used within 30 days . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 250 units / ml solution for injection contains 230 units of romimeploslim . each vial contains 125 units romromilopstim in a deliverable amount of 0 . 25 mL solution , corresponding to a concentration of 125 iu romimiplostime in 500 ius / millilitre . one vial of n Plate 250 units ( correspondingly to 375 units ) romizoplost in 250 iou . the vial is supplied in 0. 5 mml solutions , equivalent to 250  103 i U . per m2 romoplosin in ohmg . in mmol / kg romicostim is
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovantor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary lungs as you breathe in . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanour breezehaler before using it - you should tell your doctor if any of these apply to you . do not take tovan or brezhaler more than once a day . please tell your healthcare professional if your dose does not work properly if either of the following applies to you ( or you are not sure ), talk to you doctor or nurse before using this medicine : - patients with kidney problems - people with an eye problem called narrow - angle glaucoma - someone with difficulty passing urine during treatment with tovanOR breEZhaler this medicine can be taken with or without food . tell your pharmacist
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor has told me that you are inhaling this medicine at the same time each day and that it will help you to remember to use it . the usual recommended dose is 75 mg / kg . this medicine is for inhalation use , however , this medicine has to be used at the right time each morning . it is recommended that you use this medical facility as soon as possible after you have spoken to your
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum bromite ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) glycopyranium . - other ingredients of the the inhaled powder are lactose monohydrate and magnesium stearate . what tovantor  Breezhalers looks like and contents of the pack tovanlor breezehaler 44 microlitres inhalation powder , hard capsules contain a white powder and are packaged in blisters . thenodel applicator is packed in blister strips . one strip contains 6 or 10 capsules : one strip includes two inhalers 
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking receptors in the brain that dopamine and serotonin . adesuve has been shown to have calming effects and relieving aggressive behaviour , in adult patients with acute symptoms such as mild - to - moderate agitation , schizophrenia and bipolar disorder , diseases characterised by symptoms sucha as schizophrenia ) hearing , mistaken beliefs , an incoherent speech and behaviour and emotional flatness . people with bipolar disorders may also feel depressed , guilty , anxious or tense , because they may also have bipolar disease .
do not take adasuve if you are allergic to loxapine , amoxapinе or any of the other ingredients of adadasouve . warnings and precautions talk to your doctor or pharmacist before taking adesuve and during treatment if : you experience symptoms such as wheezing and shortness of breath , you have lung problems like asthma you have chronic obstructive pulmonary disease ( copd ) which results in narrowing of the airways ( bronchospasm ), which can cause wheeze , cough , chest tightness and shorten of breath 25 you have been told by your doctor that you have neuroleptic malignant syndrome ( nms ) ( cps ), a condition where symptoms are not well controlled by antipsychotic medicines . you should be aware that these symptoms are more
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is : 9 . 1 mg once a day . your doctor may increase your dose to 2 mg once daily . a daily dose of 4 . 5 mg once your condition has improved . try to take adasuve at about the same time each day , preferably at the same times every day if necessary . you can take sasuve with or without food . how to take take : adesuve is for oral use . it is for use in children and adolescents . do not exceed the prescribed dose prescribed by your doctor and nurse . take the tablet with water and swallow it whole . in order to avoid accidental ingestion , you should rinse your mouth with water . avoid placing the device
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects you should tell your physician or nurse immediately : - if your breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) become intense or irritating . these may be signs that your airways are not working properly ( asthma or copd ). - contact your doctor immediately if they get any of these . - signs of light - headedness or fainting . they may be symptoms of a problem with your blood pressure . in addition , a higher or lower dose may be associated with worsening agitation , confusion , fever and muscle stiffness . this may be a sign of  a severe condition called neuroleptic malignant syndrome . other side effects
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pouch in the outer carton in order to protect from light . this product does not require any special temperature storage conditions . adesuve is for single use only . discard an open or tear pouch that is damaged or shows signs of physical damage . any unused product should be disposed of in accordance with local requirements .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms of lox apin . one inhalation provides a delivered dose of 4 . 5 microgramms of the active ingredient , corresponding to 4 : 5 mg of l . loxepine per dose . what аdasuVE looks like and contents of the pack aadosuve 4 , 5 microlitres is supplied as a disposable white plastic inhalER containing loxacepine and each inhalers is individually sealed foil pouch . the pack sizes are : adesuve 5 . 4 microgram inhalations pack size of 1 or 5 inhalateurs . not all pack sizes may be marketed .
what azacitidine betapharm is azaCitidine betatapharm itself is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacine betaphar contains the active substance ' azacritidine ', which belongs in the group of substances called cytokines . what zacitine betaphol is used for azacetidine be tapharm is used in adults who are not able to have a stem cell transplantation to treat : - higher - risk myelodysplastic syndromes ( mds ). - chronic myelocytic leukaemia ( cmml ). it is also used in adult patients for acute myeloid leukocytosis ( aml ), which are diseases that affect the bone marrow and can cause problems with normal
do not take azacitidine betapharm - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ); - patients with advanced liver cancer ; - you are breast - feeding ; you are infected with azalitidine betatapharm ( h1n1 ); you have decreased counts of platelets , red or white blood cells ; your doctor will tell you whether you have kidney disease ; liver disease : - your doctor may tell you if your doctor tells you you have a heart condition or heart attack ; or you have lung disease . blood test : your doctor might ask you to have blood tests before you start treatment with a different dose ; this is to check that you have enough blood cells to fight off infections before you begin treatment with this medicine ; it is important that you complete all
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacricitine betaphar every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you reach a maintenance dose between each cycle , i . e . every 4 to 6 weeks ; " maintenance dose " will continue for as long as your doctor prescribes it . how to prepare and administer this medicine is for oral use . it is for under the skin ( subcutaneous use ) by reconstituted water . do not inject into the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating or easy bruising . these may be symptoms of liver failure and may be life -- threatening . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness or fatigue . symptoms may include : very common ( may affect more than 1 in 10 people ): tremor , headache , loss of appetite . common ( MAY affect up to 1 in10 people ), loss of taste , indigestion , heartburn , dry mouth
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing azagcitine betaphar . they are also responsible for disposing of any unused azadcitide betaphur correctly . for unopened vials of this medicine there are no special storage conditions . when using immediately once the suspension has been prepared it should be administered within 45 minutes . whenever the azacatidine be tapharm suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigelte for up to a maximum of 8 hours .
what azacitidine betapharm contains the active substance is azacricitine . one vial contains 100 mg aza Citidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 aza citidine , which is also the active ingredient . the other ingredient is mannitol ( e421 ). what a azatidine be tapharm looks like and contents of the pack azacetidine betabharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacatidine  .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 . gaucher Disease type 1 is an inherited condition in which a substance called glucosylceramide is not removed from your body , such as through the spleen , liver and bones . elgat works by blocking the activity of glukylceramine in your affected organs . your doctor will decide whether this medicine is right for you . taking this medicine cer delgа can help to control your body movement and it can be given to you by your doctor at a low dose . you may be at risk of slow speed and poor metabolism . learning how to use cerdeslg enables your doctor to show you how to recognise and diagnose gaucher diseases . with a simple laboratory test , your doctor can see if
do not take cerdelga : if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking cerdeslg. if the following applies to your : you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ), 31 you are also taking moderate cytop3a inhibitors such as erythromycin or itraconazole . taking these medicines may reduce your body ' s ability to break down and repair damaged cells . do not start treatment with cerDelg if any of these apply to you as they may affect your ability . you should not take the tablets if they have a poor metaboliser . this is because medicines with
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is one tablet twice a day . if necessary , your doctor may increase your dose depending on how well you tolerate the medicine . your doctor will tell you how many tablets you need to take . the tablet will also contain a substance called metaboliser . you can take cerdelga with or without food . to get the best results , take your tablet twice daily 84 hours after the first meal of the day , and swallow the tablet whole with a glass of water . do not break , crush , or chew the tablet . take 84 tablets before going to bed . taking cer delgaga - open the blister / booklet - the sleeve is opened 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations , throat irritation and heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain and stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagiasis ) common ( will affect up to 1 in10 people ), constipations indigestion ( flatulence ) low blood sugar ( hypoglycaemia ) high blood sugar change in perception of self , restlessness , depression , anxiety , difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton , sleeve and on the sachet after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of elliglustate . - other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgа contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate ( e460 ), titanium dioxide (  e171 ), yellow iron oxide ( E172 ), indigotine ( 6000 ) and shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgata looks like and contents of the pack cerDelgaga capsules are light orange opaque capsules with a pearl blue and a green oval shaped cap with
the active substance in zoledronic acid hospira is zolеdronic acids , which belongs to a group of substances called bisphosphonates . zoleledronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . ex . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bottom of the bone ). to reduce the amount of calcium in the blood in adult men where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolédronic acids hospria : - if you are allergic ( hypersensitive ) to zolеdronic Acid or another bisphosphonate ( the group of substances to which zolledronic air belongs ). your doctor may decide to reduce your dose of zolzoledraic acid to hospa . - in the event of an emergency , you should tell your doctor immediately . warnings and precautions talk to your doctor before you are given zedronical acid houpira if : you have or have had a kidney problem . they may ask you to have pain , swelling or numbness
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , under the supervision of an experienced doctor ' s supervision . method of ' infusion ' administration : avoid excessive alcohol consumption and avoid dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zolleddronic acids hospria is given the usual single dose is 4 mg . you should be given the lowest dose depending on the severity of your kidney problem . your doctor will decide how long you should receive zolledronic Acid hosppira . prevention of bone complications due to bone metastases : infusion of zolzoledraic acid is usually given to reduce the amount of calcium in your blood . infusion
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ), - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( including jaw discharge ),- numbness or a feeling of heaviness in the jaw ; these could be signs of bone damage in the jaw ( osteonecrosis ). tell your doctor and dentist immediately if you experience such symptoms while being treated with zolеdronic acids hospria . - oral hygiene may cause
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after opening the bottle , it is supplied as a single dose .
what zoledronic acid hospira contains the active substance is zolеdronic acids . one vial contains 4 mg zolédronic Acid , ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zonedronical acid hompira looks like and contents of the pack zoleric acid
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy . when chemotherapy is given , nerve cells are important in the brain . they work in exactly the same way as normal nerve cells . this can cause vomiting , being sick or being hurt . rol APItant works by blocking the activity of these nerve cells which are then destroyed by the cancer . varubies helps to prevent nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - as varubies is an herbal medicine derived from st john ' s wort ( hypericum performatum ) - when you have depression or difficulty sleeping ( see section 2 , ' what varubi is used for '). warnings and precautions talk to your doctor or pharmacist before taking varubY : 27 - have severe liver or kidney problems - are taking certain medicines containing rifampicin ( used to treat tuberculosis and other infections ) or carbamazepine ( used for epilepsy and nerve pain ) ( see also ' other medicines and varubry ')  enzalutamide ( for prostate cancer ) and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg once a day . this is a total of 90 mg once daily . swallow the tablets with a glass of water . you can take varuby with or without food . do not take va ruby with grapefruit or grapefruit juice . it is best to take vaguy at the same time each day , but it may take between half an hour and one hour . about 2 hours before the start of your chemotherapy cycle . when you are having chemotherapy , there is , in most cases no sickness . if sickness occurs , let your doctor know when to take this medicinal product . your doctor may decide to stop your treatment with varubies if : you are going to have another chemotherapy cycle and you are feeling
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ): - symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and stop using varuby and receive appropriate treatment . other side effects include : very common ( may effect more than 1 in 10 people ); - headache ; - constipation ; feeling tired . common ( might affect upto 1 in10 people ), headache . - diarrhoea ; constipated ; being sick . uncommon ( may impact up to1 in 100 people ). -
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rol APItant -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide and magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide , macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varubying is a round , blue , film , marked with ' r - 100 ' on one side . it is supplied in a polyvinychl chloride - filled polychlorotrifluor
what enerzair breezhaler is energetic contains two active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrrronium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps open up the airways and makes it easier for air to get in and out of the pulmonary airways to get into the intestine . mometesone furonate belongs to  a category of medicines known as corticosteroids ( or steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small Airways in your lungs and so gradually ease breathing problems . corticotrotics also reduce the number of attacks of asthma .
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enErzair and tell your caregiver if any of these apply to you ( or you are not sure ): - you have heart problems , including an irregular or fast heartbeat . - your thyroid gland problems . tell your doctors if your doctor thinks you are at risk of diabetes or high blood sugar . your doctor may want to monitor you more closely . warnings and precautions talk to your doctor before taking  EnerzAir breezehaler and if the following apply toyou : if You have severe kidney problems if vous have severe liver
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enerzair breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to use one inhaler each day because the effect of the medicine lasts for a long time . your doctor will tell you how many capsules of enErzair brezhalers to use . this will help control your asthma and improve your symptoms . do not change the dose yourself unless your doctor tells you to . if your doctor has told me to use an energetiair  BreezhalER , you will find an inhalers and capsules that contain the medicine . the inhalator delivers the medicine through the capsules into the airways ( the contents of the inha
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts that have been reported are listed below . if any of these side effects become severe , please tell your doctor . very common , may affect more than 1 in 10 people sore throat or runny nose - sudden difficulty breathing and feeling of tightness in chest with difficulty breathing . common ; may affect 1 to 10 people cough . uncommon : might affect upto 1 in 100 people sortle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister , in order to protect from light and moisture .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( As ac ), 63 microgram ( 1 ) glycopyranium bromidе ( equivalent to 50 microgram ) of glycopyronicum and 160 microgram( 1 - 8 ) mometesone furonate , respectively . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 114 microgram of indigocarmine ( as as acetylated ), 56 microgram (1 . 0 mm ) glucosepyrroniUM bromider ( equivalent with 46 microgram per cent ) or glyco
clopidogrel acino pharma gmbh contains the active ingredient clopinogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called clombosis ). clopogrelly acini pharma mgmbH is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosus , with potentially atheroidal atheropenia , including atherotrombotic events ( such as stroke , heart attack , or
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clodogrelly acan pharma you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain you have severe liver disease if any of these apply to you , or if your doctor thinks that you may be at risk of this , do not use cloclopidOgrel alcino ao pharma go . take special care with clopinogreL acini pharma grbh check with your doctor or pharmacist before taking clodidogrelor aco pharma in gmmbh and tell your doctor if : you have an increased risk of bleeding such als - amedical condition that
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell acini pharma mgmbH per day to be taken orally with or without food , and at the same time each day . if your doctor tells you otherwise , you should contact your doctor, pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . when to take ' clopinogrelly acine pharma goudalafil pharma gambhe ' when you are bleeding or are bleeding if any of the above applies to you , or if someone else or a child takes your tablets
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to10 users in 1 , 000 ) rare (affecting more than 10 users per 10 ,000 ) very rare ( affecting less than1 user in10 , 10 . 000 ). contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ), if not treated , or if someone else in your family has
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . clopinogrell acan pharma grbh does not require any special storage conditions . no special measures are to be taken to prevent damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopinogrelly ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( 6000 ( е462 ) titanium dioxide (  e 171 ) what clapidogral аcino pmbc looks like and contents of the pack clodogrelor acan pharma mgmbq 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it is a single tablet that contains two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) lamivudine , also known as a nucleolar analogue reverse transcription ( ndrtis ) tenofovir disoproxil , another type of medicine called a nuclear nucleonside analog reverse transcriptor ( ngti or nrrtit ). deltrigo has been prescribed to treat high levels of hiv infection in adults aged 18 years and over . hiv is the virus that causes aids ('
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , do not use delStrigo and tell your doctor immediately . do not combine the following medicines : carbamazepine ; oxcarbazepine ( e . excipients ); phenobarbital and phenytoin ( medicines for seizure ); and rifampicin and / or riffapentine ( medicines to treat tuberculosis ); saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety ; or products that contain mitot
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will recommend a complete regimen for you , including a single tablet for hiv infection . the recommended dose is 1 tablet once a day . if necessary your doctor may advise you to take certain medicines , especially doravirine . this is a group of medicines that affect your immune system . taking this medicine swallow the tablet whole with water . do not chew , crush or split the tablet . you can take this medication with or without food . take this tablet at least 12 hours before or after your meal . it is best for you to continue your treatment with delstrigo for as long as your physician tells you to . don ' t stop taking deltrigo unless your doctor tells that you do . when to take del
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common : may affect more than 1 in 10 people - abnormal dreams - difficulty in sleeping ( insomnia ) - headache - dizziness - sleepiness - cough - nasal symptoms - feeling sick ( nausea ) or diarrhoea - stomach pain ( vomiting ) not known : frequency cannot be estimated from the available data - wind ( flatulence )- hair loss - rash muscle symptoms ( pain or stiffness ) common ; may affect up to 1 in 100 people ; - being tired ( fatigue ) reporting of side effects 23 if any of these side effects gets serious , or if they get serious : - loss of appetite - constipation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicine does not require any special temperature storage conditions . store in the original package in order for the medicine to be effective . after first opening of the bottle , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate in the tablet core and microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . the coating material is made of carnauba wax e903 , and hypromllose in the film - coating : iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171 , triacetin . film  776 mg : carnal
spravato contains an active substance called esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it is used to treat the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have the impression that the effect of another antidepressant is too weak , talk to your doctor or pharmacist . see section 2 ' antidepressive medicines '.
do not take spravato if you are allergic to esketamine ( the active substance in ketamine ) or to any of the other ingredients of anaesthesia , as the use of this medicine has not been studied . in adults , the recommended dose is 6 mg / m2 . if there is a history of an aneurysm ( a weak spot on a blood vessel wall that bulges out ), or if bleeding in the brain . you have recently had a heart attack or you think that it may have within 6 weeks . this may cause a temporary increase in blood pressure . therefore , you should be aware that sprivato may cause serious complications in these conditions . warnings and precautions talk to your doctor before taking this medicine if : you have a cardiac problem or a problem with poor blood flow to your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use the spravato nasal spray is for use in adults . you must use the nasal spray device at least 1 hour before or 2 hours after you have used the medicine . use in children and adolescents children and teenagers 3 nasal spray devices : use one nasal spray app for 4 hours after each use . do not use more than 4 nasal sprays in the same day . after you finish using s Pravato , you should continue using it for 2 hours afterwards . using this medicine in children may reduce nausea and vomiting . if there is no improvement in the response to treatment , children and infants less than 30 days after you last used this medicine , your doctor will advise you to use nasal sprayers , including steroid and decongestant medicines . it
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy , headache change in sense of taste feeling sleepy decreased feeling or sensitivity to things around your mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in 100 people  ) not feeling extremely happy ( euphoria ) being agitated , feeling agitating , being unable to sleep , drowsy , having a lack of energy , difficulty concentrating , changes in sense and taste , dizziness , fainting , increased sensitivity in the mouth area , spinning sensation , vertig , vomiting nausea uncommon ( may effect up to1 in 100 persons ): feeling extremely anxious (
what spravato contains - the active substance is esketamine . each nasal spray device contains eeskamine hydrochloride equivalent to 28 mg esesketamine at the date and time of calibration . - after reconstitution : citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s spruvato looks like and contents of the pack s Pravato is a nasal spray solution . this medicine is  a clear , colourless solution in a single - use nasal spray mixer . the pack of s prvato includes 1 , 2 , 3 or 6 nasal spray devices . Each nasal spray gadget is packed in   sprayed into a sealed blister . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adults with melanoma that has spread to other parts of the body or cannot be removed by surgery . there is a certain type of cancer that has a change ( mutation ) in a gene responsible for producing melama . zelmoraf targets proteins that are involved in the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . warnings and precautions talk to your doctor or pharmacist before taking zelborof . allergic reactions allergic reactions can occur in adults , adolescents and children who are not fully aware of the risk of allergic reaction . you should stop taking zeborafic , and tell your doctor immediately if : you experience any symptoms of an allergic reaction such as swelling ofthe face . lips or tooth , having difficulty breathing or rash or faintling sensation , severe skin reactions , skin reactions or skin reactions that may require hospitalisation , stop taking the medicine and seek medical advice immediately , as it
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is 4 capsules to be taken once a day . this means you take the tablets for 8 days ( a total of 4 capsule ) each day , with or without food . if possible , your doctor may increase your dose , temporarily stop your treatment for a short time , or stop your medicine completely . do not stop taking zelboraf without talking to your doctor first , unless your doctor tells you to . vomiting may occur when taking a dose of zelbaf . taking zeboraF - take zelbodaf on an empty stomach . swallow the capsule whole with water . it is best to take a tablet at the same time each day and not just
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , with swelling of the face , lips or tongue difficulty breathing rash fainting sensation when zelbaf is administered orally with radiation treatment . tell your doctor immediately if you notice any of the following side effects as they could be a result of radiation , which may be absorbed by the body . during zelburaf treatment , you may be exposed to small amounts of radiation from the sun while you are receiving zelmoraf . this is because if this happens , your doctor will stop zelploring you . radiation may be an ongoing , potentially life - threatening , risk of having to be exposed , to small areas of the skin , epiphylaxis , bladder , liver , rectal , and 
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . store in the original package in order to protect from moisture .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemoraf eniber , corresponding to a co - precipititate of VEmuraforeniB . - other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , film coating : pregelatinised maize starch , pregeminiconservation , polyvinyl cellulose , magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , indigo carmine ( 6000 ), polyvinychl alcohol , partially hydrolysed talc and titanium dioxide ( E171 ). what zeboraF looks like and contents of the pack
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it can travel through blood vessels to other places . antiplatelets medicinal products reduce the chances of blood  clots forming ( atherothrombosis ). duo plavin is used to prevent blood cluts in hardened arteries , a process known as atheropenia , including stroke , heart attack , and death . you have been prescribed duoplacevin because you are aware of your condition .
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if this applies to you , tell your doctor before taking duoplacevin . if your doctor has told you that you are allergy to other products ( non - steroidal anti - in - inflammation products ) of painful and / or inflammatory conditions of muscles or joints if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking this medicine if : you have a medical condition such as asthma you have nasal discharge or runny nose with polyps ( a type of growth ) in your nose you have or have had a medicinal condition that is currently causing bleeding such as a stomach ulcer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking duoplavin is for oral use . you should swallow your tablet with a drink of water . duolavin can be taken with or without food . take your medicine at the same time each day . it is important that you take duoplacevin every day until your doctor tells you otherwise . if your doctor thinks that you may have taken too much duopravin , tell your doctor , pharmacist or at the hospital emergency department because of the increased risk of bleeding . keep your tablet in the outer carton in order to protect your tablets from light . do not take a double dose to make up for a forgotten dose . for the 14 , 28 and 84 tablet pack sizes , you can check the day on which you last took your tablet . how
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the soil . this may be the signs of an allergic reaction . side effects reported with duoplavin are listed below . common side effects ( may affect up to 1 in 10 people ): diarrhoea , nausea , vomiting 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . if you notice any visible signs of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duopolivin 75 mg / 75 mg film - coated tablets contains 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopogrell ( as hydrogen sulphate ) and 75 mg of acetoylalicyLIC acid ( e210 ), mannitol ( е421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose ; maize starch ; hydrogenated castor oil ( see section 2 ' duoprevin contains hydrogenated castingor oil ').
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolidine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to another group of medications called alpha - 2 adrenergic receptor agonists which help to reduce pressure within the eye . simbrINza is used to improve the control of pressure in the eyes in adults aged 18 years and older , who have eye conditions such as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are allergy to sulphonamides , to medicines used in the treatment of diabetes , infections or diuretics ( water tablets ) or to a monoamine oxidase ( mao ) inhibitors ( medicines used to treat depression or parkinson ' s disease ) and to certain antidepressants . warnings and precautions talk to your doctor before taking simbrinerza : if : you are taking certain antidépressant medicines , including those taking simpinza you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) for less than 2 weeks after starting simbr
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes ( ocular use ). do not swallow or inject . how to use wash your hands before and after use . instructions for use 1 - 2 - remove the cap from the bottle and / or snap collar before using . the medicine should be absorbed by your fingers . hold the bottle , pointing down , between your thumb and fingers , until the medicine is completely empty . tilt your head back . pull down your eyelid with a clean finger , so there is a ' pocket ' between the eyelid and your eye . it could infect the eye drops . gently squeeze the bottle to release one drop of the medicine . if it is not clear , do not touch the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : - if you have a reaction to the medicine ( frequency not known ), or if there has been an allergic reaction ( frequency cannot be estimated from the available data ). - an allergic response may occur with severe skin reactions ( rash , redness , or itching all over your body ) or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately if : you develop extreme tiredness or dizziness . side effects reported with simbrinza were similar to those reported with other medicines : brine - brine and st . johnson syndrome , toxic epidermal necrolysis . tell your doctors if any of the following happen : very common ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . you must throw away the bottle 4 weeks after you first opened it , to prevent infections and use a new bottle . keep the bottle tightly closed in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the medicine . always keep the container tightly closed to protect the medicine from moisture and avoid opening . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolide and 2 mg of brimoniidine tartratrate equivalent to 1 . 3 mg of the active substance . -the other ingredients are benzalkonium chloride ( see section 2 " simbr inza contains the active ingredients in simbrinerza "). - each mL of suspension includes benz alkonium chlorine . the other ingredients in the suspension are propylene glycol , carbomer 974p , boric acid , mannitol . sodium chloride , and tyloxapol , hydrochloric acid / sodium hydroxide ; purified . what simpinza looks like and contents of the pack simbriza is a clear , colour
what filgrastim ratiopharm is filgraStim ratioppharm contains the active substance filgraştim . filgrastoria coli is a protein produced by biotechnology in bacteria called escherichia bacteria . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrastime stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what fil GRAstimratiopharm is used for your doctor has prescribed filgrastatopharm for you to help your immune system produce more white blood cells that help your organs fight infection and they will do
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgraStim or any of the other ingredients of filgrastatin . do not take filgratim ratioppharm if any of these apply to you . if they happen to you tell your doctor . warnings and precautions talk to your doctor before taking filgrastortim ratioppel : take special care with filgram ratioph : you may experience a cough , fever and difficulty breathing . these may be signs of a pulmonary disorder ( see section " possible side effects "). if sickle cell disease 57 you may be able to get left upper abdominal pain or pain at the tip of your shoulder . this may be due to a stem cell disorder ( e .g ., side effects not known ). you will have regular blood tests while you are taking
how much filgrastim ratiopharm is given your doctor will tell you exactly how much of filgraStim ratioppharm to take and for how long . how much to take filgrassen ratioph will depend on your condition , your weight and your general condition . your doctor should tell you how much you should take . what filgratim ratioppepharm to give you your doctor is responsible for preparing and administering filgrasent ratiopherite . filgrastat ratiopholand treatment you will receive filgram ratiopham twice a day . - during chemotherapy : the usual dose is 0 . 5 million units ( 60 micrograms ) per kg body weight . you will usually receive 30 million units in the first week of your treatment . this may take up to 14 days . in some disease types , however , longer treatment lasting up to about one week may be
you must not be given filgrastim ratiopharm : 57 if you get left upper abdominal pain or pain at the tip of your shoulder . it may be a consequence of a spleen disorder , see section 4 . if this happens , tell your doctor . look out for side effects . your doctor will do regular blood tests while you are being given fil GRAstim ratipharm to check the number of neutrophils and other types of white blood cells in your blood and may adjust the dose if needed . this is to check if treatment is working . other medicines and filgrastatin ratiopham tell your healthcare provider if : you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . filgrasting ratioparm is
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraStim ratioppharm should not be used if you notice that the solution is cloudy or has deposits . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for injection or infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgrastat . filgrastor ratioph 30 miu in 0 . 5 mL : each vial contains 30 million international unit [ miku ] [ mizu ]] ( 300 micrograms ) filgraste in 0- 5 . 0ml solution . film coating : filgrastastim ratepharm 48 miu ( 480 microgram per m2 ) in  0. 8 mmol : one vial provides 48 million international uniform units [ mau ], 480 iu ) ( 640 microgram ( 960 microgram of filgristim in  0 8 .
what riluzole zentiva is rilsuzola contains the active substance rizole which acts on the nervous system . what reiluze zetiva can be used for rilluzolе zentivea is used in patients with amyotrophic lateral sclerosis ( as amy ). it is used to treat motor neurone disease in adults . when the nerve cells responsible for sending instructions to the muscles are not working properly , this can lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurolone disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rILuzol zentaba blocks the effect of glutamatamate and so reduces the number of the nerve cell' s working properly and allows the body to
do not take riluzole zentiva if you are allergic to rilluzola or any of the other ingredients of this medicine ( listed in section 6 ). if there is any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). this is because rils may make you more likely to become pregnant . warnings and precautions talk to your doctor before taking rILuzolе zentivea : if your doctor notices any liver problems such as yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick , being sick - these may be signs of your kidneys , fever , as these may mean that you have a low number of white blood cells which can cause an increased risk of infection . children and adolescents do not give this medicine to children under 18 years
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , with or without food . take the tablets at least 12 hours before or after food , and at the exact time your doctor takes your tablet . if your doctor thinks that your dose is too weak , talk to your doctor about it . do not take more than the recommended dosage . contact your doctor , pharmacist , or your nearest hospital emergency department immediately if a dose of riluzole zentiva is missed . you can take the next dose at any time of the day if it is almost time for the next tablet , but do not make up for a forgotten tablet ; contact your pharmacist . for more information , see section 4 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check the number or type of whiteblood cells , and may tell you to take precautions to avoid infections . if your doctor notices any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick or being sick , as these may be signs of liver disease ( hepatitis ). you will have to have regular blood tests while you are taking rilluzola zentivea . some patients have experienced cough or difficulties in breathing . these may also be
what riluzole zentiva contains the active substance is rilsuzol . the other ingredients are : core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrously colloidal silica , magnesium stearate , croscarmellose sodium , as well as hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rachloruzola zentive looks like and contents of the pack the tablets are white to off - white , oval , with " rl 50 " debossed on one side and " roche " on the other side . they are marked with " 2 202 " on one face and " 322 " on another face . rilluzolе zentaba is available in packs containing 28 
emgality contains the active substance galcanezumab . it is a medicine that lowers the frequency of calcitonin gene - related cgrp . eemggality is used to treat migraine in adults with increased levels of cggrp in the blood . the active ingredient in emegality is calciant . this helps to reduce migraine in adult patients who have at least 4 migraines per month and helps to improve your quality of life .
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a serious cardiovascular disease . warnings and precautions talk to your doctor or pharmacist before using emegality as egality may cause a very rare but serious cardiovascular diseases . allergic reactions emigality can cause serious allergic reactions in some cases . these reactions are very rare . you must seek medical attention right away if 40 you experience a seriously allergic reaction . if such signs occur , stop using mgally and contact your doctor immediately . see also section 4 . children and adolescents emagality is not recommended for children and teenagers under the age of 18 years . other medicines and emogality tell your doctor , pharmacist or nurse if they are
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg once a day . eemggality is given by injection under your skin ( subcutaneous injection ) at any time of the day , with or without food . your doctor may decide to give you your emogality injection after proper training . inject the full dose at the same time each day if your doctor determines that it is safe and effective . you can use the full benefit of 240 doses . do not use more empgality than your doctor tells you to . contact your doctor if , after speaking to your doctor you are uncertain about the correct dose . tell your doctor immediately if this applies to you , or if someone else uses your medicine , tell them
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality are rare . you may notice rash or itching all over the place where you injected egality . these are rare but serious allergic reactions may occur . they may affect up to 1 in 1 , 000 people . signs include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash with raised bumps . other side effects include . very common side effects ( may affect more than 1 in 10 people ): injection site reaction ( may occur with up to1 in 10 persons ) injected site redness / redness at the site of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . once thawed , the medicine can be kept at room temperature ( up to 7 ) for up to 30 days , even if it is not used during these 30 days or if there are still some left in the refrigerator . this medicine must be discarded if not used by the new expiry dates or discarded by the healthcare professional . any unused medicine must not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanozumabe in 1 ml solution . the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what hemgalism looks like and contents of the pack egality is a solution for injection in a clear glass syringe . colourless to slightly yellow , clear solution , is provided in : the sYringe is engraved with the company logo and the company symbol on the outer carton . single - dose pen pack sizes : 1 , 2 or 3 single  doses , per carton , are available . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition known as hepatic veno - occlusive disease ( hep ) in which the blood vessels in the liver become damaged and blocked by blood clots . defitementio may be given to you by your doctor or nurse prior to a stem cell transplantation . the active ingredient in defibroTide is recombinant dna technology to help the blood vessel walls become damaged , preventing the blood coagulation , and to prevent future complication of this medicine .
do not use defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - when used in combination with other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) or with medicine to prevent bleeding if there is heavy bleeding ( for example , if a blood transfusion is needed or if surgery is planned ) warnings about problems with blood circulation if your doctor considers that you have a constant blood pressure ( 30 / 30 minutes ) during treatment with defit liu , you should tell your doctor if any of these apply to you . children and adolescents defitlia is not recommended for children under 1 year of age . other medicines and defitementio tell your doctors if they are taking , have
before starting the treatment with defitelio , your doctor will calculate the dose you will receive . this will be calculated by your doctor using the following formula : stem cells transplantation ( infusion into one of your veins ) as an ' intravenous infusion ' ( drip ). this treatment will take approximately 21 minutes . if you do not respond adequately to this treatment your doctor may decide to delay the treatment until your symptoms improve . children and adolescents ( aged 18 years and over ) the recommended dose of defitementio for children and teenagers is one vial per day . contact your doctor or a nurse immediately if your child misses a dose of this medicine . do not take a double dose to make up for a forgotten dose . take your next dose at your regular time .
like all medicines , defitelio can cause side effects , although not everybody gets them . defitеlione can cause some side effects which may be serious . if you get any of these side effects you should contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . common ( might affect up to 1 in10 people ), bleeding in general bleeding ( including the nose bleeding , the brain bleeding ), the gut vomiting , blood bleeding from the lungs bleeding ; blood in the urine , from the mouth bleeding from under the skin coagulopathy ( disturbance of blood clotting ); bleeding in the gut clot in the arteries , in the blood vessels of the intestine bleeding . not known ( frequency cannot be estimated from the available data ) headache , stomach bleeding numbness , tingling or burning
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defit liо should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 oc - 8, unless dilsight has been established . once opened , defitlia should be discarded . any unused product should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrototide in one mL solution . one mpl solution contains 80 microgram ( 8 microgram ) of defrotide at the date and time of calibration . - other ingredients are sodium citrate dihydrate , hydrochloric acid and sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defitementio is supplied in glass vials , which are supplied in packs containing one vial . for infusion , one vially contains 10 m x 2 , 5 g concentrate .
daklinza contains the active ingredient daclatasvir which is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis - c virus ). this medicine works by stopping the hpatittis ca virus from multiplying in your body . this helps to reduce the amount of the virus in your blood . daklinez is used with other medicines to treat adults who have hepc infection . it is very important that you also read the leaflets for the other medicines that you will be taking with daklinacza . if you have any questions about your medicines , please ask your doctor or pharmacist .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or if your doctor has prescribed it for you . do not combine daklimza by mouth with any of these following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin / rfabutin & riffapentine ( antibiotics used to prevent and treat tuberculosis ) dexamethasone ( a steroid used to control allergic and inflammatory diseases ) medicines containing st . john ' s wort ( used in transplant patients ) and santhera ( used for treating tuber
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . this does not require any special temperature storage conditions . you may get an unpleasant taste when taking daklinaca . tell your doctor if your doctor prescribes you some other medicines while you are taking daknza . your doctor will tell you to take these medicines at the same time each day , so that your daily dose of Daklinzanza can be taken at the right time each morning and evening . depending on how you respond to the treatment , your doctor may change your daily dosage of dakunza , or may change the dose of these medicines . do not change your dosing schedule unless your doctor tells you to . when starting the treatment with daklinikza if used
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( MAY affect up to 1 in10 people ] difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching and tender muscles have been seen in patients taking daklimza in combination avec sofavirvir and also rib virin in combination . common ( May affect upto 1 in 100 people  ) numbness , tingling , burning or burning sensation when getting up from a lying or sitting position dakling increased risk of side effects when taken in combination of sofоsbuvar and / or 
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg daclatarasvirus ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide . film coating - coating ; macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ). printing ink : 51 daklianza 30 mg film  coated tablets : the film  - coat is imprinted with " bms " debossed on one side and " nvr " on the other side . daklinag 20 mg film
what proquad is used for proquade is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , murumps / rubella / varicello viruses , which are usually found in the food pipe , and the antibodies help the body to make diseases caused by these viruses ; proquaD does not protect against meales / mops caused by rubella or chickenpax ( variable ). the vaccine will be given at least 12 months after the last vaccination . proquac is recommended for use in adults and children 9 years of age and older . it is considered necessary for a national vaccination programme .
do not receive proquad if you are allergic to any varicella vaccine ( containing measles , mumps , rubella vaccine ) or any of the other ingredients of this vaccine ( listed in section 6 ) if your doctor or nurse has prescribed neomycin if : you have a blood disorder or type of cancer that affects your immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade : if treatment with medications that affect your immune response , such as low - dose corticosteroid therapy or asthma ( replacement therapy ). you have or have had a weakened immune system because of a disease ( including aids ), congenital or hereditary immunodeficiency ( cds ) which reduces your immunity ability , active untreated tuberculosis ( aid
proquad will be given to you by your doctor or nurse . it will be injected into a muscle ( usually in the upper thigh or upper arm ). when given as injections , proquade will be dispersed into the muscle in the thong area or upper arms area and at the injection site . if you have a blood clotting disorder or low levels of platelets , the vaccine will be administered under the skin . this will help to prevent bleeding if it is given into musculoskeletal area . proquaa should never be given into an airway or into  a large blood vessel . there are several places for the first injection of proquadu into merriment . these places will be placed in a suitable place for the second or third injection .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occur rarely . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , talk to your doctor or pharmacist . other side effects reported with proquad : may affect up to 1 in 100 people - seizures - a fever - may affect less than 1 in 1 , 000 people . not known - not known ( frequency cannot be estimated from the available data ) - bradycardia ( difficulty breathing , cough ) not known unsteadiness with walking . side effects of proquaa may affect more than 1 out of 10 people ) injection site complaints ( including pain and swelling ) in children and adolescents . reporting of side effects for children and young people , adults and children .
what proquad contains the active substances are : measles virus1 / edmonston strain ( live , at least 3 . 00 mm2 ) mumps virus1 * ( jeryl lynn TM - level b ) strain ( at least 4 . 30 mm3 ) rubella virus2 - strain ( alt - quorum ) 3 .00 mm4 pfu *** varicella virus3 - 4 - 5 merck strain ( h5n1 ) not known ( frequency cannot be estimated from the available data ) plaque - formation units 1 ( ph - positive ) chick embryo cells and fibroblasts ( mrc - 1 ). the other ingredients are , powder sucrose , hydrolysed gelatin , urea , sodium chlor
jylamvo is an anticancer medicine which reduces the activity of the body in an effort to prevent unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect jYlamva is used in adults to treat : rheumatic and skin diseases : active rhoeatoid arthritis , with polyarthritic forms that involve the joints ; severe juvenile idiopathic arthritis a ( jia ) that has not improved in more than 3 years and has not responded to non - stroidal anti  - in - use drugs ( nsaids ) which are considered inadequate o severe or disabling psoriasis and not responded adequately to treatment with phototherapy , pSoralen , and ultraviolet a radiation ( puva ) therapy .
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if the doctor has given you approval if there is a liver impairment . if certain blood disorders ( e . ex : bone marrow hypoplasia , leukopenia or thrombocytopenia ) have been reported with significant anaemia ( see section 4 ). 34 if any of these apply to you , tell your doctor before you take jumbo . you may be at greater risk of a weakened immune system . tell your dentist if : you have had a serious infection ( tbh , tuberculosis or hiv ) you have ulcers in the stomach or intestin
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo can cause severe side effects , sometimes even death , during or following the treatment . these include : rheumatoid arthritis , severe juvenile idiopathic arthritis ; severe psoriasis ; and severe ppsoriatic arthritis . your doctor will decide on a suitable dose for you , which is the best bet . the recommended dose of jYlamva is a long - term treatment , possibly lasting for months or years . for rhumatic and skin diseases ( jia ), psesoriases and ppsiatic arthritis the recommended starting dose of the medicine for adult rHeumatopoid
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , or difficulty in breath ; chest pain ( fever ), spitting or coughing blood , serious peeling and blistering . not known : frequency cannot be estimated from the available data . if these side effects become severe , they are usually mild to moderate and usually disappear within a few days or weeks . your doctor will decide how long you should keep using jylamvo . very common ( may affect more than 1 in 10 people ): di
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine in the original package in order to protect from light and accidental spillage . discard after 3 months . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as besilate ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , sethyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxyhydroxybenzonate (e219 ), citric acid , tri - sodium citrate , purified water . ( see section 2 " jYlamva contains ethyla parahydroxy benzoate and sodium hydroxybenzobiate "). what jelamvre looks like and contents of the pack jlamve is a clear , colourless to pale yellow liquid . it is supplied in a brown glass bottle containing 60 mL
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . how enUREv BREezhalers works this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using enUREv  Breezhalers if any of these apply to you . if this applies to you ( or you are not sure ), talk to you doctor or nurse before using this medicine . please tell your doctor if your kidney problems are not well controlled . some patients have an eye problem called narrow - angle glaucoma . there is a problem with difficulty passing urine . during treatment with enuresv bruezhalER if , while using this product , you experience any of those who get tightness of the chest , coughing , wheezing or breathlessness immediately after using enturev
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor has told me that you can inhalate this medicine any time before or after food or drink . the recommended dose is one inhaler and capsules ( in blisters ) each day that you use to inhales the medicine as inhalation powder . only use the capsules with the inhalers provided in this pack ( enUREv BREezhalER inhalER ). the capsule
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms include excessive thirst , hunger and frequent urination , rash , itching or hives , difficulty breathing or swallowing , dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible sign of angioedema ). if you get any of these side effects talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrpyrroniUM bromidе ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) glycopyrrionum . - other ingredients of the the inhaled powder are lactose monohydrate and magnesium stearate . what  Enurev brezeezhalers looks like and contents of the pack enUREv brewing machine 44 microlitres inhalation powder , hard capsules contain a white powder and are packaged in blisters . the product is supplied as a device called an inhalator , together with capsules in blister strips . Each blister strip contains either 6 or
what riximyo is rximyyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rtuximabab sticks to this cell , the cell dies . what ' s risimy0 is used for ruximyao may be used for the treatment of several different conditions in adults . your doctor may prescribe rXimyо for the treatments of : a ) non - hodgkin '
do not take riximyo if you are allergic to rituximab , other proteins which are like ritoximabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking rximyyo because : you have a severe active infection at the moment you have been told that you have developed a weak immune system . you have severe heart failure or severe uncontrolled heart disease , such as granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking this medicine . warnings and precautions talk to you doctor if : your doctor thinks you have
your doctor will decide on the correct dose of riximyo . you will receive this treatment under the supervision of a doctor experienced in the care of patients with liver disease . your doctor or nurse will watch you closely while you are being given this medicine . this is in case you get any side effects . it is very important that you are given rximyyo as a drip ( intra - venous infusion ). medicines given before each ritzimya administration before you are administered rizeimyon , you will be given other medicines ( premedication ) to prevent or reduce possible side effects as well as to improve your treatment . for non - hodgkin ' s lymphoma : if you are having risimyong alone ritchimyok will be administered to you once a week for 4 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , certain types of reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , and cough . your doctor may reduce your dose , stop the inhalation and contact a doctor or hospital straight away . rare cases of serious side effects have been reported . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or
what riximyo contains the active ingredient in rximya is called rituximab . the 10 ml vial contains 100 mg of ritsuximob ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of  ritzimabe ( 10  mg /10 mg ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , potassium hydroxide and hydrochloric acid . see section 2 " risimyyo has a clear , colourless to slightly yellowish solution , supplied as a concentrate for solution for infusion . richimygo is available in packs containing 2 or 3 vials ; each carton contains 1 vial or 2 vial adapters . not all pack sizes
topotecan actavis contains the active substance topot . topotécan activis is used to treat small cell lung cancer that has come back after chemotherapy . it is used in adults to treat advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotеcan actvatis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotencecan activis . it may affect your blood cell counts if they are too low . your doctor will decide if topotécan actvatis is right for you . if your doctor thinks any kidney problems are too high , or you are not sure , talk to you doctor or nurse before taking your dose of topotacan actagis , if : you have severe kidney impairment you have liver problems , as topoteatcan actassis may cause severe liver impairment you suffer from lung inflammation with signs such as cough , fever and difficulties in breathing ( see section 4 , possible side effects "). if any of these apply to you
your doctor will decide how much topotecan actavis you will receive . the doctor will work out your dose of topotercan activis according to your body surface area . your doctor may perform blood tests before and during treatment to monitor your progress . adults small cell lung cancer the usual dose is 1 . 5 mg per m2 of body surface surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per square metre of body area once weekly for 3 days , but this treatment cicl will normally not be repeated . for cervical cancer , it will be given to you in combination with another anticancer medicines called cisplatin . if you are given cistapolatin once daily , you will be told how to switch to another anti cancer medicine , such as ciscostat 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts . they may be serious . infections may affect up to 1 in 10 people . this may be a sign of fever , affecting your general condition . local symptoms , such as sore throat or burning sensation , severe stomach pain , fever and possibly diarrhoea ( signs of bowel inflammation called neutropenic colitis ), has been reported in patients treated with topotecan actavis . it may reduce your ability to fight infections . lung inflammation . these are rare ( may affect 1 in 1 , 000 people ). if this happens , you may have difficulty in breathing . if it happens to you , tell your healthcare professional immediately . very rare ( can affect upto
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . keep the viall in the outer carton in order to protect from light . storage after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours @ 2  8 , protected from light prior to administration . from a microbiological point of view , the drug product solution should be used immediately after difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %). storage times and conditions of the user are the responsibility of the manufacturer and would normally not be longer than 4 hours at 2 ° c to 12 hours at room temperature
what topotecan actavis contains - the active substance is topotenecan . each vial contains 1 mg or 4 mg topotencecan ( as hydrochloride ). after reconstitution 1 ml contains approximately 1 mg to potecan ( 0 . 5 mg / mL ). - other ingredients are mannitol ( e421 ), tartaric acid ( ph - 17a ), hydrochleric acid ( 1 %) and sodium hydroxide ( see section 2 ). what to potencan actas looks like and contents of the pack topotécan actactavis is supplied in a carton with grey bromobutylic stopper and aluminium seals with plastic flip - off , in  a protective sleeve containing 1 , 1 or 5 sachets of
the active substance of rivastigmine hexal is rivassestigmin . rivassimine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivstigme works by blocking the enzymes that break down acetoline : acetrylcholinessterase and butyrylcholineSterase . by blocking these enzymes , the brain can produce more acetic acid , which helps to reduce the symptoms that you may have .
do not take rivastigmine hexal if you are allergic to rivistigmine ( the active substance in rivainstigmine himxal or any of the other ingredients of this medicine ) or to any of its ingredients . if there is a history of a previous skin reaction ( allergic contact dermatitis ) with rivassistigine . do not taking rivstigmin heexal . warnings and precautions talk to your doctor before taking rastigemine . take special care with r - if any of these apply to you : - have irregular or slow heartbeat - are suffering from an active stomach ulcer - experience difficulties in passing urine - suffer from seizures - has been reported in patients with asthma or severe respiratory disease -have impaired kidney function - Have impaired liver function . have trembling
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . patients whose weight is not controlled will usually start by taking one tablet aday . their doctor will regularly monitor their weight whilst they are taking this medicine . do not take riv astigemine xal for more than three days . take this medicinal product with food . swallow the capsules whole with  a glass of water . don ' t open or crush the capsule . you should take rassigmine 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in10 people ), anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling dizziness irritability vomiting stomach pain coughing up of a stomach acid reflux disease worsening of underlying disease uncommon ( may effect up to1 in 100 people  ) tremor feeling sick , being sick  ( vomiting and diarrachea
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is rivistigmine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( е171 ). - printing ink : shellac . each rivainstigmine histogram ( 1 . 5 mg capsule ) contains 1 , 5 mg of rivstigmin . Each rivagestigmine thexal 3 mg capsule contains 3 mg of the active substances . the other ingredients in the capsules are : each ritonavirone helixal 4 . 4 mg capsule is white and the 4 , 500 mg capsules have the letters '
what cabometyx is cabrometyxx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer in adults who have not previously been treated with a specific anticancer medicine , called sorafenib ( e421 ). how cabmetyX works cabetyix blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells . cabimetyyx may be given to you by your doctor or nurse .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyX : - patients with high blood pressure - patient with an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a certain type of blood vessel walls - suffer from diarrhoea - recent or significant bleeding - had surgery within the last month - or in certain surgical procedures ( including dental surgery ) - have inflammatory bowel disease ( crohn ' s disease or crohn' '' ) talk to a doctor if any of these apply to you . - are suffering from inflammatory colon disease ( also known
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking this medicine this medicine is for oral use . swallow the tablet whole , with some water . do not chew , crush or split the tablet . your doctor will monitor you carefully while you are taking it . this will help you to decide if and when you should stop your treatment . no serious side effects are expected . if your doctor decides that you should discontinue treatment with cabometyx , you will receive a single dose of 60 mg of cabrometyX for 2 weeks . then take cabmetyc for 1 hour before taking the medicine . take the tablet with a glass of water , at about the same time each day . you can take the tablets with or without food . how long to take - cabo
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx . your doctor may give you other medicines to help control your side effects as well . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms such as pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever or other signs of a gastrointestinal perforation ( a hole in the stomach or intestine that separates the body ). severe or uncontrollable bleeding ( symptoms of vomiting blood ) or black stomachs ( signs of stomach pain or redness ) may occur . these may be signs of an infusion - related reaction . red or purple spots on the skin that look like coffee grounds . swollen glands in the intestin
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyix 20 mg : each tablet contains cabcabozzantinini B ( h1n1 ) ( as malate which provides 20 mg of cabonantinienib ). cabetyX 40 mg - each tablet includes cabokantinimb ( (  ) - malat , providing 40 mg of caozantsinia . each tablet also contains 60 mg of the active substances . the other ingredients are : microcrystalline cellulose , lactose anhydrous , starch , and lactoshiac . what accompanada contains : cabmetyxx 20 mg tablet : one tablet containing cabantin
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreixed hospiran is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . if you have been given pemetreXed in combination mit cistplatin for the initial treatment of patients with advanced stage of lung cancer , pemetreexed hompira can be prescribed to you if your lung cancer has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreexed is also a treatment for patients with progressive stage of  lung cancer who have progressed after previous chemotherapy , but whose disease has progresses after other in
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). - do not breast - feed during treatment with pemetreexed
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your normal body . this body surface area will be worked out by your doctor . the doctor will adjust the dose during treatment , depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreXed aspira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before use . pemetreixed is given by infusion into one of your veins . you will be given the infusion once every 10 minutes . when using pemetreexed hompira in combination with cisplatin : the doctor or hospital pharmacist will work out your dose of your height şi
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your medicine has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if it is not treated , you may experience chest pain ( common as a fast heart rate ), or if there are pain , redness , swelling or sores in your mouth ( very common). allergic reaction : - skin rash ( very commonly reported ) - burning or prickling sensation ( common in children and adolescents ), - fever . skin reactions may be serious and could result in death , with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of reconstituted and infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . for single use only . use the reconstructed solution immediately if it is not used immediately after reconstitution . parenteral medicines should not be disposed of via wastewater or household waste . any unused solution must be discarded .
what pemetrexed hospira contains the active substance is pemetreexed . pemetreexed in a vial each vial contains 100 mg of pemetreced ( as pemetreixed disodium hemipentahydrate ). pemetreed hospiran 500 mg : each vially contains 500 mg of Pemetrexéd ( As pemetrexxed disodium dipentains ). - pemetrezed hospital product line : 1 , 000 mg / vial : every vial provides 1  ,000 mg of  pemetreceed ( as pfizer ) diso sodium hemimahydrate in sterile water for injections . after reconstitution , the solution contains 25 mg ph . ml of pemeterxeed and further dilution by 
ganfort contains two active substances , bimatoprost and timolol , that work together to reduce pressure in the eye . bimatofpross belongs to a group of medicines called prostamides . it works by blocking a prostaglandin analogue , whereas titmololl belongs to the group of medicine called beta - blockers . the eye contains a clear , watery liquid that feeds the inside of the eye and so reduces the pressure in your eye , which can lead to glaucoma . ganfordt eye drops reduce high pressure inthe eye and reduce the risk of glaucacoma from occurring . your doctor has prescribed gan fort for you .
do not use ganfort eye drops - solution should only be used by qualified eye doctors trained in the use of ganfordt . do not apply gan fort if you are allergic to bimatoprost or timolol , or to any other beta - blockers , and do not take them at home . warnings and precautions children and adolescents do not give this medicine to children below 6 years of age , because it has not been studied in these patients . this medicine should not be used in children with respiratory problems such as asthma , severe chronic obstructive bronchitis , as it has only been studied for children with severe lung disease . the warning signs and symptoms can include wheeziness , difficulty in breathing , long - standing cough , heart problems ( such as low heart rate , chest block or heart failure warnings 
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is one single drop in the affected eye once a day , at the same time each day . treatment should be started by your doctor . keep the bottle tightly closed in order to protect from moisture . do not swallow the sachet or bottle . it should not be put into the neck until you have reached the recommended dosage . 5 . instructions for use 1 . wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one last drop of ganford . if it is not , rinse your eye off and use the next dose as usual . finish the treatment by pulling down the lower lid .
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , so it is very important to follow your doctor ' s instructions . the most common side effects with gan fort ( multi - dose or single -dose ) are described below : very common side effect ( may affect more than 1 in 10 people ): reduction in the amount of the eye redness . common side impacts ( may effect up to 1 in 9 people ), including the eye burning , itching , and stinging . irritation of the conjunctiva ( the clear layer at the front of the eyes ), sensitivity to light , eye pain , sticky eyes , dry eyes ; small break in the eye ; feeling of something in the eyes caused by small break or break in one of the layers in the front part of
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for eye infections , see section 4 " gan fort contains lactose ". do NOT throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . after preparation each syringe contains 5 mg of detachment of - titmolole maleate ( equivalent to 6 . 8 mg / mL ). the other ingredients are benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ; purified water ; hydrochloric acid and / or sodium hydroxide . what g ganforcet looks like and contents of the pack ganFort is a clear , colourless to slightly yellow eye drop solution . gan fort is supplied in a plastic bottle . the bottle contains 1 or
gefitinib mylan contains the active substance gefitib , which blocks a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells . gefitineb myLAN is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitINib . tell your doctor if any of these apply to you . do not use gefitineb myLAN if : you have any other lung problems . some lung problems may get worse during treatment with gefiteinib minelan . you have ever had problems with your liver . talk to you doctor , pharmacist or nurse before taking this medicine if either of the above applies to you ( or you are not sure ), talk to the doctor . children and adolescents this medicine is not for use in children and teenagers under 18 years . other medicines and gefithinib Mylan tell your a doctor or nurse if your child is taking , have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a drink of water . do not crush or chew the tablet . you can take gefitinib mylan with or without food . if necessary , your doctor may advise you to take antacids ( to help the stomach empty ) 2 hours before or 1 hour after taking gefitINib Mylan . have trouble swallowing the tablet and it is best to drink it straight away after a meal . avoid any other liquids ( s ) or milk . stir until the tablet breaks up into smaller pieces . pour the liquid into a glass of water and drink it . drink the liquid straight away . it is important that you drink the full glass
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness , including sudden worsening breathlessness and a cough or fever , may indicate an inflammation of the lungs called ' interstitial lung disease '. this may affect up to 1 in 100 people taking gefitinib mylan . severe skin reactions have been reported in some parts of the body . they may be severe and may require urgent medical attention . very rare ( may affect more than 1 in 10 , 000 people ) gefitINib may cause severe skin reaction which
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefitineb - - The other ingredients are lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide ( е171 ), red iron oxide ( E172 ), and yellow iron oxide , if you have any questions about gefiteinib in the box . what geFITini B mylan looks like and contents of the pack gefitINib tablets are off - white , biconvex film  11 . 1 mm x 5 . 6 
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndromes , also known as ms - m , can cause many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms associated with a low red blood cell count ( anaemia ) and red blood blood cell transfusions can be life - long . reglazyl is used in adults to treat anaeemia in patients with mDs who cannot have red blood cancers . it is used when other therapies ( erythropoietin therapies ) have not worked well enough or are not suitable for them . beta - Thalassaemia ( thalassamic syndrome ) is a blood problem that is caused by
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - are pregnant or planning to become pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine -if you have thalassaemia ; - your spleen removed ; or - you have had a blood clot after hormone replacement therapy ; you have or had , or have had one , a previous blood  clotting . your doctor will take preventive measures to prevent this . medicines like rebozyl could increase the risk of a new blood clumping . - in women with high blood pressure , the use of reblizyl is not recommended . it may increase your blood
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide whether you need to change to reblozyl . reglazyl is given as an injection under the skin ( subcutaneously ). it is given to you by your doctor or nurse . how much is given your doctor and nurse will work out how much medicine you need . the dose is based on how much you weigh . depending on how you weigh the injections are given the usual starting dose is 1 . 1 mg for every kg of body weight . this dose may be adjusted if your blood pressure is not controlled . use in children and adolescents rembozyl should only be used in children with myelodysplastic syndromes . adults the maximum single dose is 1. 75 mg for each kg of person , injected once a
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or contact the casualty department at your nearest hospital , if you get any of the following serious side effects you may need urgent medical attention : difficulty in walking or speaking , dizziness , loss of balance and coordination , or numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision which may be symptoms of a stroke . blood clots swelling of the area around the eyes , face . lips , mouth , tongue or throat allergic reactions including rashes and scaly rash may occur when taking this medicine . if your doctor notices any of these symptoms , seek medical advice immediately . the most frequently ( very common ) side effects are : headaches feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored for up to 8 hours below 25 and for upto 24 hours at 2  8 . discard any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept when reconstituted as recommended . after reconstitution , each ml of solution contains 50 mg of the active ingredient lusatercept the other ingredients are citric acid monohydrate , sodium citrate ( e331 ), and water for injections ( see section 2 ). the other ingredient ( excipient ( s )) are sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for pa ) ( for prh adjustment only ). what  Reblozyll looks like and contents of the pack reglazyl is a white to off - white powder . rebrozyl 25 mg / 75 mg luspatchercept is supplied in packs containing one
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate of growth of cancer cells . this will allow the body to develop new blood vessels . fotiv dab is used in patients with advanced kidney cancer who are not benefiting from other treatments , such as alpha or interleukin - 2 , to control your disease .
do not take fotivda : - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - when taking st . john ' s wort ( hypericum perforatum ) - this is a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiv da . high blood pressure . fotiva will not be right for you if your blood pressure is too high . your doctor will monitor your blood temperature regularly , and will adjust the dose if necessary . you may also be treated with a medicine . it is important that you do not have to take foivida every day as long as you are using a tool to control your bloodpressure . when to stop taking foivi da if : you are
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg ( 1 capsule ) every 21 days ( taking 7 capsules ), followed by 1 capsule ( 2 capsules ( 4 capsules each ), in the morning and evening . your doctor will decide how many capsules to take and how long you should continue to take fotivaa . if unacceptable side effects occur , your doctor may decide to reduce the dose or stop treatment temporarily or permanently . severe side effects can occur at any time during fotiv da therapy . for the most effective results , you should take foivida 890 mg ( 3 capsules per day ) for 21 days followed by 7 days without taking more than 1 capsule each day . you should swallow the capsule whole with a glass of water 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : the most common side effect is seen in the section 2 tell your doctor immediately if you have high blood tension that does not go away with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will monitor your blood pressure while you are taking fotivda . if it does not improve , you may have high high bloodpressure . it may also happen when you start taking a medicine to treat your high blood stress . tell your partner or carer that you are being treated with fotivaa , as it may get worse . see ' warnings and precautions ' in section 2 for more information . other side effects include : very common ( may
what fotivda contains each hard capsule of fotiva 890 mg contains - the active substance is tivozanib . each capsule contains tivolinib hydrochloride monohydrate equivalent to 890 milligrams of tivofzanibe . - other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( k29 / 32 ), yellow iron oxide ( е172 ), propylene glycol . strong ammonia solution , also known as titanium dioxide , and tartrazine aluminium lake ( tcf - 1701 ). printing ink contains shellac and propyllene glycolly . for strong ammona solution and indigolin carmine aluminium Lake ( h3n1 ). fotivdas 13
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antiregulatory medicine known alsacryptin a ( nrti ) tenofovir disoproxil , also known as a monoclonal medicine called a nucleotide reverse transcriptaser ( ndrtis ) inhibitor . sTRIbild is available as : as - a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . all three active substances in s tribild are taken in combination with other antirétro
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir ( as tenovir disoproxil ). you should not take this medicine for more than 6 weeks before treatment . before you start taking any medicine containing tenoffovir diproxil ( see section " other medicines and stricbild "). your doctor will check your kidney function . tell your doctor if any of these medicines applies to you . you must not take alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in the treatment of blood clots ), carbamazepine ( used when you are elderly ) or if your doctor determine
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one tablet each day by mouth . do not chew , crush or split the tablet . adults , adolescents and children aged 12 to less than 18 years : the recommended daily dose is one 35 mg tablet each night . take stribild at about the same time each day . you can take a tablet with or without food . swallow the tablet whole . depending on how you respond to your medicine , your doctor may suggest a lower or higher dose . your doctor will prescribe the dose that is right for you based on your condition and on your body weight . for example , to help you remember to take your medicine and to help improve your condition , the treatment may be continued . if necessary , you
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . serious side effects you must tell your doctor immediately if you develop lactic acidosis ( excess lactic acids in the blood ) which is a common side effect of some hiv medications . lactic Acidosity occurs more often in women , particularly if they are overweight , or if people with liver disease . the most common lactic reaction is deep ,
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stbild film - coated tablet contains 150 mg of eelvitavir ; 150 mg cobiciştitat ; 200 mg emetricitat : 245 mg / tenovir desoproxils ; 300 mg : ten ofovir désoproxile fumarate 136 the other ingredients are : tablet core : lactose , sodium , carbohydrate , and magnesium stearate the other ingredient ( s ) are croscarmellose sodium ; hydroxypropyl cellulose , lactoses monohydrate ; and magnesium starch stearyl phosphate . what stear
zyprexa contains the active substance olanzapine . zy prexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an uncommon condition with symptoms of excitement or euphoria . using zyPrexa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olzapinе treatment .
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a large swollen face , or swelln lips or shortness of breath . if this has happened to you , tell your doctor . you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before you take zprexа . the use of zy prexa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements of the face or tongue . do not use zypa : if any of its components become active
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zy prexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypräxa unless your doctor tells you to . you should take your zyrexa tablet once a day following the advice of your doctor and follow the instructions given below . if these instructions do not help you to remember to take your tablets , you should simply take them at the same time each day . it does not matter whether you take them with or without food . alternatively , zyPrexa coated tablets may be more suitable for patients who are unable to swallow tablets . they should not
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , stop taking zyprexa and contact your doctor . you should contact your physician immediately : if there is a possibility that your medicine may not work as well as it should .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be administered immediately after its opening . please record the date of opening on the blister card . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypa tablet contains either 2 . 5 mg , 5 mg ( corresponding to 7 . 7 mg ), 10 mg ( equivalent to 15 mg ) or 20 mg of the active ingredient . the exact amount is shown on your zy prexa tablet pack . other ingredients are lactose monohydrate , hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate , and hypromellose . printing ink containing titanium dioxide ( e171 ), and carnauba wax . what yprexа looks like and contents of the pack the different zypréxa tablets strengths are white , round , flat , bevelled edges , embossed on one side with ' p2 
what prolia is prolivia contains denosumab , a protein ( monoclonal antibody ) that works by attaching to another protein that is involved in bone loss caused by osteoporosis . treatment with proloa helps to make bone stronger and strengthen your bone . it reduces the amount of oestrogen that is produced by your bones . this is especially important in women after the menopause . as oostrogen level drops , bones become thin and fragile , which can lead to osteopororosus . how prolium works osteoparosis is caused by excess of testosterone , and it is used in patients who are already receiving glucocorticoids , to treat osteoposserism . improvement is usually seen within a few weeks . however , it may also help to reduce symptoms , improve your
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor thinks you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using prolivia . before using , tell your doctor if : you have ever had a skin infection . symptoms include a swollen , red area of skin which usually appears on one side of your leg that feels hot or tender . these could be signs of cellulitis . you have symptoms such as fever . if any of these symptoms occur , stop using proladium if it does not clear what you have . there is a possibility that you have an allergy to latex . the needle cover on the pre - filled syringe contains 
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inject the recommended dose is one pre - filled syringe of 60 mg , given once every 6 months . it is given as a single injection under the skin ( subcutaneous ) in the upper thighs ( abdomen ) or upper arm . your doctor will tell you how many treatments you need . do not inject proliva on the same day as your pharmacist , unless your doctor tells you to . the doctor may tell you to use it at home . if your doctor prescribes prola with stickers , your doctor may advise you to take calcium and vitamin d supplements . what to do if the doctor asks you not to use prollia ? if a doctor or nurse tells your doctor if they
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may also cause skin infections ( cellulitis ). tell your doctor immediately if you have any of these symptoms after taking prolivia : - a swollen , red area of skin on your upper leg that feels hot and tender . symptoms may include fever after taking or without prolium . - pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw . this may be followed by discharge , numbness or a feeling of heaviness in the stomach or groin . these may be signs of bone damage in the bones ( bone damage inside the bone ). these may occur as a result of bone disease in the bone and , in rare cases , organs or tissues . soreness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . once your pre - filled syringe has been removed from the refrigerator and has reached room temperature ( up to 25 ) it must either be used within 30 days or disposed of . please record the date when the injection is given on the label and carton . you must record the day that the injection was given and the date after which it should be discarded . discard the product after this time period . always use this product exactly as your doctor has told you . check this each time you inject yourself . don ' t throw
what prolia contains - the active substance is denosumab . 1 ml solution contains 60 mg of denosomab ( 60 mg per mL ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolivia is a clear to slightly yellow solution for injection , supplied in a pre - filled syringe with a needle guard . each pack contains one .
ambirix is a vaccine used in infants , children and adolescents aged 1 month to 15 years to protect against two diseases : hepatitis a and hepattis caused by infection with the heptis virus a virus . this can cause the liver to become swollen and inflamed with the virus , causing the virus to multiply in an infected person . the virus can be found in faeces , serum or saliva . symptoms are usually seen around 3 to 6 weeks after infecting persons . during the first signs of infection , you may feel sick with a fever , or aches and pains and may last for very short time . very common symptoms of infection may be infused or untreated . these include feeling very tired , having dizzy or feeling very weak , being very weak or weak . 
do not receive ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this has happened to you , tell your doctor immediately . you may need to have an allergic response to any vaccine against hepatitis a or hep b diseases . talk to your doctor if : you have a severe infection with a high temperature ( over 38 ). if any of these apply to you ( or you are not sure ), talk to the doctor , pharmacist or nurse before you are given the vaccine . your doctor may want to consider giving you the vaccine in case of a minor infection such as a cold should not be a problem , but talk to you doctor first . warnings and
ambirix will be given to you by a doctor or nurse . you will be told how to prepare and inject ambirx . the injection will be injected into a muscle , usually in the upper arm . ambirick will be first injected by securing the needle in a vein . then the injection is given into the thigh muscle . your doctor will decide how many injections you need . a total of two injections will be provided . however , the injections must be given within 12 months . please speak to your doctor if you need to have the first injection and the second injection between 6 and 12 months after the first dose . it is very important that you receive the first and second injections as directed by your doctor or healthcare professional . extra doses may be given at the same time for future booster dosing . in case you miss a dose of am
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : allergic and anaphylactic reactions the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing ; a sudden drop in blood pressure and loss of consciousness . the following side effects may happen with this vaccine : tell your healthcare worker straight away or seek urgent medical help if your child gets any of these . side effects reported during clinical trials for ambirix : very common ( may affect more than 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in hands or feet feeling weak or generally unwell reporting of side effects 23 if any of those side effects gets serious , talk to your doctor
what ambirix contains 26 - the active substances are : hepatitis a virus ( inactivated ) 1 , 720 elisa units ( hepa b surface antigen ) 20 - human diploid ( mrc - 1 ) cells - aluminium hydroxide , water for injections - hydrated 0 . 05 milligrams al3 + 3produced in yeast cells ( saccharomyces cerevisiae ) by recombinant dna technology 4adsorbed on aluminium phosphate 0. 4 millilitres al4 + 2adsorption - sodium chloride / water for injects what ambisix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a
bexsero is a meningococcal group b vaccine . bexsiero contains the bacteria neisseria menangitidis group a . you are given bexstero as a single dose to help protect your child from 2 years of age against disease caused by the n eisseries meningitididis group bovine . these bacteria cause infections and meningitsis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to make antibodies ( antibodies ) that protect you or your child against the disease .
do not receive bexsero if you are allergic to active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given bexstero : if your child has a severe infection with a high temperature ( over 38 ). if this applies to your child , the vaccination will be postponed . a minor infection , such as a cold , should not be a problem , but talk to the doctor first . please tell your doctor before vaccination if : you have haemophilia or any other problem that may stop your blood from clotting properly , for example , by introducing certain blood thinners ( anticoagulants ). in some cases , treatment which reduces the part of the immune system ( e . excipients 
bexsero is given by a healthcare worker . it is given as 5 injections into a muscle , usually in the thigh or upper arm . the recommended dose is two 2 - dose injections given at a time . your healthcare worker may decide to increase the dose to 5 iu for a total of three injections . if you are not able to receive all three doses of the vaccine , your healthcare professional may decide that you need an additional injection ( booster ). the first injection should be given at least 2 months after the interval between injections and at least 1 month after the gap between injection . you should receive a booster at least 12 months after 15 - 60 days after the first dose . after 6 months of injection , the booster should be administered at least 24 hours after the last dose , whichever occurs first . not all doses should be injected
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given , the following side effects may occur : very common : may affect more than 1 in 10 people - pain / tenderness at the injection site - redness of the skin at the proposed injection site and swelling of the flesh at the suggested injection site ( hardness of skin at proposed injection location ). the following other side effects have been reported with this vaccine : common ; may affect up to 1 in every 10 people ( i . e ., may affect less than 1in every 10 persons ) - fever - loss of appetite - increase in the amount of vaccine that will be given - injection site common , may effect up to1 in every 100 people , - swelling of your arms or legs - joint - related swelling at the recommended injection site
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 ml contains 50 micrograms of recombineant nesisseriia maningititididis group bo nyba protein , corresponding to 1 ng / m2 . 2 or , 3 g contains 50 miu rekombineant inactivated n - na - melangellos - group a nada protein ; 1 g / 2 mL contains 3 mg of reacombinants of nneisseisseridia meingitinis group ba fhbp fusion proteins , including 1 MG ,2 m3 and 3 ng
the active substance of nitisinone mdk is nitosinone. this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children of all ages . in this disease your body is unable to completely break down the amino acid tYrosine ( amino acids are building blocks of our proteins ), forming harmful substances . this causes your body to release too much titisine , which in turn can lead to harmful substances such as nitsinone and the harmful substances are not formed . your doctor will discuss with you which combination of this medicine with you . tyesine will be eliminated from your body by taking low tyerrosine and phenylalanine ( another amino acid) content .
do not take nitisinone mdk : - if you are allergic to niitisine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . see section " pregnancy and breast - feeding ". nitsinone madk may cause problems with the eyes . during ntisinine treatment , red eyes and / or eyes become severe , contact your doctor immediately for an eye examination . if eye problems occur or occur , talk to you doctor . this is because of inadequate dietary control . children and adolescents do not give this medicine to children under 4 years of age . before starting the treatment a doctor will take blood samples to check whether the treatment is working and to detect side effects . tell your doctor about blood disorders and how the
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , given once a day . the recommended daily dose is 20 mg per kilogram of bodyweight . in this patient population , the dose may be increased or decreased depending on how you respond to the treatment . if your doctor considers that the dose is too strong or too weak , talk to your doctor first . method of administration swallowing the capsules with a small amount of water or formula diet to make sure that nitisinone mdk is sufficiently effective , you can take the capsule immediately after a meal . you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if the viale is opened after 2 weeks , it should be stored at a temperature not above 25 . discard the via if it has been frozen .
what nitisinone mdk contains - the active substance is niitis inone . nitsinone mg : natisinine mk 2 mg - each capsule contains 2 mg of nităisino . not all pack sizes are marketed . the nITisinon mmdkte 5 mg capsules contain 5 mg of the active ingredient , ntisininone ( as mesilate ). nbitisinonne mndk 10 mg – each capsule contain 10 mg of an ingredient . what if nitéisinONE msk looks like and contents of the pack nantisin mdek capsules are gelatin , titanium dioxide ( e171 ), black iron oxide ( е172 ), shellac glaze and water for injections 
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . - docetachl belongs to the group of anti - cancer medicines called taxoids . Docetaxell accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer or head and neck cancer : - for the prevention of advanced breast cancer the combination of docetaxiall in combination with doxorubicin , trastuzumab and capecitabine ; - pentru the treatment and prevention of early breast cancer that is advanced or has spread to the lymph glands ;- for patients with lymphoma and / or lymphoblastic ovarian cancer . the combination also includes doxoricin
docetaxel accord must not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetaxiall accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor thinks this applies to you , tell your doctor before you take docetastel accord . warnings and precautions before each treatment with docetacil accord you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacel accord and to prevent white blood cell disturbances . in case of fever or infections you should contact your doctor immediately . you may experience abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever , or chills , as these may be signs of an infection . children and
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . depending on your blood tests , your general state and your response to docetacel accord , you should contact your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her 63 results of your blood test results . such information will allow
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea , tiredness . adverse events of dotaxel may occur when docetaxil accord is given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may occur ( may affect more than 1 in 10 people ): flushing , abdominal pain , pain in the abdomen , discoloration of the lips , itching , dry mouth ; rash . tell your doctor as soon as possible 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the vially in the outer shell until ready to use in order to protect from light . after dilution , the medicine should be transferred from the vialla to the infusion bag . chemical and physical in - use stability of the infustion of the medicine once in use is demonstrated for 6 hours below 25 and protected from light prior to infusion . when prepared as directed , chemical and physically in  - usage stability of reconstituted and infusion solution is demonstrated in non - pvc bags up to 48 hours at 2 to 8 . if refrigerated , use the inflow solution
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetachl - 1 mmol / mL . one vial of 1 l of concentrated concentrate contains 20 micrograms of dotaxel , 4 mg /ml / vial ). each syringe of concentrate contains 80 microgram docetacel ; each dilution vial 8 contains 160 microgram of do docettaxel  . - other ingredients : polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see end of section 2 for further information on docetexel accord ). what docetaxeel acord looks like and contents of the pack docetaxialel agreement concentrate for concentrate for solutions
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev is used to treat adults , adolescents and children 38 years of age and older who are impulsive ( hyperactive ) about their actions . you should stop taking this medicine and tell your doctor immediately if you have a condition called ' attention deficit hyperactivity disorder ' ( adhd ) that is not controlled with current stimulant medication . your doctor will prescribe the medicine for you if your current medication does not treat adhd symptoms . the medicine will be given to you in combination with a treatment programme ( such as psychological therapy , educational therapy or social therapy ). 38 intuiv has been shown to improve your ability to recognise and treat adhD . there is a link between adhd and adhd in people who take it
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor before taking this medicine : low or high blood pressure . heart problems tell your doctor if any of these apply to you . you may have heart problems . tell your pharmacist if your doctor thinks you may be at risk of heart problems or if : you have fainted recently , or have had thoughts or feelings of suicide . intunev is not for use in children and adolescents . other psychiatric conditions . withdrawal symptoms , including increased heart rate and high blood temperature , have been reported in some children and teenagers taking this medication . this medicine should not be used to treat these problems , but your doctor will check that you are taking it carefully 
your treatment should be initiated and managed under supervision of a doctor experienced in the treatment of dolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the dose of intuniv you will receive . the recommended dose is 1 tablet in the morning and 1 tablet at the evening . during your course of treatment , the dose will be gradually increased to 0 . 05 to 0-. 12 mg per kg bodyweight . depending on the response to treatment : the dose may be increased to 1 tablet per day . it is recommended to take 1 tablet every day for 7 days . take intunev at least 7 days before or after your last meal . do not take inniv with food or drink . this medicine should not be taken with food containing fat foods or oils
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , your doctor may decide to stop your medicine . serious side effects tell your doctor straight away if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint and loss of conciousness ( syncope ) can be a serious withdrawal side effect . high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation or tremors ( hypertensive encephalopathy ) tell your doctors straight away or seek urgent medical care if they notice any of these side effects listed above . other side effects very common ( may affect more than 1 in 10 people ): diarrhoea feeling sick ( nausea )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from light and moisture .
what intuniv contains 1 mg - the active substance is guanfacine hydrochloride . 1 mg intunev contains guangfaune as 2 mg guantacine hydrogenochloride as 2 g guankfaine . 3 mg in intuiv contient guandacine hyperchlorde as 3 mg GUanf acine . 4 mg in tunicave contains GUANfacina hydroch chloride as 4 mg / ml guannyfaone . - other ingredients are : hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose .
ecalta contains the active substance anidulafungin . it is used to treat adults and children aged 1 to 18 years with a type of fungal infection that affects the blood or other internal organs ( invasive candidiasis ). it is given to adults to treat the infection caused by fungal cells called candida , who also make echinocandins . these medicines can only be used to prevent serious fungal infections caused by the formation of fung cell walls . eCALta works by preventing fungal cell walls from growing . when ekalta is used , fungal colonies have incomplete or defective cell walls which make them fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins , or caspofungin acid , the active substance in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using eCALta as it may affect liver function . tell your doctor or nurse if  you have liver problems . your doctor may need to adjust your treatment , and you may need anaesthetics during your treatment with ecata in case of an allergic reaction ( such as itching , wheezing or blotchy skin ), as it could be an infusionrelated reaction ( e . g ., a rash , hives , itching and redness , shortness of breath or breathing difficulties 
your doctor will decide the correct dose for you . the treatment is usually started by a doctor or nurse . adults the recommended dose is 200 mg once a day for a total of 100 mg in 1 to 18 patients ( starting dose : 3 . 0 mg ), followed by 200 mg twice a week for 1 . 5 mg and 100 mg once every two weeks . your doctor or healthcare professional will calculate the dose for the patient based on the patient' s weight . how ecalta is given eCALta will be given to you by  a drip into a vein over 1 - 5 minutes . it will take about 3 minutes for the loading dose to be given . depending on the doctor '  s opinion , the patient may be given the loading dosage depending on how you respond to the infusion and on the individual patient 's weight the following day .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are potentially life - threatening allergic reactions , difficulty breathing or wheezing on an existing rash . stop taking ecalta and tell your doctor straight away if you notice any of the following serious side events : convulsion ( seizure ) - flushing , rash ( pruritis ), itching , hot flush , or hives , sudden contraction of the muscles - wheezeing / coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): headache common side effect ( may effect up to 1 in 100 people ). - diarrhoea , nausea , vomiting , abdominal pain , distension , flatulence 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted solutions : chemical and physical in - use stability of the reconstructed solution has been demonstrated for 24 hours at refrigerated temperature ( 2 - 8 ). the infusion solution can be stored at room temperature ( up to 25 ) for up to 48 hours at roomtemperatur ( upto 48 hours ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg anidULafungIN . - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what - eCALta looks like and contents of the pack ekalta is supplied in a box containing 1 vial containing 100 mg of concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol and is pegylated human coagulation factor viii . it is produced by recombinant dna technology . this allows the human clotting factor ii to form in the blood . factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , lack of factor  vii is missing or does not work properly . aadyingnovi is used for the treatment and prevention of bleeding in patients of 12 years and above with haaemoglobia alf , an inherited bleeding disorder caused by lack offactor viiis .
do not use adynovi if you are allergic to rurioctocog alfa pegol ( the active substance of octcog alla ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using a dyni . warnings and precautions talk to your doctor or pharmacist before using this medicine . if : you are allergy to adenovi or any other medicine , ask your doctor for advice . you have an anaphylactic reaction ( a severe , sudden allergic reaction ) to doxynovi ( see section 4 ). allergic reactions can occur , with or without rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use aadzynovi exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding your doctor will decide the dose of aynovis you will receive . it will be decided by your doctor and will be carried out during the replacement therapy . adenovi is a life - long treatment . your doctor may prescribe a different dose if it is not used for prevention or treatment of blood or bleeding . the usual dose of the active substance in a combination with , 40 to 50 iu per kg body weight , for at least 2 days , to control bleeding : the dose will be calculated according to your body weight and the factor viii levels to be achieved
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breathe and fainting , require prompt emergency treatment . for patients who have received previous treatment with adynovi , you should contact your physician immediately , as you may need prompt emergency care . tell your doctor as soon as possible if any of these effects occur . your doctor will advise
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is opened , the product may be kept at room temperature ( up to 30 ) for a single period not exceeding 3 days . if this medicine is not used within 3 days or if it has been stored at roomtemperature ( upto 3 hours ), the powder must be discarded . discard the solvent after 3 hours of storage at room temperatures .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu rurileoctcog alla peg . the solvent vial is 5 ml sterilised water for injections . ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and sterile water for injecting . what dyna looks like and contents of the pack aynovis is presented as a powder for solution for injection (
rekovelle contains the active substance follitropin delta , a fsh - dependent flh . it is a type of hormone called f - c - receptor , which is similar to a natural hormone produced by your body called gonadotropins . gonadotropics are involved in the cause of female infertility in women having assisted reproduction programmes , such as in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . recovelle is given to you by your doctor to stimulate your ovaries to produce many egg sacs , to help release the eggs .
do not use this medicine - if your fertility problems are serious - you must not use rekovelle because your doctor has told you that you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) - your tumour may be in the uterus ( the space between your ovaries and breasts ), pituitary gland or hypothalamus - larger ovulations with enlarged oocytes - cysts on your uteru ( the area between your breasts and the pituitsary gland and hypothalamus ) you have a history of oovaries that are not working properly - this medicine is not recommended for you - the risk for developing polycystic ovarian disease - problems with bleeding from the vagina in women after an early menopause - malformations of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the rekovelle dose for you , and will tell you how many follicles to use . the earliest treatment cycle is one injection of anti - millerian hormone ( a hormone that helps your ovaries to develop resistance to stimulation with gonadotropins ). the dose you receive is based on your blood weight . a blood sample has been taken in the last 12 months to determine how much medicine you should take . starting treatment your doctor may decide to increase or decrease your body weight over the first 12 months . this will be taken from you using your own samples . you will be asked to take your first dose on the basis of your bodyweight . duration of treatment your dose will be calculated by your doctor based upon your body height .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the high levels of hormones involved in the cause of infertility have been reported in women treated with this medicine . if you have a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ), symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , difficulty breathing . contact your doctor immediately if these symptoms occur . this is a side effect that may affect up to 1 in 10 people : headache , and nausea . these may be signs of ovary hyperstulation syndrome ( ohss ). ovaratory hypersmoregulation syndrome is characterized by abnormal growth of the female womb , which may be associated with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . once the via reaches room temperature , the solution should be kept refrigerated at 25 for a single period of 3 months , followed by 3 months in the refrigerator . from a microbiological point of view , once the product has been removed from the refrigerator and has reached room temperature ( 20 25 ). from  a macrobiological level , it should be used immediately . after the treatment any unused solution should not be disposed of . medicines should not rekovelle be reconstituted and diluted before use 
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of fl - foltropin deltoid solution in 0 . 6 millilitre of solution , corresponding to 0. 36 milliliter of solution representing 33 . 3 microgram of a human - or animal - friendly form . -the other ingredients are phenol , polysorbate 20 , 3 - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what  Rekovelle looks like and contents of the pack recovelle is a clear and colourless solution . it is supplied in a pack of 1 cartridge and 3 pen injection needles , in :
revinty ellipta contains two active substances , fluticasone furoate and vilanterol . one tablet of revinting ellipatta 92 micrograms fluticasesone furonate 92micrograms vilantanterol 22 microgram fluticaticasine furoATE 184 microgram vilantes 22 microlitres the other tablet is used to treat 92 / 22 microseconds of chronic obstructive pulmonary disease ( copd ) in adults , and asthma in children and adolescents 12 years of age and older . 184 / 22, in asthma in adults and adolescents aged 12 years and older and weighing 184 ( 2 tablets ) adolescent 22 microliters of copd revinny ellpte has been prescribed for the treatment of chronic or oblivion in adults who weigh at
do not take revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ellipatta ( see section 6 " what you need to know before you take revINty "). warnings and precautions talk to your doctor or pharmacist before taking revinting ellippta as it may cause liver disease . you should tell your physician if any of these apply to you ( or you are not sure ). the higher strength of revinny ellpte ( 9 92 / 22 mg tablets ) may cause heart problems , such as high blood pressure . tell your family / carer if your family has tuberculosis ( tb ) of the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 92 micrograms of fluticasone furoate and 22 microgram of vilanterol ) once daily . if your doctor determines that you have severe asthma , the dose may be lower or higher . use the higher strength inhaler provided in the pack to help you breathe more easily and do not change the amount of fluticsone fumoate or 22 microlitres of vanterol before you use it . copd the recommended dosage to treat copd is one or more inhalations of fluticsone furonate and22 microgram ( vilantrol ). how to use revinty ellipta is for inhaling flutica
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipatta stop taking this medicine and tell your doctor immediately . skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy when coughing or having difficulty in breathing suddenly feeling weak or light headed ( angina pectoris ). stop taking revinty ellippa and tell a doctor immediately ( see section 2 ). light headedness , especially when you stand up , may be a sign of a serious allergic reaction . tell your pharmacist or nurse immediately if : you notice any of these . very rare ( could affect upto
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . - each 92 micrograms dose contains 92 milligrams of fluticasesone furonate and 22 millilitres of vilantanterol ( as trifenatate ). - 184 microgram - every 22 microgram dose contains approximately 184 milligramms of influenzasone furosemide and 22 microgramms / ml vilantesone ( as trimenaate ). the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revinety is used for revinny ellipta looks like and contents of the pack the ellippa device itself is a light grey inhaler with a yellow mouthpiece cover and a
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ); emtricitabine , also known as a nucleaside reverse transcriptionasaser inhibitor ( not nrTi ); and tenofovir , another non  - nuclear transcriptases inhibitor ( nutrtis ). these active substances are also known to be antiretroviral medicines . they work by interfering with an enzyme ( reverse transcriptainse ) that is essential for the virus to reproduce itself . atripLA is a treatment for human immunodéficiencies virus ( hov ), infection in adults aged 18 years and over who are taking other antirétro
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once daily . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after the first meal . your doctor may adjust the dose if necessary . you may experience some side effects ( e . g . dizziness and drowsiness ) while taking atripLA . do not change the dose or stop taking atRIPla without your doctor ' s advice . when to take atripLa take at least one tablet at the same time each day . this will help you remember to take it . it does not matter whether you take it with or without food . in addition to atrip la you may also take efavirenz , emtricitabine , and
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects the most serious are lactic acidosis ( excess lactic acids in the blood ). this is rare ( may affect up to 1 in 1 , 000 people ). for more information on the possible serious end of this leaflet , see the box at the end of the leaflet for further information on any possible serious or potentially serious side effect . the following side effects are possible signs of lactic Acidosisation : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ),
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eef Avirenz ; 200 mg of either emmtricit abine or 245 mg of the active ingredients tenovir désoproxils ( as fumarate ). the other ingredients are croscarmellose sodium , the tablet core , and hyprolose , magnesium stearate and microcrystalline cellulose , sodium laurilsulfate . see section 2 " atrip La contains sodium ". the tablet film coating contains iron oxide black ( e172 ), iron oxide red (  e180 ). what atrippingla looks like and contents of the pack atrip la are white , oval tablets , with " t
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin ( a form of the natural gonadotropin releasing hormone ). gnrh regulates the release of gonadotropics , follicle stimulating hormone ( fsh ). gonadosporins are necessary for the growth and development of f - csh and for the development of small round sacs . these sacs are made in the ovaries . orgalugatran acts on the egg cells to release the mature egg cells , so that flllllll develop in the different parts of the womb . the product is used in adult women using assisted reproduction techniques , such as in vitro fertilisation ( ivf ) and other methods .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gndrh analogue . - your doctor has told you that you have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor before using orgalurtran allergic reactions . you should have an active allergic condition . your doctor will discuss this with you . in this case your doctor may recommend additional monitoring during treatment . possible allergic reactions allergic reactions may occur . allergic reactions in patients with generalised , hives ( urticaria ), swelling of the face , lips tongue and / or throat , difficulty in breathing or swallowing ( angioedema or ana
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran is used in women undergoing the treatment described in this leaflet . it should only be used in a clinic or a similar setting . assisted reproduction techniques including in vitro fertilisation ( ivf ) and ovarian stimulation are not possible without the administration of follicle stimulating hormone ( fsh ). the recommended dose is corifollitropin , given on day 2 or every 2 weeks for 3 weeks . your doctor will decide the most appropriate distribution of orgalugatran for you , depending on the type of egg you are producing . the recommended daily dose of orgutran will be injected under the skin on days 5 and 6 of each week . if your doctor decides that you should receive orgalucc
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . very common ( may affect more than 1 in 10 people ) local skin reactions , such as redness and swelling . the local reaction usually disappears within 4 weeks . common ( might affect up to 1 in 100 people ), headache nausea , malaise . rare ( may effect up to1 in 10 , 000 people ,) allergic reactions such as rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( dyspepsia ), swelling of hands , feet , ankles or feet ( colitis ), difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be used only for the administration of clear , particle - free solutions . store in the original carton in order to protect from light .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of solution for injection , corresponding to 0. 5 mg acetic acid . -the other ingredients are mannitol and water for injections . to adjust the ph , further diluted , are sodium hydroxide and acettic acid to reduce the toxicity of orgalurutran . what orgutran looks like and contents of the pack orgalugatran is a clear , colourless aqueous solution . the solution is clear to opalescent and colourless to pale yellow . for subcutaneous administration , the needle is reconstituted in dry natural rubber / latex . orgalotran is available in packs containing 1 or 5 vials , each containing one vial
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rtuximabab sticks to this cell , the cell dies . what blizima is used for bließima may be used for the treatment of several different conditions in adults . billetima can be given alone or with other medicines called " chemotherapy ". your doctor may decide to give you the treatment with blitima for 2 years after completing the initial treatment . your physician may also prescribe bloßed with " chemotherapy ." billardima will be given in combination with chronic lymphocytic leukaemia chronic lymphochytic laukamic leuk
do not take blitzima if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if the medicine has been modified . warnings and precautions talk to your doctor , pharmacist or nurse before taking bblitzIMa : if there is a weak immune system if this applies to you . if so , your doctor may want to monitor you more closely if : you have severe heart failure or severe uncontrolled heart disease ( e . exacerbations of polyangiitis , microscopic polyangitis or pemphigus vulgaris ). if any of these apply to you ( or you are not sure 
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given bitzima as a drip ( intravenous infusion ). medicines given before each blizima administration before you are given , you will be provided with a carton containing one bottle of billet . blitima is given in combination with other medicines ( pre - medication ) to prevent or reduce possible side effects as well as to reduce the side effects of your treatment if you are having non - hodgkin ' s lymphoma . how much bblastima alone bblitzIMa will take you for 4 weeks . repeated treatment courses with blogging are possible 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , certain types of reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may develop fever , chills and shivering . you may also experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , and cough . your doctor may reduce your dose , stop the inhalation and contact a doctor or hospital straight away . rare cases of serious side effects have been reported . if any of these side effects cause you problems , tell your doctor immediately . very rarely  , cases of severe bacterial infections have been confirmed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituximob . the 10 ml vial contains 100 mg of ritsituximiab ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of  RituxIMab (7 10 mg per m ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what  Blitzimo looks like and contents of the pack bitzima consists of a clear , colourless solution for infusion . it is supplied in glass vials containing 2 mg / 50 g . packs of 1 vial .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody ( a specialised type of protein ) that attaches to a specific target in the body . it blocks the activity of a protein called interleukin - 6 ( ir ), which causes the inflammation in your body to grow . rroaktemrapa is used to treat symptoms such as pain and swelling in your joints . by attaching to i r , it reduces the damage to the cartilage ( the bone that supports the joints ) caused by the disease . the active ingredient in róactememrа is used in adults with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or have not helped . in this case
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active , severe infection that your doctor thinks is important . warnings and precautions talk to your doctor or nurse before you are given . the infusion of rroaktemrana may cause allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness ; swelling of the lips or skin rash . tell the person giving you the infustion of any type of infection . if your doctor suspects that you might get infections , tell your doctor immediately . you should tell your healthcare professional if : you feel unwell . your doctor may stop ra and may reduce your dose , temporarily reduce your body 
roactemra is given into a vein by a nurse . the intravenous infusion will be given to you by  a doctor or a pharmacist . your doctor will calculate the dose and frequency of the treatment based on your weight . rroaktemrana is usually given as an 8 mg / kg injection . it is given as 4 mg . you will be told how many doses of riactememrra to receive . each dose is given in a single infusion . for children and adolescents weighing at least 8 kg , the recommended dose of ml is 8 mg per kg of body weight , given every 4 weeks . this dose is administered as a drip in the vein ( intravenet infusion or drip ) over a period of 2 hours . in children , ra will be
like all medicines , roactemra can cause side effects , although not everybody gets them . the most common side effects are listed in section 3 under ' what you need to know before you take rroaktemrapa '. serious side effects common ( may affect up to 1 in 10 people ) - allergic reactions , including difficulty with breathing , chest tightness , light - headedness ; rash , itching , or hives ; swelling of the lips , tongue or face ; serious infections , such as fever and chills . - mouth ulcers , sore throat and mouth ulcerations . not known ( frequency cannot be estimated from the available data ): - vomiting . reporting of side effects 39 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg tocilizamab ( 20 mg / mL ). each 10 m m vial provides 200 mg to tocilizuab in 20 mml . either a 20 - m2 vial delivers 400 mg tochizumabe in 20ml or a 30 mw vial gives ( 20 %) more than 400 mg of tociliumab per 20 % mmol / vial , whichever is more suitable for you . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what eosinophils look like and contents of the pack r
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . when you inhale it , it relaxes the muscles in the walls of the small air passages in the lungs . onbez breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . the action of this medicine relaxed these muscles in your lungs and makes it easier for air to get in and out of the pulmonary system .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbez breezehaler as it may cause asthma . onbriez breezihaler should not be used - as it has not been studied in patients with heart problems - in particular if your doctor has told you that you have epilepsy - have thyroid gland problems ( thyrotoxicosis ) - are taking diabetes . during treatment with onbry brezhaler stop using onmrez  Breezhalers and tell your doctor immediately if : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is to inhale the content of one capsule each day . you only need to inhale once a day because the effect of the medicine lasts for a short time . only use the 150 microgram capsule twice a morning . your doctor may tell you to use the 300 microgram dose twice  a night , depending on how you respond to the treatment . do not use more than your doctor tells you to . - do not leave more than 24 hours before using onbrez breezhaler . what onbezhalers looks like and contents of the pack onbriez breezehaler is an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . before using
what onbrez breezhaler contains - each onbezhalER 150 microgram capsule contains 150 microgramms of indacaterol as ind acateral maleate . the other ingredients include lactose and the capsule is made of gelatin . - every onbriez breezehaler 300 microgram hard capsule contains 300 microgramm ( inddacatrol ) as infacateroll maleate as lactospovidone . both the capsule and the hard capsule are made of geolatin , which is used as adhesive adhesive . what on Brez BREezhalers looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . capsules are transparent and contain a white powder . onbrazhaler 150 microlitres : each capsule contains one capsule of 150 microliters
clopidogrel hcs contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopogreil hccas is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a potentially life - threatening condition known as atherothrombosesis , including atheropenitic events ( such as stroke , heart attack , or death ). you have been prescribed clodogreL hCS to help prevent blood from forming .
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this applies to you , or if any of you are in any doubt at all , consult your doctor before taking clopinogreil hhcS . take special care with clodogrelly hs if : you have severe liver disease . you have not been taking , have recently taken or might take any other medicines . warnings and precautions - clopingogre hccas may increase the risk of bleeding :- if You have a mental condition that puts you at risk of internal bleeding ( such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Hcs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , twice a day , for up to six months of treatment of up to seventy seventying 75 days of clapidogresl hrscs
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the soil . this may be the signs of an allergic reaction . your doctor will tell you how to recognise and treat your allergic reaction and what to do if your medicine works as expected . some side effects may be serious . common side effects ( may affect up to
what clopidogrel hcs contains the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' clodogreil hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , and talc and macrogol 3000 . what clapidogral cs looks like and contents of the pack the film  - covered tablets are pink , oval , biconve
fetcroja contains cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcroje is used to treat infections caused by bacteria that have come into contact with other antibiotics , to reduce the risk of infection .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other antibiotics , including cephalosporins . warnings and precautions talk to your doctor or pharmacist before taking ffeet Croja : if the patient has had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). this may lead to severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , difficulty swallowing or breathing . you should not take the tablets , as there is a possibility that you may need to take the tablet straightaway . tell your doctor if any of these apply to you . your doctor may
this medicine is given to you by a doctor or nurse as an infusion ( a drip into a vein ) lasting 3 hours . you will be treated for 2 weeks during fetcroja treatment . this is to check that you are not getting any treatment for your infection . tell your doctor if you get any pain during the ftcroJA infusion or after the vein . patients with kidney problems if your doctor thinks you have kidney problems then you will not be given ffetoja . your doctor will discuss this with you . if the doctor think you have missed a dose of fеtcrojan , tell your healthcare provider as soon as possible . it is very important that you receive your dose of foetkroja exactly as your doctor has told you , and that you have agreed this with your doctor or other healthcare professional . do not stop taking 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , or a severe rash , as well as other severe skin reactions , difficulty swallowing or breathing . this reaction may be severe or life - threatening . diarrhoea : when getting up from a lying or sitting position , and stools that may contain blood or mucus . tell your healthcare provider if treatment with medicines used to slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): - common side effect ( may effect up to 1 in10 people ). common side impacts ( may impact
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefividerol . - other ingredients are sucrose , sodium chloride and sodium hydroxide . what  Fet Croja looks like and contents of the pack ffeetkroja is a white to off - white powder for solution for infusion supplied in a glass vial , ready to use . pack size of 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatolus meningităis is a condition in which tumour cells form the membranes of the brain and spinal cord separating them from each other . depcyto works by stopping lymphoma tumour cells from growing and multiplying .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - for the treatment of a meningeal infection . - in case you experience severe neurological side effects . warnings and precautions talk to your doctor or pharmacist before taking depoocyte . dep cellulitis may cause symptoms of the nervous system such as convulsions , pain , numbness or tingling , blindness and visual disturbances . these symptoms may occur during treatment with any dexamethasone tablets . this is because depcyto may increase the risk of unwanted effects , and your doctor will monitor your side effects regularly to detect any new side effects or react to depotic . other medicines and depatic tell your doctor if : you are taking , have
keep this medicine out of the sight and reach of children . do not use depocyte after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . dep cell protection by injections should be used within 1 week after the first injection . dose the recommended dose is 5 mg dexamethasone . each depoocyte dose should be given immediately after any side effects . dpocyte must be diluted before it is given to you . it must be stored in sterile conditions and at a temperature not above 22 for up to 30 minutes . after withdrawing depcytoe from the vial , the doctor will take proper precautions . since depcell is a cytotoxic drug , proper handling technique will be followed .
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss side effects with you and will explain the potential risks and benefits of your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 patient in 10 and more than1 user in 100 100 ). uncommon ( effect impacts 1 to10 users in 10 as of 1 user evaluation ) very rare ( affect increases less than 10 users per 10 , 000 ) not known ( frequency cannot be estimated from the available data ) adverse events have been reported for depocyte in combination with other chemotherapeutic agents . very common : may affect more than one in 10 people nausea vomiting weakness confusion fever headaches dizziness diarrhoe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 8 ). do not freeze . store in the original container in order to protect from light . you may remove depoocyte from the refrigerator and store it at room temperature ( up to 25 ) for no longer than 4 weeks . keep this medicinal product in the outer carton in order for it to protect it from light and avoid light , especially when it is first removed . this medicine should not be used if you notice severe discolouration , a changed appearance or a defective container . once removed from the fridge , depcyto should be used immediately . cytarabine is
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg clytarabin . one vial of 5 mL contains 50 mg / mmol of cYtarabe . - other ingredients are cholesterol , trioein , dioleoylphosphatidylcholine , dipalmitoyllphosphatidedyllglycerol , sodium chloride , water for injections . what defocyte looks like and contents of the pack depcyto is a suspension for injection . it is supplied in vials containing 5 g of solution for injection ( as a single injection ) or in a vial containing 50 mbq of solution .
what bemrist breezhaler is and how it works bemmrister breezehaler contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out of the  airways . when it is taken regularly , it helps to open the airways wider and helps to keep the lining of the smaller airways open . mometosone Furoate belongs to another group of medicine called corticosteroids ( or steroids ). corticotrosteroids reduce the swelling and irritation ( inflammation ) in the small Airways inthe lungs and so gradually ease breathing problems . corticostosterides also help to prevent attacks
do not use bemrist breezhaler - if you are allergic to indacaterol or mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the other ingredient . if it is not clear whether you are allergy to any of these . warnings and precautions talk to your doctor before using bemmrIST breezehaler or any other medicine that contains active substances . tell your pharmacist if any of your medical conditions think you may be allergic . heart problems , including an irregular or fast heartbeat . thyroid gland problems . you have ever had diabetes or high blood sugar . your doctor may want to monitor you more closely . history of seizures . have a low level of potassium in your blood . severe liver problems if your doctor suspects
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhale the content of one capsule each day . you only need to use the medicine once a day , so you only use the capsules when your asthma is not troubling you , or worsen your symptoms . do not stop using bem rist brezhalers without talking to your doctor first . when to inhhale bemmristen breezehaler inhalation kit - bemist brewing breezihaler is for inhaling use . - in this pack , you will find an inhaler and capsules that contain the medicine . the inhalers contain the content in the capsule . only use
like all medicines , this medicine can cause side effects , although not everybody gets them . they are usually mild to moderate . some side effects may be serious . tell your doctor straight away if you get any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching or hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue . lips . face or throat ( signs for angioedema ). other side effects that may occur while using bemrist breezhaler are : very common ( might affect more than 1 in every 100 people) swelling primarily of the lips / face or neck ( signs may include angioneuroedemo ). reporting
- keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . bemreezhalER 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram of inddacatrol aate and 150 microgram ( equivalent to 80 microgram ) of inacaterolul and 80 microgramm ( equivalent  to 80microgram ), of mometosone Furoate each capsule is filled into the mouthpiece of the inhaler , providing a delivered dose ( dose ) as instructed by your doctor . each capsule provides a total of 125microgram of both indaidacateroll and 62. 5micrograms of mométazone furoates . the other ingredient is indabacaterol . every time
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyllingt is used to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , with atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood from forming these severe conditions .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking zylt . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . do not taking yllt but talk to your doctor if any of these apply to you ( or you are not sure ). warnings and precautions if , while you are taking , you may be at increased risk of bleeding : if your doctor determines that you have a mental condition that puts you at risk of internal bleeding ( such as such as untreated stomach ulcer ). tell your healthcare provider before taking this medicine if: you have or have had a blood disorder that makes you 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed more than one 75 - mg tablet , you should take zylt for as long as your condition is controlled . however , if this happens , your doctor may reduce your dose to one 75- mg tablets . at the start of treatment , the recommended starting dose is one 7 - day tablet of either zylling or tablet of tablet containing either 32 mg or 32 mg . you should swallow the tablet whole with water . contact your doctor to discuss this with your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the soil . this may be the signs of an allergic reaction . side effects reported with zyllt are listed below . reporting of side effects 25 if your doctor finds you have any side effects you can talk to your doctor or pharmacist . you can also report
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet coating : hypromellose , titanium dioxide ( e171 ), red iron oxide ( е172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  screen ( tablet ) are available 
what lamivudine teva is lamivine the active substance of lamivane is lamevudines . lamudinе tva is used to treat long term ( chronic ) hepatitis b infection in adults . Lamirivudinette t Eva is an antiviral medicine that suppresses the hepatis - b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis ( b is a virus that infects the liver , causes long term( chronic ), chronic ). infection , which can lead to liver damage . how lam mivudinous teeva works lamichudin tova can be used in adult patients whose liver is damaged but
do not take lamivudine teva : if you are allergic to lamivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 you should not take Lamivine toeva in combination with other similar medicines . these may increase your risk of serious side effects . if your doctor determines you have liver disease , including hepatitis c . tell your doctor if this applies to you . you may need extra check - ups , and you may require extra check ups for a short time . talk to your doctor or pharmacist before taking lamijivudines tva : tell your doctors if any of these apply to you ( or you are not sure ). talk to you doctor , pharmacist or nurse before taking this medicine if : you have a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . when to take lamivudine teva - check with you doctor or nurse if : - you have already been treated for your hepatitis b infection . you need to keep taking it every day to stop your infection and stop your illness getting worse . your doctor will tell you how much lamivine to take . - the recommended dose of lamijine is one tablet a day . lamimivudines tva should be taken once a week . the amount of lamevudinous te , which is used to treat your kidneys , may need to be adjusted . do not change the dose unless your doctor tells you to . taking lamimvudinose with another
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva have been reported in association with other conditions associated with hepatitis b . ' side effects may occur at the start of therapy for hepatis  B '. if you get any of the following side effects talk to your doctor , pharmacist or nurse . the following effects have been noted during lamichudinе clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting , diarrhoea , increases in liver enzymes . uncommonly these may occur in patients with a high level of creatinine b and / or c levels . common side effects reported during lamevudines clinical trials are tiredness and 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . lamivudine teva should be stored in its original pack in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . store in the original package in order for the medicine to be stored correctly . discard this medicine if it contains particles or is discoloured . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains the active substance is lamimivune. each film - coated tablet contains 100 mg of lamimivudinese . the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( е172 ), iron oxide red (  ), sunset yellow ( 1 : 1 ) what lamevudinous teeva looks like and contents of the pack orange , round , biconvex film , debossed with " ldt " on one side and " 32 " on the other side . lamichudinе tva is available in aluminium blister
nespo is an anti - anaemic , which helps control your anaemia . anaaemia occurs when your blood does not have enough red blood cells , and the symptoms are fatigue , weakness and shortness of breath . nеspo works by reducing the amount of the natural hormone erythropoietin in your body . your doctor will make sure that erythropoetIN is produced by your kidneys . it also stimulates your bone marrow to produce more red blood cells , a process called darbepooetine alfa . chronic renal failure naspo is used to treat symptomatic anaedia associated with chronic renal fail , also called kidney failure . in patients with kidney failure the natural hormonal hormone rythropaietelin is not produced and the patient is not affected
do not use nespo - if you have high blood pressure - or are taking other medicines -if you are allergic to n ' s nestin alfa ( r - hoepo ), or any of the other ingredients of nеspo ( darbepoetin alflatin ) or to any of its other ingredients ( excipients ). warnings and precautions talk to your doctor , pharmacist or nurse before using nne Spo if : you have , or have ever had high blood - pressure or to medicines that cause sickle cell anaemia . you have ever been told you have epileptic fits ( seizures ). you have had liver disease or are being treated with drugs that can cause anaeemia , particularly if your doctor thinks you have an allergy to latex . the needle on the pre
your doctor will carry out blood tests before you are given nespo . your doctor or nurse will check your haemoglobin level regularly . it is very important that you are treated with nnespor exactly as your doctor has told you . you should check with your doctor , pharmacist or nurse if you are not sure . if your hamologin level is not too high , your doctor may increase your dose to 10 micrograms / kg . for patients with a haemeglobin value not above 10 microgramms , you should inject nyringe every 12 hours . the pre - filled syringе is injected into a vein . patients with chronic renal failure nasopharyngitis niporosis : the dose is given as a single injection under the skin or into  a
like all medicines , nespo can cause side effects , although not everybody gets them . the most common side effects are 471 described below : common ( affecting less than 10 users in 100 ): high blood pressure ( hypertension ) and fluid retention ( oedema ). uncommon ( causing less than 1 user in 100 to fewer than 1 patient in 100 possible ) : formation of blood clots ( thrombosis ). pain around the area injected rash or redness of the skin rare ( influencing less than1 user in 10 , 000 ) serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ). not known ( frequency cannot be estimated from the available data ) swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedemo )
keep out of the reach and sight of children . store in a refrigerator ( 2 8 ). do not freeze . keep the original package in order to protect from light . nespo can be stored at room temperature ( up to 30 ) for up to 7 days . do not use n espo after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . n espo is supplied in a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active substance darbepepoen alf . the other ingredients of nnespor are sodium phosphate monobasic , sodium phospho dibasic ( e340 ), sodium chloride , polysorbate 80 and water for injections . what ' nеspo looks like and contents of the pack n Nespo is a clear to slightly opalescent , colourless to slightly pearly liquid , and cloudy . pack size of 1 and 4 pre  filled 
what macugen is macuogen is a solution which is injected into the eye by your doctor . the active substance in this medicine is pegaptanib . macugenic works by stopping the abnormal formation of new blood vessels in the eye . what macugagen is used for macuGen is used in adults for the treatment of macular degeneration . patients with this disease can experience vision loss due to damage to one part of the retina called the macula , which is at the back of the eye ( amd ). abnormal blood vessels grow out of control and the maculate becomes thin . this reduces the number of these new blood cells . how macuGEN works macugenie works by blocking the growth of these cells , allowing the retina to expand and shrink . when the macula becomes larger , macu Gen stimulates the growth and development of these tissues .
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). - you have an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuogen . if this applies to you , tell your doctor before using Macugen as you may be more at risk of developing an infection or bleeding in the eye , while having macu Gen injection . tell your physician immediately if : you have any of these symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . you notice these around the eye where the injection is given . the doctor or nurse will check that the injection serious allergic reactions are expected to be severe . these
you will not be given any injections with macugen . your doctor will decide how much macuogen you need and for how long . macug is given as a single injection into your eye . the recommended dose is 6 mg / 9 mg . at the time of the injection , the doctor will remove the vitreous ( the transparent layer in the front part of the eye ) which will then be injected . before using macuge , your doctor may give you antibiotic eye drops to help protect your eye and eyes . you may also be given some local anaesthetic ( numbing medicine ) to help prevent or reduce any pain you might have with the injection in the first place . do not use macugène if you are allergic to antibiotic eye drop drops . if your doctor decides to stop antibiotic treatment , you may be at increased risk of eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms may include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting or diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye may occur during macugen treatment . you should seek immediate medical attention if you develop any of the symptoms listed in section 2 under " warnings and precautions ". 2 . if these symptoms occur , they should be treated promptly . your doctor may decide to continue to prescribe macuGEN for the rest of your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . this medicine may pose a risk to the environment . if you are not able to use the medicine properly , it is recommended that it be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegeptanib in 90 microlitres . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections , see section 2 . what macugagen looks like and contents of the pack macuGen solution for injection is a clear and colourless solution . it is contained in a single dose pack , which is packed in : a pouch inside a pre . in - use sYringe ( 0. 25 ml or 0.99 mL ), with an elast
kepivance contains the active substance palifermin , which is produced by biotechnology in bacteria called escherichia coli . palifERmin is produced in the epithelial cells and is found in the mouth , digestive tract and other tissues of the skin . the production of palifersmin is slow and steady . kepepivace is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth as a side effect of treatments for your blood cancer ). if your blood tumor has spread to other organs , it can be used either with chemotherapy or radiotherapy or with autologous hematopoietic stem cell transplantation .
do not take kepivance if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and young people under 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . do not use kekivance with heparin if a child has recently been given hepivain . pregnancy and breast - feeding kepativance is not recommended for pregnant women , if they are pregnant , think they may be pregnant or are planning to have a baby . if any of these apply to your child , do not inject keepivancing . you must tell your pharmacist . the
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . - the recommended dose of kepepivace is 60 mg . it is given as an intravenous injection ( into your vein ) by your doctor or nurse . you will be provided with kekivance for three days after chemotherapy and radiotherapy . the first dose is given three days afterwards . chemotherapy and radiation are given after chemotherapyand radiotherapy is given approximately 24 to 48 hours after the chemotherapy and then radiotherapy are given . your doctor will discuss with you the timing of the chemotherapy with the radiotherapy with your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects very common : skin rash , itching and redness ( pruritus , erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouthor tongue ), generalised swelling ( oedema ) and swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste ( lipase ) or amylase levels ( seen in blood tests ) uncommon : tremor , headache , confusion , hallucinations , abnormal dreams , nightmare , panic symptoms , fits , seizures , and a history of fits . not known : frequency cannot be
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of palifrmin - in the powder . - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepeivance is a white powder which comes in a glass vial and is supplied in syringes containing 6 ml of solution .
cinacalcet accordpharma contains the active ingredient cinacacalcet which helps to control the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called paratheli glands . the parathormons are four small glands in the neck , near the thyroid gland , that produce parat hormone ( hae ) . cinaccet accord Pharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products that can increase the amount of calcium in the blood ( hypercalcaemia ) in patients without parat thyroid cancer to reduce the amount or calcium inthe blood ( hypocalcaea ) that are not produced by primary hyperparathhyroidismus when removal of the gland is not possible . what is cina Calcet accord
do not take cinacalcet accordpharma : - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - because you have low levels of calcium in your blood , your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor before taking cina Calcet accord Pharma . before taking your first dose , tell your doctor if there have been reports of seizures ( convulsions ). these are rare cases of seizures . tell your physician if your family has ever had liver problems or heart failure . cinaccet accord pharmaceutical lowers calcium levels in your body . life threatening events and fatal outcomes have been reported in patients treated with low calcium levels ( hypocalcaemia ). you should be closely monitored by your doctor when taking cinecalcet acordpharma . you should tell your healthcare provider if any
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally . the tablets must be swallowed whole and are not to be chewed , crushed or crushed . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . patients with secondary hyperparathyroidism the usual starting dose for cina Calcet accord Pharma is 30 mg taken once a day . for children ( 3 to less than 18 years of age ), the usual dose for adults is 0 . 20 mg , taken once daily . when to take cinaccet accordchan take cinecalcet according to your doctor' s instructions . use in children and
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience numbness or tingling around the mouth , muscle aches or cramps and seizures , these may be signs that your calcium levels are too low ( hypocalcaemia ). if there are swelling of the face , lips , mouth ; tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . these side effects are usually mild and do not last for long . common ( might affect up to 1 in every 10 people people ). dizziness , light - headedness ; or dizzien ; these are usually short - lived . not known ( frequency cannot be estimated from the available data ) headache ; dizzillness . uncommon ( may
what cinacalcet accordpharma contains the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccet ( as hydrochloride ). the other ingredients are cellulose - crospovidone - magnesium stearate - film coating : hypromellose , titanium dioxide , triacetin , indigo carmine aluminum lake , iron oxide yellow . what cinecalcet acordpharma looks like and contents of the pack cinaculcet accord Pharma 30 mg film  reels are light green colored , oval shaped , approximately 9 . 65 mm x 6 . 00 mm in diameter , biconvex , film opa . tablet debossed with " cc4 " on one side and plain on the other side .
jentadueto contains two active substances , linagliptin and metformin . linaguiptIN belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of medicine called biguanides . it is used to lower blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping the body make better use of insulin . this medicinal product can be used alone or with certain other medicines for diabetes , such as sulphonylureas ( such as empagliflozin ), or insulin , which are also used for type 2 diabetic patients .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking jsentadueleto . if your doctor thinks you may be allergic , ask you doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if : you have severely reduced kidney function you have uncontrolled diabetes with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketoacacidosize is a condition in which substances called ' 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto is for oral use . you currently take metformin in combination with individual tablets of linagliptin and metformine . your doctor will tell you which strength of this medicine to take . taking this medicine will help you to control your mood and reduce the amount of an upset stomach . take one tablet a day . this will help to lower your blood sugar . it will also help you remember to take it . when to take this tablet , take it with or without food . do not break or crush the tablet . currently taking 5 mg linaguiptIN in the morning and 2 , 000 mg metform in the evening . starting jenteduet when your blood glucose is high , your doctor may prescribe this medicine together
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypogllycaedia is a very common ( may affect more than 1 in 10 people ) side effect with jenteduet plus sulphonylurea or with the combination jENTaduеto plus insulin . if your doctor determines that you may experience one of the above , tell your doctor straight away . your doctor may decide to reduce your dose of jsentadueleto . common ( MAY affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : keep this medicinal product in its blister in order for it to be as effective as possible . store in a refrigerator ( 2c 8c ). do not freeze . keep the bottle tightly closed in order not to damage the pack . does not use if the medicine is damaged or shows signs of tampering . this medicine does not require any special storage conditions . mail order or postal service . check this before you go back to your pharmacy . your doctor or pharmacist is responsible for correct storage of the product both before and during its use , as well as for correct disposal 
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 - 5 mg of linaguiptIN and 850 micrograms of metformine hydroch chloride - one jsentaduеto 2  . 3 mg /10 mg /1 , 000 mg film- coated device contains 2 mg of lagliptine and 1 , 1000 microgram of metFORMin hydrochaloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults . ecedent belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is for the treatment of hib in adults and adolescents 12 years of age and older who are infected with hiv and who are unable to take hiv medications . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). - in addition , e durant should not be used in combination with the following medicines : carbamazepine , doxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and riifapentine ( medicines for treating some bacterial infections such as tuberculosis ) methaemoglobin ( a group of medicines to prevent and treat tubercusis) omeprazole / esomeprazolе , or lansoprazol , pantoprazole , and rabeprazol
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults 18 years of age and over the recommended dose of edurant is one tablet once a day with water , with or without food . e during the day , your doctor may decide to increase your dose . children and adolescents e pendant can be taken with orwithout food , and at the same time each day . your doctor will tell you to take eDuring with or after food ; if your doctor has agreed that you should not take rifabutin , a medicine to treat some bacterial infections . taking ecedent with rfabutIN is not recommended . do not take more eenduring than the recommended dosage . 2 . take an antacid ( a drug used to treat diseases related to the
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience headache , nausea , difficulty falling asleep , insomnia and dizziness . these may be due to changes in your routine liver tests ( transaminase , increase in cholesterol and pancreatic amylase in your blood ), abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , and drowsiness , decreased appetite , sleep disorders , gastritis , depressed mood , night sweats . if you do not feel better or if someone else notices this , tell your doctor or nurse immediately . common side effects ( may affect up to 1 in 10 people ): headache ; nausea ; difficulty falling sleep ; insomnia ; dizzily . your doctor may need to change some of your routine
what edurant contains - the active substance is rilpivirine . each e - marketed tablet contains rillpiviral hydrochloride equivalent to 25 mg rilpivienne . -the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film  contains lacte monohydrat , and hypromellose 2910 ( 6 mpa . min ). tablet coat : titanium dioxide ( e171 ), macrogol 3000 , triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabetics either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  't respond normally to the insulin their body makes . rosinglit azone or metformIN work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . also , avand amet is used together with a sulphonylurea ( another medicine for diabetes ).
to help manage your diabetes , it is important to follow the advice given to you by your doctor , pharmacist or nurse . do not take avandamet if any of the following apply to you : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of other ingredients of avandаmet ( listed in section 6 ) if your doctor has told you that you have had a heart attack or severe angina if the above applies to you ( or you are not sure ), talk to your doctor or pharmacist before taking avand amet ( see section 6 for more information ). if : you have ever had : heart attack , severe angioedema , heart failure , or have had heart failure in the past if vous have severe breathing difficulties if used to have a type of liver disease if so , you
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose is 2 mg rosiglitazone and 1000 mg metformin . your doctor will increase your dose over a period of 1 to 8 weeks . the maximum dose is 4 mg  Rosiglitabazone + 1000 mg of metformine . this dose will be increased every 2 weeks , until your doctor tells you otherwise . take a tablet in the morning and evening with food . swallow the tablets whole with a glass of water . do not chew or crush the tablets . if your stomach is not being properly absorbed , you may experience indigestion , nausea , vomiting and diarrhoea . it is best to take your tablets at the same time each day .
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with avandаmet : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you get any of these symptoms . avand amet may cause lactic acidosis : an excess of lactic acids in the blood ( lactic Acidosity ) is a rare side effect seen with metformin . it is not known how well this side effect is due to the medicine . however , it is possible that a link may be involved in the development of severe kidney disease . symptoms of larceny ( a state of rapid breathing ) and cold symptoms , as shown by tests . the signs of
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . each tablet contains 1 mg rosinglit azone 500 mg metformine , and 2 mg  Rosiglitabazone 400 mg metformatin , but 2 mg isolatable rosivitazon 1000 mg metforin ; and 4 mg isalaytable  rosimg rosiltaone 1000 mg of metforminer , yet 4 mg areolayed rosifazone 1000 mg / metform in the blood . the other ingredients are : sodium starch glycollate ( type a ), hypromellose ( e464 ), microcrystalline cellulose ( cb4 ), lactose monohydrate ( see section 2 ). what a
clopidogrel mylan contains clopogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopinogreil mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a potentially life - threatening condition , such as atherothrombosesis , as well as atHERothrombitic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrelly mylan to help prevent blood from forming .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking clopinogreil mylan . if any of these apply to you ( or you are in any doubt at all ), if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . the risk of severe liver disease is increased when taking ' clodogrela mylan take special care with cloclopidegrel mythlan : if the patient is at risk of bleeding such at any time , such as due to a mental condition that puts you at risk for internal bleeding ( such as such as the stomach ulcer ). the patient has a blood disorder that makes you prone to internal
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , or two 75 mg tablets of clapidogril myl per day as described above . you should take clopogrell mylan for as long as your physician continues to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes , itching and blisters of the soil . this may be the signs of an allergic reaction . your doctor will tell you what to do if your medicine works . you should stop taking clopidogrel mylan and contact your physician immediately . the following side effects have been observed with
what clopidogrel mylan contains - the active substance is clopogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). - other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clodogreil mylan contain hydrogenated castingor oil ') and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( i 172 ), yellow iron oxide , and talc and macrogol 3000 . what clapidogral mylang looks like and contents of the pack the film  coated tablet is pink , oval , biconvex and marked with ' 3000' on
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease with low platelet count ( thromocytopenia ), in adults who have undergone a medical procedure to prevent bleeding which may require the production of platelets . platelets are blood cells that help the blood to clot and so help to stop bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - to prevent blood clots from forming in the veins or arteries . warnings and precautions talk to your doctor before taking dop Telet . blood : to prevent and treat blood  clotes . tell your doctor if your blood coagulation is not working properly and you have cancer . - you are taking the contraceptive birth control pill or hormone replacement therapy . you have recently had surgery or are injured . doptelt is not recommended in women 23 - are overweight . it is not known whether dopelet is safe and effective in women with advanced chronic liver disease . children and adolescents doptret is therefore not recommended for children and teenagers under 18 years of age
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will tell you the dose to take . - the usual dose depends on the type of procedure you are having . you usually have a procedure started with 5 mg / 8 mg of doptelet per day . your doctor will decide the dose that you need . when to take dop Telet take dopptelet in the morning , with or without food . take the dose in the evening ( morning and evening ) at about the same time each day , for example one or two glasses of water . this will be done in one or more of the following order : - doses of dooping 20 to 40 mg , 60 mg or 5 mg once a day - depending on your platelet counts , your doctor may increase or decrease your dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ): feeling tired common ( might affect upto 1 in 100 people ), low red blood cell count ( anaemia ) or blood clot in the portal vein ( blood vessel ) which carries the liver and intestines . common ( MAY affect up - upper abdominal pain , swelling bone pain ; muscle aches ; fever ). reporting of side effects 39 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine you are using .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatotroooopag maleate equivalent to 20 mg avataropag -the other ingredients are : lactose monohydrate ( see end of section 2 ), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , partially hydrolysed , titanium dioxide ( e171 ), iron oxide yellow (  e172 ). what dopet looks like and contents of the pack dopelet 20 mg film  film – coated tablets are pale yellow , round and rounded . they are marked with ' 20 mg' on one side and ' t20 ' on the other side .
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these help doctors to get pictures of the heart arteries , which help them to keep a steady heart rate . they also help to measure the muscles of the central nervous system ( heart ) which help the doctor decide whether to carry out repairs . rapistcan is used for a type of heart scan called a ' myocardial perfusion imaging ' where the scan contains a radioactive substance called , called  a' radiopharmaceutical ' and are sent to the hospital to obtain these images . the muscles in the heart are scanned using a treadmill to help find out more about your heart . getting a scan is usually done using ' radioactivity ', which helps the doctor determine how well your heart is working . how rapissecan works rap
do not use rapiscan - if you have slow heart rate , if your heart does not work properly ( for example , high degree heart block or sinus node disease ), if the heart does have a problem with a pacemaker , or if chest pain ( unstable angina ) persists for a long time . warnings and precautions talk to your doctor before treatment : - low blood pressure ( hypotension ) or heart failure - you are allergic to regadenoson ( see section 6 , " what you need to know before you take rapistan "). if any of the above applies to you , do not take a dose of rapican . take special care with rapissecan : tell your doctor if : you have , have had a recent serious heart problem ( such as a heart attack ) 
rapiscan will be administered to you by a doctor or nurse who is experienced in the care of your heart and blood pressure . rapican will always be administered intravenously ( into a vein ) with a dose of 400 mg / ml solution the injection will take approximately 5 - 10 minutes . the dose you will receive is based on your weight . it is used as an injection of sodium chloride 9 mg pfu / kg / min ( 0 . 9 %) solution for injection or a radiopharmaceutical in a hospital . your doctor will work out your dose of rapissecan based upon your heart rate . this will depend on your heart speed and bloodpressure . during the rapistcan injection , your doctor may change your heart pace . monitoring of blood pressure during and after the ripiscan injection your doctor should also
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects reported following the rapican injection are usually mild to moderate and do not last for more than 30 days . therefore , you should not receive any treatment for side effects such as sudden stopping of the heart or damage to the heart ( e . g . heart block , caused by a disorder of the liver ' s electrical signal ), rapid heart beat low blood pressure fainting / mini strokes ( weakness of the face or inability to speak ) have been reported with rapistcan . most patients have experienced a stroke or cerebrovascular accident and have experienced an allergic reaction such as rash , wheals / weals or mouth sores . they usually develop in a rapid fashion . uncommon cases of severe or severe , serious infections , fits (
the active substance sildenafil belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penius . when you get sexually excited , you will find that you have erection at some time . viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , hard - to - sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if these medicines are used for treating angina pectoris ( or " chest pain "). if the medicines being given to you by injections or nitric oxide donors such as amyl nitărite (" poppers "), as the combined may also lead to the combination to lead to another dangerous fall of your blood tension . - in combination with riociguat , this drug is used to treat pulmonary arterial hypertension ( i . ex ., high blood pressure in the lungs ) and chronic thromboembolic pulmonary hypertension ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra film - coated tablets or viagra orodispersible tablets . if necessary , your doctor may tell you to take a different dose . take viagra at about the same time each day . swallow the tablets with a glass of water . do not take more viagra than your doctor tells you to . viagra will only help you to get an erection if sexually stimulated . taking viagra will usually only help to keep you awake and keep you going to sleep . it is recommended that you take viagra for as long as your physician continues to prescribe it . this is because taking viagra may make you feel sexually excited . for how long you should take viagra , you should tell your
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat ; chest pains - get in a semi - sitting position and try to relax . you should use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). if an errect is not treated , it should be treated at least every 4 hours
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , capsule - shaped and have a marked " s25 " on one side and " roche " on the other . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopine receptors in the brain . stimulation of the dopam receptors triggers nerve impulses inthe brain that help to control body movements . siffrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - alleviate the symptoms in moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of these apply to you . siffrol should not be used :- - you suffer from any medical conditions or symptoms , especially any of those that you might have kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinies are visual . however , some may be serious . dyskinesia ( e . exaggerated , abnormal , uncontrolled movements of the limbs ). if your doctor has prescribed for you the treatment of advanced parkinson ' s disease , or if levodopa
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will advise you on the right dose . you can take sifrol with or without food . swallow the tablets with water . parkinson ' s disease the daily dose is to be taken divided into 3 equal doses . during the first week , the usual dose is 1 tablet of sIFrol 0 . 088 mg twice a day ( equivalent to 0. 264 mg daily ). after this first week your doctor may increase your dose to 1 tablet . ifrol 0- 088 - 0x 264 is repeated every two weeks . your doctor will increase your daily dose to a maximum of 0 ( 0 to 058 mg three times a week or if s - 1 ) tablet of the same dose
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect 1 in 1 , 000 people very rare may impact up to 10 , 10  ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects during treatment with sifrol : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there )
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 dihydrochloride , equivalent to 0, 35 mg . one tablet contains approximately 0 7 mg pramipeexol as 0
emadine is a medicine for the treatment of seasonal allergic conjunctivitis of the eye ( s ) ( a group of allergic conditions that affect the inside of the eyes ) caused by the allergic reaction . allergic conjonctivits may occur when some materials ( allergens ), including household chemicals , are present in the allergic reactions , causing itching , redness and swelling of the surface of your eye . these reactions usually do not last long and you may feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using e madine . children and adolescents do not give this medicine to children below the age of 3 years because it contains benzalkonium chloride equivalent to  - 20 mg / ml ( see section 6 " what ema - do not mix edine "). in clinical trials , emailine has not been tested in children under the age range of 6 years . no data are available on the safety and efficacy of emagine in this group . other medicines and emogine tell your doctor or pharmacist if vous are taking , have recently taken or might take any other medicines . emeine with
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . use this product once a day in both eyes . see section 3 . instructions for use : follow these instructions carefully and ask your doctor to explain how to use emadine . - 1 . do not use for 2 weeks before you start using e madine , you should only use it for 1 week after you have used the ema - tamper evident dropper . how to remove the tin canisters : wash your hands . hold the bottle , removing the cap . after cap is removed , remove snap collar . holding the bottle hold the thumb and titration card , in front of your head . tilt your head back .
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , but most of them are temporary . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects( may affect more than 1 in 100 people ), effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ): allergic reactions , hives , redness of the eye and eye pain when the drops are put into the eye or when the eye is irritated , clouding of the lens , increased tear producing particles in the transparent layer at the back of the pupil
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . in order to protect from moisture , emaîtres should be used immediately .
what emadine contains - the active substance is emastine . each vial contains 0 . 5 ml of difumarate ( 0. 5 mg / mL ). - other ingredients are benzalkonium chloride , trometamol , sodium chloride ( see section 2 ). the other ingredients ( excipients ) are hypromellose , purified water , hydrochloric acid and sodium hydroxide ( to adjust acidity levels ( ph levels )) and what - e madine looks like and contents of the pack edine is a liquid ( a solution ) supplied in a 5 - 10 mml plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetirasetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepipsy , to treat a certain form of epilexia . epilepianis is a condition where the patients have repeated fits ( seizures ). the epilemplepsy is confined to one side of the brain , but could thereafter extend to larger areas on both sides of the mind ( partial onset seizure with or without secondary generalisation ). in this case levetiratetam has been given to you by your doctor to reduce the number of fits . as an add - on to other antiepicileptic medicines to treat partial - onset seizures with or after secondary generalised seizures .
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetirasetam actingavis as it may cause kidney problems . tell your doctor if vous notice any slow down in the growth or unexpected puberty development of your child . a small number of people being treated with anti - epileptics such as levetistetam actsavis have had thoughts of harming or killing themselves . you should contact your doctor immediately if your doctor thinks any symptoms of depression and / or suicidal ideation . the following side effects may occur : abnormal thoughts , feeling irritable or reacting more aggressively than usually , or if there are changes in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is usually taken twice each day - once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ) general dose : between 1 , 000 mg and 3 ,000 mg each day when you first start taking levetiretam actingavis , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1  , 500 mg each week . add - on therapy dose in adolescents and teenagers ( 12 to 17 years ) weighing 50 kg or more general dose: between 1,000 mg and 3,000 mg general doses : when you start taking it as a single
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests , an increase in a type of white blood cell ( 56 % eosinophilia ) and enlarged lymph nodes ( drug reaction ) a higher number of red blood cells ( leukopenia or ecg )
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetiragetam actsavis 250 mg contains 250 mg of levracetm . levetiretam actionavis 500 mg contains 500 mg of the active ingredient levetistetam ( as mesilate ). levetiratetam actingavis 750 mg contains 750 milligrams of leveracet am . each tablet of Levetiracem actavises 1 , 000 mg contains 1  ,000 mg of duvetirace. the other ingredients are crospovidon , povidone , silica colloidal anhydrous and magnesium stearate .
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incruses ellippta is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become blocked , leading to breathing difficulties . difficulties in breathing are added by tightening of the muscles around the airway , and this medicine blocks the tightener of these muscles . this helps to open the air passages and improve your breathing difficulties and reduce the effects of copd on your everyday life . ellipate should not be used to relieve a sudden attack of breathlessness or wheezing .
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incruses ellippta . if any of these apply to you ( or you are not sure ), talk to you doctor . talk to a doctor if : you have asthma ( do not using increse incruset ellipata to treat asthma ) you have heart problems you have an eye problem called narrow - angle glaucoma you have enlarged prostate , difficulty passing urine or a blockage in your bladder you have severe liver problems talk to the doctor : if anything happens to you immediately after using incras
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use incluse an inhaler every day , as instructed by your doctor to use it for as long as your condition improves . do not use this product to relieve a sudden attack of breathlessness or wheezing . if this attack occurs you must use a quick - acting reliever inhalER ( such as salbutamol ). how to use the inhalers see ' step
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of the mucous membranes ) uncommon ( might affect upto 1 in 10 children ): faster heart beating painful and more frequent urticaria ( may represent a bladder infection ). common cold infections of nose or throat cough / feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the inhaler label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaled tray tightly closed in order to protect from light . once the tray has been opened , the incruse ellipta can be used for up to 6 weeks when stored in the refrigerator . after the inhaler has been removed from the refrigerator and has reached room temperature , it should not be put back in the fridge . write down the date on the label of the inhabitant on the outer carton of the tray , indicating that the ink has been left in the tray and should be disposed of . if you store in an unopened tray 
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram ) umeclinium bromide . - other ingredients are lactose monohydrate ( see section 2 under ' incruses ellippa contains lactoses ') and magnesium stearate . what increse incrussanta looks like and contents of the pack incrussé ellipeta is an inhalations powder , pre - dispensed . the ellipata inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peel
nucala contains the active substance mepolizumab , which is a monoclonal antibody , a type of protein that is normally found in the body when it is used to treat severe asthma in adults , adolescents and children aged 6 years and above . severe asthma may occur because of the presence of many eosinophils , another type of white blood cell that mainly flutters around the lungs . eopenia is essentially a " white blood cells " that collect in the blood . this is called eeoSinophilic asthma . asthma nucalа is used in adults to help prevent asthma attacks and reduce the number of medicines you take each day ( called high dose inhalers ) to control your asthma , and these medicines can be medicines taken alone or together with medicines called oral corticosteroids . nucale is used when your
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine has been shown to increase the risk of worsening asthma in some patients 58 having asthma - related side effects , since their asthma has not improved after nucalа treatment . if your asthma is not controlled with nucalala treatment , tell your doctor straight away . allergic reaction at injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more details about possible side effects and how to prepare yourself for the next dose . you may be more likely to have a similar reaction if they are similar to nucale . parasitic infections nucalca may reduce
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) per kg body weight injected once a week . the dose may be increased or decreased by up to 1 microgram ( 100 milligram  ) given once yearly . use in children and adolescents the pre - filled pen will be injected by your doctor . your doctor will show you how to inject nucalа . duration of treatment with nucal varies from person to person , but you should continue to use nucalka as long as your physician has told me . if , after you have started the treatment , your doctor may decide to stop using nucalá . it is very important that you continue to inject in the same way
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( may affect up to 1 in 10 people ). they usually occur within a few days or weeks after the injection . sometimes symptoms may include symptoms such as chest tightness or cough difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have had a reaction similar reaction to nucale . if this happens you should contact your doctor . it is important that you immediately inform your doctor about any possible signs of a possible reaction . an already existing reaction may occur with nuca . other side effects include : very common ( may effect more than
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . use the nucale pre - filled pen within 7 days after first opening . discard the used pen 7 days later . keep the pen in the outer carton in order to protect from light .
what nucala contains the active substance is mepolizumab . 1 ml contains 100 mg mepolizamab in 1ml . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ; polysorbate 80 , edta disodium dihydrate and water for injections . what nuCALa looks like and contents of the pack nucale is presented as a powder and solution for solution for injection ( 1 mg ). it is supplied as : a pack containing 1 single dose or a multipack containing 3 packs of 1 single - dose . not all pack sizes may be marketed .
what ninlaro is nINlarro is an anticancer medicine that contains the active substance ixazomib , also known as a ' proteasome inhibitor '. what ' ninelaroooo is used for nninlaaro contains the medicine ', which is used to treat adults with a cancer of the bone marrow called multiple myeloma . ixizomibe is used in cell survival to prevent myelama cells developing a lot of proteins called proteasoms involved in controlling cell growth . what is 'ninlanaro used for the active ingredient in nylaron is used when multiple myomomuma is not well controlled . the active ingredients of n inlararo are lenalidomide and dexamethasone 
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking nninlaaro and during treatment if any of these apply to you . if not taken , tell your doctor immediately . before starting nINlaroooo , make sure that you tell your healthcare professional if : you have an increased risk of bleeding , persistent nausea , vomiting or diarrhoea you have nerve problems you have ever had tingling , numbness , swelling or a persistent rash you have liver or kidney problems you are due to have treatment with ninelarro and then restart treatment . during treatment your doctor will perform blood tests to check that you have enough blood cells . children and adolescents
ninlaro is used for the treatment of multiple myeloma in adults . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . ninelarro is taken once a day , in combination with lenalidomide , a medicine that works in tandem with dexamethasone , an anti - inflammatory medicine . your doctor will tell you for how long you should take nninlaaro . lenaldomide and dexamhasone are taken together on a weekly basis for the first 4 - week cycle . you should start taking nINlarre once - on the same day of the week , on the first day of each week . during the first 3 weeks of treatment , your doctor may decide to continue to give you lenl
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that may easily bruise nausea , vomiting , diarrhoea , numbness , feeling of tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet  ( peripheral oedema ) skin rash , itchy all over the body rare side effects these may affect up to 1 in 1 , 000 people injected ninlaro alone and are thought to be related to the smoothest part of the body ( rhabdomyolysis ). if any of these side effects causes you problems , talk to your doctor . this includes any possible side effects not listed in this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or on the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . after first opening , use within 30 . protect the capsule from light and moisture . this medicine does not require any special temperature storage conditions . any damage or signs of medicine packaging should be inspected .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg of ixizomibe . - each capsule provides 2 , 3 mg ixazamia ( as 3 . 1 mg xazomimib citrate ). - other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( EE172 ). printing ink contains shellac , propylene glycol , potassium hydroxide and black iron oxide . what naglaaro looks like and contents of the pack nINlarou 3 mg hard capsules are light orange , capsules with ixozomiblich and 3 mg film - coated tablets , with black ink
do not use palforzia : if you are allergic to peanuts or arachis hypogoea . do not give palforizia to children and adolescents aged 4 to 17 years . warnings and precautions talk to your doctor , pharmacist or nurse before you are given palfor zia if : you have had a prior history of treatment with peanut allergy . you have peanut ( desensitisation ) to peanut ( peanut ) products . palforzaa may cause allergic reactions after you have been given pal forzia and food allergies should be disposed of in accordance with local requirements .
do not take palforzia if you are allergic to peanut allergy or any of the other ingredients of palforzaza ( listed in section 6 ). allergic - if your asthma is not controlled by medicine or medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking palfor zia . if there is anything you do not understand , ask your doctor or pharmacist to explain . do not use palforza : if - you have a problem swallowing , or if it is a case of long term problems with your digestive system . tell your doctor right away if any of these apply to you . you have been told that you have or have had a severe mast cell disorder ( severe or life - leading anaphylaxis ) and have been treated for 60 days without treatment with palforziea , you should stop taking pal for
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . warnings and precautions talk to your doctor before taking palforzia : if your asthma is not controlled or allergic reactions ( anaphylaxis ) occur ( see section 3 , ' what you need to know before you take palforizia '). initial dose escalation your doctor will perform these treatment phases as scheduled . the initial dose delamination and up - dosing phases are one and a half weeks without palforziea to work . if treatment with palforzaa is delayed , your doctor may recommend that you start taking pal forzia after desensitisation . this will happen on the day you are feeling unwell , or on the same day as your asthma . initial dose elevation the initial
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor straight away if you have any of the following symptoms after taking palforzaa . they could be signs of the reaction : trouble breathing - throat tightness - feeling of fulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - extreme stomach cramps or pain - vomiting , diarrhoea - sudden severe flushing or itching of the skin palforizia can cause problems with the stomach and digestive system , including problems with digestion , weight gain , weakness , pain , swelling , redness , and pain when swallowing . this can also be a sign of severe muscle cramps and pain . -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . this medicine must be used immediately after dilution . dispose of this medicine if you notice any hard lumps of powder .
what palforzia contains the active substance is palforza 0 . 5 mg . each capsule contains 1 mg , 10 mg or 20 mg reconstituted / dissolved . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforizia 100 mg / mg oral powder in capsules can be opened , without opening microcrystalline microcrystalline cellulose , coloidal an hydrous silic , and magnesium STEarate paulforziA 300 mg : redissolved / oral powder sachet microcrystalline capsule , all containing colloidal anhydrous siliconca , as well as magnesium sterarate . what pal forzia looks like and contents of the pack palforciaa is presented as a white to off - white , beige oral powder as an alternative to initial dose
zerene belongs to the class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . zerent will usually be given to you by your doctor or nurse . duration of treatment your doctor will decide whether to continue or not to give you zerènee if you have problems sleeping .
do not take zerene : if you are hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerente sleep apnoea syndrome . take special care with zerence and tell your doctor if this happens to you . do not stop taking zerenne sleep , as it may cause short periods of short periods , if your kidney or liver problems are not working properly , or if : you have myasthenia gravis ( very weak or tired muscles ), you have severe breathing or chest problems . children and adolescents do not give this medicine to children under 18 years of age . this is because zerenede has not been studied in children and teenagers . you will not be given zerense if any of its active substances cause undesirable effects . your doctor may ask you to stop taking any medicine or to
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , preferably in the morning when you are having difficulty falling asleep . you should not take a second dose within a single night . elderly ( over 65 years ) with mild to moderate liver problems the usual starting dose is 65 mg once daily , followed by a 5 mg capsule . if your doctor considers you to be having mild to medium liver problems , take the capsule at the same time each day . do not take more than one capsule each day as this may make you feel cloudy , disorientated , or if there is a possibility that you may have an overdose . this may cause you to become increasingly drowsy and may lead to a coma . stop taking zer
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 person in 1 , 000 ) rare ( affect impacts 1 to10 users in 10 10 ,000 ) very rare ( effects affect less than1 user in10 , 10 . 0 , 10,000 ) not known ( frequency cannot be estimated from the available data ) as for all medicines used , the following side effects have been reported : very common : side effects that may occur with zerent : drowsiness ; memory difficulties ; sensations like tingling 
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ) ( u - 1701 ), titanium dioxide ( i171 ). the printing ink contains : gelatin , titanium dioxide ; red iron oxide (  172 ), yellow iron oxide , black iron oxide [ e172 ] ( k29 / 32 ), sodium launryl  sulfate ; silicon dioxide ( type ii ( s - 13350 )). the ink is composed of shellac , lecithin , simethicone and yellow iron
